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EVALUATION OF THE EFFECTS OF VITAMIN K ON GROWTH PERFORMANCE 
AND BONE HEALTH IN SWINE 
 
 
 
 The role of vitamin K in the blood clotting cascade has been well 
documented. Vitamin K has recently been implicated in improving bone health. The 
current studies were conducted to determine the effects of vitamin K in diets with and 
without mycotoxin contaminated corn on growth performance, bone characteristics, and 
related blood metabolites in pigs from weaning to market. Menadione sodium bisulfite 
complex (MSBC, 33% vitamin K) was chosen as the source of supplemental vitamin K 
because it is the most common form fed to swine. Vitamin K was tested at 0, 0.5, and 2.0 
ppm in a corn-soybean meal based diets on two generations of pigs to evaluate any time 
and dose responses. The first generation of pigs was subjected to mycotoxin 
contaminated corn in the nursery phase to test for any interactions between the toxins and 
vitamin K. The addition of 0.5 ppm vitamin K reduced (P < 0.0001) prothrombin time. 
No additional decrease in prothrombin time was detected when increasing vitamin K 
inclusion from 0.5 to 2.0 ppm. With regard to growth performance, daily gain, feed 
intake, and feed efficiency were unaffected (P > 0.10) by supplemental vitamin K. 
However, pigs fed mycotoxin contaminated corn ate less (P = 0.005) and grew slower (P 
= 0.015) compared to those receiving good corn. The addition of vitamin K did not 
alleviate the negative growth effects in response to corn type. Vitamin K did not affect 
bone characteristics (P > 0.10), blood Ca (P > 0.05) or OC (P > 0.10). Other than blood 
clotting it does not appear that dietary vitamin K provides any additional benefits at these 
levels of inclusion and stages of swine production. 
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CHAPTER 1. Introduction 
 
It is estimated that humans domesticated pigs between 6000 and 9000 years ago 
(Mellen, 1952). The purpose for their domestication was similar to that of other animals 
which was to provide food. Since that time pork has been a staple of many civilizations. 
In the U.S. from 1970 to 2001, per capita consumption of pork (22.10 and 22.05 kg, 
respectively) has remained relatively constant (Pork Industry Handbook, 2007). If the 
trend of decreasing number of swine farms continues, producers must become more 
efficient in order to meet the world’s demand for pork. A better understanding of the 
nutritional needs of the pig is one means of achieving this goal. 
Many of the challenges of modern pig production systems are related to nutrition. 
The objective of the feeding program is to ensure that all animals consume sufficient feed 
on a daily basis to meet their energy and nutrient requirements for growth or 
reproduction. A balanced swine diet should contain the necessary nutrients in the correct 
proportions to nourish the animal for proper growth. Diet formulation should consider 
amino acids, minerals, and vitamins with enough energy to drive growth and any 
reproductive needs. Fat is required to supply essential fatty acids, but it is usually 
adequate in practical diets without supplementation. Water is an important nutrient and 
normally is provided with free access, so it is not considered for diet formulation 
purposes. A palatable energy source like corn can be transformed into a nutritionally 
balanced diet if nutrient deficiencies are corrected by using additional ingredients. A 
properly balanced diet should promote feed intake in an attempt to maximize growth. 
However, it is not as simple as just adding ingredients. New functions and properties of 
nutrients are being discovered, many of which we still do not understand today. This new 
information creates a shift in importance changing how nutrients are ultimately included 
in diet formulation.  
The volatility of corn prices has prompted inclusion of alternative feedstuffs to 
maximize least–cost feed formulation. This has had a significant impact on swine diets. 
In addition to price, the increasing prevalence of mycotoxins in corn is of major concern 
in the swine industry. Significant economic losses have been experienced over the years 
due to feed containing mycotoxins (Vesonder and Hesseltine, 1981). Detrimental effects 
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of mycotoxins in swine include feed refusal, poor feed conversions, lower productivity, 
and immune suppression (Grove et al., 1969). Attempting to alleviate the detrimental 
effects is often difficult because symptoms can be hard to identify and/or prevent 
depending on the toxins present. The use of supplemental nutrients that would be 
beneficial in increasing the utilization or efficiency of this less desirable corn (or other 
contaminated ingredient) would be of great value to the industry. 
The efficacy of supplementing swine diets with vitamin K is in question, 
especially with the current state of the corn supply. Vitamin K was the last of the fat 
soluble group of vitamins to be discovered and is available in multiple natural and 
synthetic forms. The predominant function of vitamin K in the body is to gamma-
carboxylate peptide bound glutamine and glutamate residues. Gamma-carboxylation 
confers Ca binding capacities to the glutamyl residue containing proteins, facilitating the 
formation of Ca bridges essential for proper function. Known vitamin K dependent 
proteins include clotting factors, coagulation inhibiting proteins, and osteocalcin in the 
bone. 
Initial studies dismissed the idea that vitamin K could have an impact on growth 
performance in swine. Two studies have been conducted with the intent of determining 
the effects of vitamin K on growth performance (Brooks et al. 1973; Seerley et al. 1976).  
However, it is unclear how the current requirement was determined from those studies 
because the levels of supplementation used were all greater than the suggested 
requirement. What was clear was that the addition of vitamin K was effective in reducing 
prothrombin time. This was especially evident when pigs were fed ingredients 
contaminated with aflatoxin, a coumarin derivative (Osweiler et al., 1970).  
Nutritional research is about more than just feeding the subject with growth as the 
end result. Growth performance might be the main focus of swine producers, but 
nutrition also influences many aspects of health and well-being. Another possible benefit 
of vitamin K other than growth, though still nutrition related, is more health and 
production focused. Lameness (defined as crippled, physically disabled, impaired, or 
weak in the feet or legs) is a major cause of culling in swine breeding herds (Dagorn and 
Aumaitre, 1978; Friendship et al., 1986). Bone conditions are just a few causes of 
lameness. Since osteocalcin is a vitamin K-dependent protein in the bone, 
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supplementation of vitamin K has the potential to reduce the incidence of lameness by 
improving bone health. Research in this area is not only important for the swine industry 
but also for adult women suffering from osteoporosis.  
Therefore, the objective of the current research was to obtain a basic 
understanding of how the presence of vitamin K in typical U.S.-type diets affects growth 
performance and bone health of modern swine (Chapter 3). The goal was not to set or 
redefine the suggested requirement, but rather set a benchmark for future human and 
animal research to be based upon. 
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CHAPTER 2. Literature review 
 
2.1. Lameness in swine 
Lameness can manifest in swine that are crippled, physically disabled, impaired, or weak 
in the feet or legs. Major causes of lameness include bone conditions (osteochondrosis, 
osteomalacia, osteoporosis, and fractures), skin and claw lesions, arthritis, and physical 
trauma (Fredeen and Sather, 1978; Dewey et al., 1993; Kroneman et al., 1993; Bonde et 
al., 2004; Heinonen et al., 2006, 2013; KilBride et al., 2009, 2010; Pluym et al., 2013). 
Lameness is the major basis for culling in swine breeding herds (Dagorn and Aumaitre, 
1978; Friendship et al., 1986) and is the reason for 8.8, 9.7, 10, 13.1, 15, 15, and 16.9% 
of culled animals in Finland, Belgium, Canada, Norway, Denmark, United States, and 
England, respectively (Gjein and Larssen, 1995a; Bonde et al., 2004; Heinonen et al., 
2006; Kilbride et al., 2009; Schenk et al., 2010; Pluym et al., 2011). Therefore, lameness 
is of major concern to the swine industry as it reduces the reproductive lifespan of the 
breeding herd. A lame sow generally produces fewer than 3 litters, whereas a non-lame 
sow produces 3.5 litters before removal from the herd (Anil et al., 2009). Additionally, 
nursing piglet mortality is reported to be 15.3% higher for lame sows than non-lame sows 
(Anil et al., 2009).  
The environment in which the animals are housed is a contributor to lameness. 
Lameness is present in sows housed individually (stalls) and in groups (Anil et al., 2007; 
Karlen et al., 2007). Lameness in group housed sows is a result of aggression from other 
sows during mixing (Gjein and Larssen, 1995b; EFSA, 2007). Lameness in individually 
housed sows has been attributed to lack of exercise and more time spent lying down than 
standing or walking (Perrin and Bowland, 1977; Fredeen and Sather, 1978). In both 
housing types, concrete slatted flooring caused more incidences of lameness compared to 
solid flooring with some kind of bedding (Baxter et al., 2011). 
Nutrition also plays an important role in lameness. Diets must be adequate in Ca 
and P to promote good bone health and are probably the obvious nutrients related to bone 
health. They will be discussed in more detail in a later section. Feed intake and feeding 
management must be monitored because being in excess body condition (overweight) has 
been linked to lameness in sows (Knauer et al., 2007). Toxic levels of Se fed to sows 
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during gestation caused heamorrhagic claw lesions in their piglets (Mensink et al., 1990). 
Two studies that fed supplemental Cu, Zn, and Mn found a reduction in severity and 
incidence of claw lesions (Anil et al., 2009; Anil, 2011). Foot lesions in reproducing 
swine can be reduced by adding biotin to diets (Brooks et al., 1977; Penny et al., 1980; 
Money and Laughton, 1981; De Jong and Sytsema, 1983; Bryant et al., 1985a and 1985b; 
Kornegay, 1986; Greer et al., 1991; Watkins et al., 1991). However, there are also a few 
studies that contradict these results concluding that supplemental biotin does not improve 
foot health and reduce lameness (Grandhi and Strain, 1980; Kornegay and Thomas, 1981; 
Calabotta et al., 1982; Arthur et al., 1983; Hamilton and Veum, 1984).   
Slevin et al. (2001) concluded that dietary protein levels do not affect bone 
strength or mineral density of gilts. However, research in humans has indicated that both 
high and low levels of protein in the diet cause negative effects on bones resulting in 
lameness. Low protein diets decreased bone mass and strength (Bonjour, 2005) while 
high protein diets reduced Ca absorption (Lutz, 1984). Protein might not be directly 
beneficial for bone health but it is needed for cross-linkage of collagen which occurs 
during bone remodeling (Heaney and Layman, 2008). Dietary lipid content and type 
might also be important because high polyunsaturated to saturated fatty acid ratios can 
improve osteoblast formation, collagen cross-links, and bone mass in pigs and other 
species (Blanaru et al., 2004; Liu et al., 2004; Corwin et al., 2006). 
 Lameness is an issue in modern swine production. Many nutrients have 
been implicated in affecting structural soundness or “lameness”. However, these studies 
are primarily in humans. There is a relative lack of information with respect to swine with 
the exception being biotin. Additionally, the research dates back to the 1980’s and should 
be updated using modern animals. It may be acceptable to infer that any nutrient that can 
affect a nutrient already known to be involved in bone or foot health, that itself has not 
been examined, could potentially have beneficial effects itself. Therefore, it is reasonable 
to believe that vitamin K might have the potential to improve structural soundness and 
possibly reduce culling rates due to its ability to affect the fate of absorbed Ca through γ-
carboxylation of OC. 
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2.2. Vitamin K 
2.2.1. Background 
“Vitamin” is a physiological term rather than a chemical term, expressing a 
certain physiological activity that is related to the organic substances responsible for this 
activity. Vitamin activity may be due to a group of chemical compounds, usually related 
structurally to one another (vitamers). The term was coined by the Polish biochemist 
Casimir Funk in 1912 and was originally “vitamine" because it was thought that the 
compound was a “vital amine”. When broken down, vita means life. Amine was used 
because they were thought to contain amino acids. The terminal -e was ultimately 
removed; -in was acceptable because it was used for neutral substances of undefined 
composition. Vitamins can be divided into two categories; those that are soluble in fat 
and those that are soluble in water.  
Vitamin K was the last of the fat soluble group of vitamins to be discovered. Its 
discovery started when chicks fed ether-extracted, purified diets developed a bleeding 
syndrome (Dam, 1929; Holst and Halbrook, 1931). Dam and Schonheyder (1934) 
managed to isolate vitamin K from green leaves and vegetables and determined that it 
could be synthesized by intestinal microflora. A few years later, vitamin K1 and K2 were 
isolated from common feed ingredients (McKee et al., 1939; Binkley et al., 1940). 
 
2.2.2. Chemical structure and forms 
The structure of vitamin K can be divided into two parts. First, there is a 
napthoquinone ring structure which is comprised of two 6 sided rings. The second 
component is a side chain composed of isoprenoid units. Vitamin K exists as two natural 
forms and multiple synthetic forms. Phylloquinone (K1, Figure 2.1) is the natural form 
synthesized by plants and is a component of chloroplasts.  Menaquinone (K2, Figure 2.2) 
is the natural form synthesized by bacteria. Menaquinones are often abbreviated MK-n 
where n is the number of isoprenoid units in the side chain (C5H8, see parenthetical 
structure from Figure 2.2). The distinction between the two natural forms lies in the 
length of the side chains, which contain repeating isoprenoid units, and the degree of 
saturation of the side chains. Phylloquinone has three isoprenoid units where 
menaquinone has been identified containing anywhere from four to thirteen. The side 
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chain of phylloquinone only contains one double bond located in the first isoprenoid unit. 
Each isoprenoid unit of menaquinone contains a double bond. The tissues of animals 
ingesting plant materials have been shown to contain phylloquinones as well as 
menaquinones. Therefore, there must be some interconversion of the side chains and it is 
thought that bacteria possibly play a role in this process. Menadione (Figure 2.3) is the 
structure upon which the synthetic forms of vitamin K are built. Menadione is the base 
ring structure (2-methyl-1,4-napthoquinone) found in phylloquinone and menaquinone. 
Three stable feed grade forms of menadione have been developed; menadione sodium 
bisulfite (MSB, 50% menadione, Figure 2.4), menadione sodium bisulfite complex 
(MSBC, 33% menadione), which is the same as MSB but has an additional menadione 
associated with the sodium ion, and menadione pyrimidinol bisulfite (MPB, 45.5% 
menadione, Figure 2.5). Menadione sodium bisulfite is limited by its instability in certain 
matrices. Menadione supplements in premixes and diets containing choline chloride, 
trace minerals, high moisture, and alkaline conditions can lose up to 80% of their activity 
over 3 months (Coelho, 1991)  However, when excess sodium bisulfite is available it 
crystallizes into a complex (MSBC) with greater stability making it better suited as a 
vitamin K source in animal feeds. 
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Figure 2.1. Chemical structure of the naturally occurring plant form of vitamin K1, 
phylloquinone. 
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Figure 2.2. Chemical structure of the naturally occurring animal form of vitamin K2, 
menaquinone (n = 4-13). 
 
 
O
O
CH3
 
 
Figure 2.3. Chemical structure of the synthetic form of vitamin K, menadione. This 
structure is used as the backbone for all other synthetic forms. 
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Figure 2.4. Chemical structure of menadione sodium bisulfite. 
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Figure 2.5. Chemical structure of menadione pyrimidinol bisulfite. 
 
 
2.2.3. Dietary sources 
To understand the relative usefulness of a source of vitamin K it is important to 
describe what is considered “adequate”. The Food and Nutrition Board of the Institute of 
Medicine of the National Academy of Science (2001) has defined adequate levels of 
vitamin K intake that are sufficient to meet the requirement of nearly all (97.5%) healthy 
human individuals within groups defined by age and gender. Adequate intakes range 
from 2 µg/d in infants to 90 and 120 µg/d in adult females and males respectively. Other 
research suggests 80 µg/d is adequate for adults regardless of gender (Suttie, 1992). The 
current recommendation for pigs of all stages of production is 0.50 mg/kg of feed as 
menadione (NRC, 2012). The total daily intake would then vary based on individual feed 
intake.  
 Phylloquinone is the natural form synthesized by plants and is a component of 
chloroplasts. Therefore, green plants are a good source of vitamin K. The USDA has 
evaluated many types of food and has reported a comprehensive list of phylloquinone 
content in food found on their web site (www.ars.usda.gov).  The report shows that 
beverages, meat, eggs, dairy products, and grains are all poor (< 5.0 µg/100 g sample) 
dietary sources. Green plants, especially those classified as vegetables in human diets, are 
a good source (100-400 µg/100 g). Research compiling the phylloquinone content of 
ingredients in Western diets shows vegetables normally in the range of 400-700 µg/100 g 
and vegetable oils (e.g., soybean, rapeseed, and olive oils) from 50-200 µg/100 g 
(Shearer, 1988; Booth et al., 1993 and 1994). Some vegetable oils, such as peanut, corn, 
sunflower, and safflower have much lower phylloquinone contents (1-10 µg/100 g). 
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Vitamin K content of human milk has a 10-fold variation in reported values of 
phylloquinone concentrations of mature (late lactation) human milk (Canfield and 
Hopkinson, 1989). The phylloquinone content of mature milk generally ranges between 1 
and 4 µg/l, with average concentrations near the lower end of this range (von Kries et al., 
1987; Greer et al., 1991). Colostrum appears to have 50% more phylloquinone than 
mature milk (von Kries et al., 1987).  
Menaquinone is the natural form synthesized by bacteria within the 
gastrointestinal tract of animals as a product of bacterial metabolism. It has been shown 
that all vitamin K homologues can be converted to MK-4 (menaquinone with 4 
isoprenoid side chain units) in vivo by bacteria but certain chain lengths are produced in 
larger concentrations (Kimura et al., 1992; Thijssen et al., 2006; Nakagawa et al., 2010). 
Quantitative measurements at different sites of the human intestine have demonstrated 
that most of these menaquinones are present in the distal colon (Conly and Stein, 1992). 
Major forms produced are MK-10 and MK-11 by Bacteroides, MK-8 by Enterobacter, 
MK-7 by Veillonella, and MK-6 by Eubacterium lentum. It is noteworthy that 
menaquinones with very long chains (MKs 10-13) are known to be synthesised by 
members of the anaerobic genus Bacteroides and are major inhabitants of the intestinal 
tract but have not been detected in significant amounts in foods. The widespread presence 
of MKs 10-13 in human livers at high concentrations suggests that these forms originate 
from intestinal synthesis (Shearer, 1988; Usui, 1990; Shearer et al., 1996). Schurgers and 
Vermeer (2000) showed long chain menaquinones are found in fermented foods such as 
cheese, curd, and sauerkraut. The Japanese fermented food “natto” contains MK-7 at an 
exceptionally high concentration. Absorption of bacterially produced menaquinone can 
occur in the hindgut and it is thought that animals and humans obtain a significant 
fraction of their vitamin K requirement from direct absorption of menaquinones produced 
by microbial synthesis (Passmore and Eastwood, 1986). However, evidence documenting 
the site and extent of any absorption is not conclusive since more recent research has not 
been able to duplicate those findings (Shearer, 1992 and 1995; Suttie, 1995). The most 
promising site of vitamin K absorption in the hindgut is the terminal ileum, where there 
are some menaquinone producing bacteria as well as bile salts. Some species might be 
able to capture and utilize fecal vitamin K through coprophagy. Coprophagy is the 
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consumption of feces. This includes eating feces of other species/individuals or their 
own. Menaquinone is found in animal products such as meat, milk, and eggs. Beef, 
chicken, pork and eggs are good sources while milk is a poor source of menaquinone 
(Combs, 1999).  
 
2.2.4. Digestion, absorption, and bioavailability 
Vitamin K must be liberated from the cells of ingested feedstuffs through normal 
digestive pathways and is incorporated into micelles. The primary site of vitamin K 
absorption is the small intestine. In rats, phylloquinone is absorbed by the proximal 
intestine by an energy dependent process (Hollander, 1973). Menaquinone absorption in 
rats occurs in both the proximal and distal intestine and the colon by a passive process 
(Hollander et al., 1976). Because the lipophilic properties of menaquinones are greater 
than those of phylloquinone, it is likely that the efficiency of their absorption, in the free 
form, is low, as suggested by animal studies (Will and Suttie, 1992). 
Very little is known about the bioavailability of the K vitamins from different 
foods. The information presented here is based on research in humans as there is a lack of 
information on this topic in swine. It has been estimated that the efficiency of absorption 
of phylloquinone from boiled spinach (eaten with butter) is no greater than 10 percent 
(Gijsbers et al., 1996) compared with an estimated 80 percent when phylloquinone is 
given in its free form (Shearer et al., 1970 and 1974). This poor absorption of 
phylloquinone from green leafy vegetables may be explained by its location in 
chloroplasts and tight association with the thylakoid membrane where the 
naphthoquinone ring structure plays a role in photosynthesis. In comparison, the 
bioavailability of MK-4 from butter artificially enriched with this vitamer was more than 
twofold higher than that of phylloquinone from spinach (Gijsbers et al., 1996). The poor 
extraction of phylloquinone from leafy vegetables, which as a category represents the 
single greatest food source of phylloquinone, may place a different perspective on the 
relative importance of other foods with lower concentrations of phylloquinone (e.g., those 
containing soybean and rapeseed oils) but in which the vitamin is not tightly bound and 
its bioavailability is likely to be greater. Even before bioavailability was taken into 
account, fats and oils that are contained in mixed dishes were found to make an important 
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contribution to the phylloquinone content of the US diet and in a UK study contributed 
30 percent of the total dietary intake (Booth et al., 1996). 
Overall evidence suggests that the bioavailability of bacterial menaquinones is 
poor because they are mostly tightly bound to the bacterial cytoplasmic membrane and 
the largest pool is present in the colon, which lacks bile salts for their solubilisation 
(Shearer, 1992 and 1995). Chain length also appears to affect bioavailability of 
menaquinones. Sato et al. (2012) showed that MK-4 present in human food does not 
contribute to the vitamin K status as measured by serum vitamin K levels. MK-7, 
however, increases serum MK-7 levels and therefore may be an important extrahepatic 
form of vitamin K. Also, the intake of a nutritional dose of MK- 4 did not increase the 
MK-4 levels in extrahepatic tissues, whereas MK-7 significantly increased MK-4 in 
extrahepatic tissues (Sato et al., 2012). They concluded MK-7 is a better supplier for 
MK-4 in vivo than MK-4 itself (Sato et al., 2007). Schurgers and Vermeer (2002) 
compared the absorption of vitamin K1, MK-4, and MK-9. MK-4 showed a short serum 
half-life and small area under the curve compared to vitamin K1, whereas MK-9 displayed 
a long serum half-life compared to vitamin K1 or MK-4.  
 
2.2.5. Tissue distribution and storage 
Similar to absorption, there are differences in tissue distribution and storage 
between phylloquinone, menaquinone, and menadione. The two natural forms of vitamin 
K, phylloquinone and menaquinone, are taken up by the liver soon after absorption. 
Long-chain menaquinones are mainly found in the liver (Kindberg et al. 1987; Shearer et 
al. 1996). However, in these studies it was not stored in the liver but rapidly excreted via 
bile into the small intestine. Kindberg and Suttie (1989) demonstrated the rapid loss of 
vitamin from the liver of rats and even with prior ingestion of a high level of vitamin K 
there was little influence on liver vitamin K concentrations beyond the first 2 d of a 
deficient period. Phylloquinone and MK-4 can be recovered from most tissues (Shearer 
1995; Thijssen et al. 1996), the latter being metabolized from both phylloquinone and 
menaquinones in animal tissues (Thijssen et al. 1996, 2002; Ronden et al. 1998). 
Menadione has been shown to be at least partly converted to MK-4 in marine 
invertebrates (Burt et al. 1977), and in the liver of cod (Grahl-Madsen & Lie 1997), 
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salmon (Graff et al. 2002), and abalone (Tan & Mai 2001) but does not appear to be 
stored and is, therefore, presumed to be rapidly excreted.  
 
2.2.6. Analysis and detection 
Vitamin K is sensitive to alkali and UV radiation and the appropriate precautions 
need to be taken during analytical operations. Colorimetric procedures are available, but 
these lack specificity and have been replaced as the methods of choice. Most analytical 
attention has been given to the measurement of vitamin K1. Most authors comment on 
the great variability of the values obtained from biological samples and emphasize the 
need for proper repeat sampling and replication of analyses (Piironen et al., 1997; Jakob 
and Elmadfa, 1996). One major problem in the analysis is the presence of lipid, which 
must be removed by digestion with lipase before extraction with hexane (Indyk and 
Woollard, 1997). The solvent is evaporated under a stream of nitrogen and the residue 
dissolved in methanol, which is applied to a reverse phase HPLC column. The eluate is 
reduced post-column with zinc and the fluorescence is then measured. Semi-preparative 
separations have been used after digestions (Cook et al., 1999) and dual electrode 
detection systems have also been proposed (Piironen and Koivu, 2000).  
Phylloquinone, the plant form of vitamin K, is a yellow oil at room temperature 
while most other vitamers are yellow crystals. Most forms of vitamin K are insoluble in 
water, slightly soluble in ethanol, and soluble in oils, fats, ether and chloroform. 
Menadione is the exception, as it is water soluble. Vitamin K vitamers are sensitive to 
light and, alkaline and oxidizing conditions but stable to heat. 
 
2.2.7. Gamma-carboxylation 
The predominant role/function of vitamin K in the body, whether it is of natural 
or synthetic origin, is to aid in gamma-carboxylation of peptide bound glutamate 
residues. Stafford (2005) reviewed the processes involved. Vitamin K is the cofactor 
needed for a specific carboxylase that catalyses the reaction. Vitamin K provides 
reducing equivalents in the reaction to form a carbanion on the target protein. Vitamin K 
is oxidized in the process. The carboxylation step follows but vitamin K is not involved. 
Vitamin K’s role can be thought of as preparing the glutamate residue for the 
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carboxylation step. The oxidized form (Vit. K 2,3-epoxide) can then be returned back to 
the reduced form by a series of reductase enzymes completing the vitamin K cycle 
(Figure 2.6). It is first reduced to the quinone form and then back to the original 
hydroquinone form which is the form that participates in carboxylation of proteins. 
Gamma-carboxylation confers Ca binding capacities to the glutamyl residue containing 
proteins, facilitating the formation of Ca bridges essential for proper function. 
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Figure 2.6. The vitamin K cycle. 
 
 
There are currently 12 known proteins that are dependent upon the gamma-
carboxylation process by vitamin K to be fully active. These proteins can be broken down 
into three main classifications including clotting factors, coagulation inhibiting proteins, 
and bone formation. The clotting factors are prothrombin (factor II) and factors VII, IX, 
Carboxylase 
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and X. The coagulation inhibiting proteins are proteins C, S, Z, and M. The proteins in 
the previous two groups can be found in multiple tissues. The vitamin K dependent bone 
formation protein, OC, is specific to bone and will be discussed in that section. Other 
vitamin K dependent proteins have been found in calcified matrices where they might be 
involved in regulation of Ca. 
 
2.2.8. Blood clotting 
Coagulation, or thrombogenesis, is the process by which blood forms clots. It is 
an important part of hemostasis, the cessation of blood loss from a damaged vessel, 
wherein a damaged blood vessel wall is covered by a platelet and fibrin-containing clot to 
stop bleeding and begin repair of the damaged vessel. Vitamin K plays a key role in this 
process. Gamma-carboxylation of the clotting factor proteins is the most well-known 
function of vitamin K. Figure 2.7 diagrams the coagulation cascade showing the vitamin 
K dependent clotting factors and their approximate half-lives. The shaded clotting factors 
are the critical warfarin targets. Intrinsic, extrinsic, and final common pathway all require 
vitamin K dependent proteins. The conversion of prothrombin (factor II) to thrombin 
plays a key role in blood clotting and is one of the vitamin K dependent steps. 
Prothrombin time is the classic response measure with respect to vitamin K status 
within the test subject. Prothrombin time is defined as a measure of the extrinsic pathway 
of coagulation, used to determine the clotting tendency of blood in the measure of 
anticoagulant treatments, liver damage, and vitamin K status. Prothrombin time is most 
commonly measured using blood plasma. Blood is drawn into a test tube containing 
liquid citrate, which acts as an anticoagulant by binding the Ca in a sample. The blood is 
mixed and then centrifuged to separate blood cells from plasma. Prothrombin time is the 
time it takes plasma to clot after reintroducing clotting factors. The effects of long chain 
MK-n such as MK-7 on normal blood coagulation is greater and longer lasting than 
phylloquinone and MK-4 (Groenen-van Dooren et al., 1995; Sato et al., 2002). The 
greater effect of MK-7 was attributed to its very long half-life in serum (Schurgers et al., 
2007).  
An anticoagulant is a substance that prevents coagulation (clotting) of blood. 
Their mechanisms of action involve the coagulation cascade, vitamin K cycle, and 
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alterations in the Ca pool available for clot formation. Anticoagulants can be used in 
vivo as a medication for thrombotic disorders, in medical equipment such as test tubes 
where analysis requires blood that has not clotted, and even as poisons such as 
rodenticides. The anticoagulant compounds are often the cause of a vitamin K deficient 
status and are discussed in more detail in that section.  
 
 
 
Figure 2.7. Coagulation cascade. Clotting factors in circles are vitamin K dependent. Red 
shading indicates warfarin targets. Factors II and IIa are prothrombin and thrombin 
respectively. 
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2.2.9. Protein C  
Protein C (PC) is a vitamin K-dependent zymogen that is converted to activated 
protein C (APC) on the endothelial surface when thrombin binds to thrombomodulin 
(Drake et al., 1989; Beutler, 2002). Binding of thrombin to this site not only accelerates 
protein C activation about 100-fold, but also blocks the ability of thrombin to clot 
fibrinogen and participate in platelet and endothelial cell activation (Esmon, 1989). The 
activation of PC is augmented by its specific receptor, endothelial protein C receptor 
(EPCR, Esmon, 2001), a 46-kDa, type I transmembrane glycoprotein homologous to 
major histocompatibility complex class I/CD1 family proteins (Stearns-Kurosawa et al., 
1996; Laszik et al., 1997). APC plays a key role in the regulation of blood coagulation 
and also has significant anti-inflammatory properties associated with inhibition of 
proinflammatory cytokines and a reduction of leukocyte recruitment (Esmon, 2002a; 
Esmon 2003). APC prevents lipopolysaccharide-induced pulmonary vascular injury and 
protects against ischemia/reperfusion-induced renal injury by inhibiting the accumulation 
and activation of leukocytes (Fukudome et al., 1998; Nicolaes and Dahlback, 2002). Ding 
et al. (2010) evaluated the effects of APC against myocardial ischemia/reperfusion (I/R) 
injury on myocardial infarction in rat in terms of the expression of proteins involved in 
apoptosis signaling cascades in rats. APC was administered pre- and post-reperfusion and 
reduced myocardial infarct size without reference to the timing of administration. Rats 
undergoing I/R had significantly impaired left ventrical contractile function. Treatment 
with APC significantly preserved impaired left ventrical contractility and relaxation. 
These results suggest vitamin K can indirectly reduce heart cell apoptosis at times of 
circulatory/cardiac stress through carboxylating PC resulting in increased function post 
stress. In vitro, APC suppresses the nuclear factor-κB pathway in both human monocytes 
(Mann et al., 1990) and endothelial cells (Grey et al., 1994). APC also inhibits 
lipopolysaccharide-induced tumor necrosis factor expression in a monocytic cell line 
(Murakami et al., 1997) and inhibits endothelial cell apoptosis (Hirose et al., 2000). The 
effectiveness of APC as an anticoagulant and anti-inflammatory agent is demonstrated by 
its efficacy as a treatment for patients with severe sepsis (Esmon, 2002b; Haley et al., 
2004; Taylor et al., 1987).  
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2.2.10. Gelatinase A 
APC can activate endothelial matrix metalloproteinase (MMP)-2/gelatinase A 
(White et al., 2000), a member of the MMP family of zinc-dependent endopeptidases that 
plays a vital role in the tissue repair process by remodeling the extracellular matrix (Joyce 
et al., 2001). In cultured human keratinocytes, APC enhances cell proliferation, 
migration, and MMP-2 activity (Xue et al., 2004; Xue et al., 2007). Recently, a novel 
function of APC as a promoter of cutaneous wound healing was identified. APC 
accelerated full thickness wound closure by stimulating re-epithelialization, promoting 
angiogenesis, and preventing inflammation in rats (Jackson et al., 2005). Nguyen et al. 
(2000) demonstrated that APC can activate gelatinase A in human endothelial cells from 
the umbilical vein. APC induced the fully active form of gelatinase A in a dose and time 
responsive manner. The inactive zymogen, protein C, did not activate gelatinase A when 
used at the same concentrations. Lay et al. (2005) compared reproductive performance 
and offspring survivability between Wild type and heterozygous deficient PC mice. The 
presence of the PC gene was vital for sustaining pregnancy beyond 7.5 days postcoitum. 
They proposed this was likely by regulating the balance of coagulation and inflammation 
during trophoblast invasion. Embryos from PC-/- females (regardless of male genotype) 
were either growth retarded or in advanced stages of resorption by 7.5 days postcoitum, 
evidence that it is the maternal PC that is vital for, and determines, the sustainability of 
pregnancy. They did not find an impact on male or female fertility. Itoh et al. (1998) 
investigated the specific role of gelatinase A (matrix metalloproteinase 2) on tumor 
progression, angiogenesis, and the invasion and metastasis of tumor cells in wild type and 
gelatinase A-deficient mice that were intradermally implanted with melanoma or 
carcinoma cells. Tumor volume 3 weeks post implantation in the gelatinase A-deficient 
mice decreased by 39% for melanoma and by 24% for carcinoma treatments. The number 
of lung colonies 3 weeks after injection fell by 54% for melanoma and 77% for 
carcinoma in gelatinase A-deficient mice. This is the first direct evidence that host-
derived gelatinase A plays a specific role in angiogenesis and tumor progression in vivo. 
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2.2.11. Vitamin K requirement for pigs 
The efficacy and requirement of vitamin K for swine has not been thoroughly 
evaluated and supported by published literature. The current suggested requirement set by 
the National Research Council (NRC, 2012) is 0.5 mg of vitamin K (as menadione) per 
kg of diet. This requirement has not changed over the past several editions of the 
publication. Seerly et al. (1976) conducted a study to evaluate the effects of MPB on 
prothrombin time in swine and to study any biological effects on growth when high levels 
of MPB were fed for 10- and 16-week feeding periods. They conducted three 
experiments with nursery and growing pigs using inclusion levels of 1.1 to 110 mg of 
MPB/kg diet. Pivalyl, a potent anticoagulant, was added to the basal diet at the rate of 1.1 
mg/kg of diet. The effectiveness of MPB as a source of vitamin K activity was 
demonstrated by the decreased prothrombin time in the nursery when 8.8 mg/kg MPB 
was fed compared to 1.1, 2.2, 3.3, and 4.4 mg/kg. Prothrombin time was not different 
between treatments when higher levels (11, 33, and 110 mg/kg) of MPB were fed. 
Growth rate and feed intake were not affected by treatment. They did observe that 
average prothrombin time increased within all treatments between 3 and 9 weeks of age. 
This is in contrast to a study using chicks that showed a shorter prothrombin time as age 
increased (Charles and Day, 1968). Hall et al. (1991) were evaluating the effects of 
various Ca:P ratios (1:1, 2:1 and 3:1) in diets having deficient (0.3%), adequate (0.6%) 
and excess (0.9%) levels of dietary P on rate and efficiency of gain and bone strength in 
growing pigs when a hemorrhagic condition occurred in pigs fed the high Ca level (3:1). 
Vitamin K as MPB (5 mg/kg diet) was added to the diets of 2 of the 4 replicates in which 
the hemorrhaging occurred. Analysis of plasma samples showed increased levels of Ca in 
the diet resulted in an increase in the prothrombin time when vitamin K was absent in the 
diet. The addition of vitamin K stabilized prothrombin time. Brooks et al. (1973) 
conducted three trials with pigs having initial weights of 7, 38, and 55 kg to determine the 
effect of menadione (MPB, 1 mg/kg) supplementation on the development of heart 
lesions and hemorrhagic syndrome. When vitamin K was added to these diets, heart 
lesions did not occur and prothrombin time was reduced but no change occurred in 
performance or carcass composition.  
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Vitamin K research in pigs has focused on weanling and growing pigs. The 
effects of vitamin K on reproducing pigs have not been reported. Also, there might be a 
difference in requirement between sexes. It appears that in rats the dietary need for 
vitamin K is higher in males than in females (Mellette and Leone, 1960; Matta and 
Johnson, 1960; Matschiner and Bell, 1973; Jolly et al., 1977). This has not been 
evaluated in swine.  
 
2.2.12. Deficiency and toxicity in pigs 
Deficiency symptoms of vitamin K in swine include blood in urine, subcutaneous 
hemorrhage, prolonged bleeding from the umbilicus or as a consequence of injury, and 
extended blood clotting time (Schendel and Johnson, 1962; Brooks et al., 1973; Seerley 
et al., 1976). These symptoms are more commonly seen in the presence of vitamin K 
antagonists, such as warfarin or dicumarol, which inhibit activity of the reductase 
enzymes of the vitamin K cycle. Cereal grains containing aflatoxins might cause 
deficiency symptoms (hemorrhaging in this case) because they contain a coumarin-like 
structure. In housing where animals are in contact with their feces the requirement might 
be lower due to coprophagy. However, fecal material might not be a good source of 
vitamin K if antibiotics are present in the diet. Antibiotics that contain the 
methyltetrazole-thiol side chain may decrease menaquinone synthesis by gut microbes 
and/or the conversion to active forms in hepatic tissues (Conly and Stein, 1994; Lipsky, 
1994; Vermeer et al., 1995) thereby increasing the dietary requirement. Schendel and 
Johnson (1962) fed purified diets with high levels of antibiotics and sulfa-drugs to 
coprophagy-restricted neonatal pigs for 5 wks before a vitamin K deficiency (increased 
prothrombin time) was evident. 
High ratios of vitamin E to vitamin K may cause a vitamin K deficient state. High 
doses of vitamin E administered to vitamin K-deficient, but not depleted, pigs resulted in 
abnormal coagulation as a consequence of under γ-carboxylation of prothrombin, 
whereas there is no effect of vitamin E supplementation in vitamin K-adequate animals 
(Corrigan, 1982). These findings supported their earlier research (Corrigan and Marcus, 
1974) and were consistent with what others were finding (Helson, 1984). Dowd and 
Zheng (1995) proposed the interaction between vitamins E and K may be explained by a 
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competitive redox reaction between tocopherol quinone and the reduced form of vitamin 
K, vitamin K hydroquinone, which would result in a depletion of the cofactor for the 
vitamin K-dependent carboxylase. Vitamin K in excess of the requirement seems to be 
tolerated well by swine. Levels of menadione up to at least 1000 times the dietary 
requirement have been fed with little adverse effects (NRC, 1998).   
 
2.3. Bone 
2.3.1. Structure and function 
Bones are rigid organs that constitute part of the endoskeleton of vertebrates.  The 
function of bone can be broken down into three main categories. First is mechanical. 
They support and protect the various organs of the body. Second is synthesis. They 
produce red and white blood cells. Third is metabolic and storage. Bone stores minerals, 
fat, and growth factors. It is also involved in acid-base balance and detoxification of the 
blood by removing heavy metals and other foreign elements. Bone tissue is essentially a 
type of dense connective tissue. It comes in a variety of shapes and has a complex 
internal and external structure, is lightweight yet strong and hard, and serves multiple 
functions. Bone contains many types of tissues including marrow, endosteum, 
periosteum, nerves, blood vessels and cartilage. At birth, there are over 270 bones in an 
infant human's body.  Many of these fuse together during growth and the total number of 
adult bones varies depending on the source. The most accepted number of bones in the 
human skeleton is 213 (Grey’s Anatomy, 2004). The largest bone in the human body is 
the femur and the smallest bones are auditory ossicles.  
 Among pigs, there is considerable variation in the size and shape of the 
skeleton and in the number of ribs and thoracic and lumbar vertebrae documented by 
extensive x-ray studies and examination of carcasses (Shaw, 1930; Berge, 1948). These 
studies found that as the number of ribs increased, the number of vertebrae decreased. 
Also, breed differences exist and selection for increased carcass length has increased the 
mean number of vertebrae over time. Therefore, the number of bones in the pig skeleton 
varies as it does in humans (Sack, 1982). 
 There are three groups that bones can be divided into: long, short, and flat. 
Mature long, and most short, bones have 3 distinct zones: epiphysis, metaphysis, and 
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diaphysis (Figure 2.8). In development, the epiphysis and metaphysis are separated by a 
fourth zone, known as the epiphyseal plate, or physis. This segment of the bone is 
cartilaginous and is the region from which the bone grows longitudinally. Diaphyseal 
bone’s primary function is structural and it is composed of thick cortical bone. The bone 
type progressively changes to trabecular bone nearing the ends of the bone. Estimates 
show the average adult human skeleton is composed of 80% cortical bone and 20% 
trabecular bone overall with different bones, and skeletal sites within bones, having 
different ratios of cortical to trabecular bone. The vertebra is composed of cortical to 
trabecular bone in a ratio of 25:75. This ratio is 50:50 in the femoral head and 95:5 in the 
radial diaphysis (Eriksen et al., 1994). Figure 2.9 shows the two classifications of bone 
density. Trabecular bone is a lattice of bony projections and serves as a shock absorber. 
Cortical bone is very dense and its main function is structural. Long bones include the 
femur, tibia, fibula, humerus, radius, ulna, metacarpals, metatarsals, and phalanges. Short 
bones are physiologically similar to long bones and only differ in their length. Examples 
include vertebrae, the patella, and sesamoid bones. Flat bones consist mainly of a cortical 
shell with a cancellous interior. They are often broad, flat, and provide protection (skull, 
sternum, ribs) or offer wide, flat surfaces for muscular attachment (scapula). 
 
 
                       Distal epiphysis                         Diaphysis                       Proximal epiphysis 
 
 
 
                                              Metaphysis                                                  Metaphysis 
 
Figure 2.8. Zones of a mature long bone. (Monegue, 2013) 
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Figure 2.9. Left – trabecular (spongy) bone; Right – cortical (compact) bone. (Monegue, 
2013) 
 
 
2.3.2. Composition 
The majority of bone is made of the bone matrix which can be categorized into 
inorganic and organic parts. Maximum bone formation/growth in swine occurs during the 
first 12 weeks of life (Brown et al., 1972) through the hardening of this matrix entrapping 
the cells. When osteoblasts become entrapped within the matrix they become osteocytes. 
The inorganic composition of bone is formed from hydroxyapatite (Ca10(PO4)6(OH)2) and 
is often referred to as the bone mineral (Field et al., 1974; Legros et al., 1987). The 
matrix is initially laid down as unmineralised osteoid (manufactured by osteoblasts). 
Mineralization involves osteoblasts secreting vesicles containing alkaline phosphatase. 
This cleaves the phosphate groups of hydroxyapatite and acts as the foci for Ca and 
phosphate deposition. The vesicles then rupture and act as a center for crystals to grow on 
(Bertazzo and Bertran, 2006). The organic part of matrix is mainly composed of Type I 
collagen and various other proteins involved in bone metabolism including 
glycosaminoglycans, OC, osteonectin, bone sialo protein, osteopontin and cell attachment 
factor (Erickson et al., 2013). One of the main things that differentiate the matrix of a 
bone from that of other cells is that the matrix in bone is hard. 
Ca bound in bones and teeth accounts for nearly 99% of all Ca (bone is 36% Ca 
on average) in the body with the remaining 1% found in the body fluids (Hollinger and 
Pattee, 1956). About 85% of adult body P is found in the bones, with the remaining 15% 
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found in the soft tissues (Institute of Medicine, 1997). Beyond the role of acquiring and 
maintaining bone mass, abnormal (high and low) Ca levels have been tied to 
neurological, cardiovascular, digestive, metabolic, pulmonary, and cancerous diseases 
(Peterlik et al., 2009). If not replenished at an adequate rate through dietary intake, the 
body will begin to scavenge the Ca and P it needs from bones (Rodriguez-Rodriguez et 
al., 2010). Regulation of Ca and P homeostasis is therefore vital in maintaining bone 
health and is discussed in the following sections.  
Animal studies have demonstrated the importance of P, in conjunction with Ca, 
for bone development (Shapiro and Heaney, 2003). These results showed that Ca and P 
are co-dependent, and that both minerals are critical to support soft tissue and bone 
growth. Concerns have been raised in the past that a high P intake could possibly 
interfere with Ca nutrition by reducing its absorption (Calvo and Park, 1996). These have 
been shown to merely be theoretical concerns, however. Research studies done to 
evaluate the effect of higher P content (and lower Ca:P) of the diet showed that the Ca 
absorption was not lowered. As long as the Ca intake levels are adequate, even higher P 
levels will not interfere with Ca absorption (Heaney and Recker, 1982). The 
recommended Ca:P in swine diets is1:1 but it is unclear if this is optimal for bone growth 
since the ratio is 2:1 in bones (NRC, 2012). 
 
2.3.3. Bone remodeling 
Bone remodeling can be described as the combined anabolic and catabolic 
processes that occur mainly at the bones surface. Remodeling of bone is a complex and 
highly integrated process involving several key cell types specific to bone tissue and has 
two distinct steps: destruction and synthesis. Remodeling sites may develop randomly but 
also are targeted to areas that require repair (Burr, 2002; Parfitt, 2002). Remodeling sites 
are thought to develop mostly in a random manner. During destruction, the proteinaceous 
matrix (osteoid) in which hydroxyapetite crystals reside is hydrolyzed. This process is 
carried out by osteoclasts and is referred to as resorption since the Ca and P released are 
reabsorbed into the blood. Resorbing osteoclasts secrete hydrogen ions via H-ATPase 
proton pumps and chloride channels in their cell membranes into the resorbing 
compartment to lower the pH to as low as 4.5, which helps mobilize bone mineral (Silver 
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et al., 1988). Osteoclast-mediated bone resorption takes only approximately 2 to 4 wk 
during each remodeling cycle (Clarke, 2008). 
Bone formation is a much more time consuming process than resorption taking 
approximately 4 to 6 months to complete. The coupling signals linking the end of bone 
resorption to the beginning of bone formation are not clearly understood. Proposed 
coupling signal candidates include bone matrix derived factors such as TGF-β, IGF-1, 
IGF-2, bone morphogenetic proteins, PDGF, or fibroblast growth factor (Locklin et al., 
1999; Hock et al., 2004). TGF-β released from bone matrix decreases osteoclast 
resorption by inhibiting the receptor activator of nuclear factor-κB ligand (RANKL) 
production by osteoblasts (Bonewald and Mundy, 1990). The bone synthesis phase 
involves the second key cell type, the osteoblast. Osteoblasts colonize the resorbed areas 
of bone left from osteoclast hydrolysis. New osteoid and collagenous organic matrix are 
formed in the space and Ca and P are removed from circulation to form new 
hydroxyapetite crystals (Anderson, 2003). 
The end result of each bone remodeling cycle is production of new osteon. The 
remodeling process is essentially the same in cortical and trabecular bone, with bone 
remodeling units in trabecular bone equivalent to cortical bone remodeling units divided 
in half longitudinally (Parfitt, 1994). Bone balance is the difference between the old bone 
resorbed and new bone formed. Periosteal bone balance is mildly positive, whereas 
endosteal and trabecular bone balances are mildly negative, leading to cortical and 
trabecular thinning with aging. These relative changes occur with endosteal resorption 
outstripping periosteal formation (Clarke, 2008). 
As mentioned above, this is a highly integrated process. Osteoblasts express two 
cytokines essential for osteoclast differentiation, macrophage colony-stimulating factor 
(M-CSF) and RANKL (Boyle et al., 2003; Suda et al., 1999). Experiments using an 
osteopetrotic op/op mouse model have established that the osteoblast product M-CSF is 
crucial for osteoclast differentiation from precursor cells (Tanaka et al., 1993) and 
administration of recombinant M-CSF to those mice restores impaired bone resorption 
(Felix et al., 1990). The expression of RANKL by osteoblasts is inducible in response to 
stimuli of bone resorption-stimulating factors such as 1,25-dihydroxyvitamin D3 
(1,25(OH)2D3), parathyroid hormone (PTH), prostaglandin E2 (PGE2), and interleukin 
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(IL)-11 (Suda et al., 1999). Osteoclast precursors express c-Fms (M-CSF receptor) and 
RANK (RANKL receptor) and differentiate into osteoclasts in the presence of M-CSF 
and RANKL. RANKL stimulation strongly induces the expression of nuclear factor of 
activated T-cells, cytoplasmic 1 (NFATc1), a pivotal transcription factor for osteoclast 
development, in osteoclast precursors (Takayanagi et al., 2002). Osteoblasts also produce 
osteoprotegerin (OPG), a soluble decoy receptor for RANKL (Simonet et al., 1997; 
Yasuda et al., 1998). OPG inhibits osteoclastogenesis by blocking the RANKL-RANK 
interaction (Boyle et al., 2003; Suda et al., 1999). Both RANKL-deficient mice and 
RANK-deficient mice develop severe osteopetrosis with no osteoclasts in bone (Kong et 
al., 1999; Li et al., 2000). In contrast, OPG-deficient mice exhibit severe trabecular and 
cortical bone porosity with enhanced osteoclastic bone resorption (Bucay et al., 1998; 
Mizuno et al., 1998). 
 
2.3.4. Bone remodeling regulation 
2.3.4.1. Parathyroid hormone and Calcitonin 
As a calciotropic hormone, parathyroid hormone (PTH) is the primary endocrine 
regulator of bone remodeling. Ca-sensing membrane receptors (CaSR) in the parathyroid 
gland monitor Ca levels in the extracellular fluid (Brown et al., 1993). Low levels of Ca 
stimulate PTH release from chief cells of the parathyroid gland (Bai, 2004). The PTH 
receptor is expressed on osteoblasts and directly stimulates osteoblastic activity. 
Osteoclasts are indirectly stimulated through the osteoblastic-derived paracrine factors 
mentioned above (M-CSF, RANKL). Low doses of PTH promote osteoblast survival and 
anabolic functions while elevated levels of PTH result in an overall increase in osteoclast 
activity (increased bone turnover and reduced density) (Mentaverri et al., 2006). PTH 
also increases Ca reabsorption in the thick ascending limb of Henle’s loop and the distal 
tubule of the kidney (Carney, 1997). 
Calcitonin, or thyrocalcitonin, is a hormone that is produced in humans primarily 
by the C-cells of the thyroid, or the ultimobranchial body in some animals, and its 
secretion is stimulated by an increase in serum Ca concentrations (Costanzo, 2007). The 
receptor is found on osteoclasts and is a G protein-coupled receptor which is coupled to 
adenylate cyclase and thereby to the generation of cAMP in target cells (Nicholson et al., 
 
27 
 
1986). It acts to reduce blood Ca by inhibiting osteoclast activity, opposing the effects of 
PTH (Boron and Boulpaep, 2004). Other than its effects on bone metabolism, calcitonin 
has been shown to lower high blood Ca levels by inhibiting absorption by the intestines 
and reabsorption by renal tubular cell allowing it to be excreted in the urine (Potts and 
Juppner, 2008). Calcitonin is similar to PTH in that it inhibits phosphate reabsorption by 
the kidney tubules (Carney, 1997).   
 
2.3.4.2. Vitamin D 
Vitamin D acting through its steroid hormone, 1,25(OH)2D3, exerts a wide variety 
of biological actions in many target organs. Studies have established its roles in Ca 
homeostasis, mineral metabolism, bone formation, and metabolism (Walters, 1992; 
Bouillon et al., 1995; DeLuca, 2008). It is well accepted that 1,25(OH)2D3 is a positive 
factor for bone development and maintaining bone mineral density (BMD) (Holick, 
1996). Such beneficial action of 1,25(OH)2D3 for bone health is supported by clinical 
treatment with vitamin D and vitamin D analogues as antiosteoporotic agents (Tilyard et 
al., 1992; Richy et al., 2005; Matsumoto et al., 2011). These biological actions of 
1,25(OH)2D3 are believed to be mediated primarily through the nuclear vitamin D 
receptor (VDR). VDR serves as a ligand-dependent transcription factor to 
transcriptionally control expression of a set of target genes (Haussler et al., 1998; Kato, 
2000; Christakos et al., 2003). The significance of VDR in the biological actions of 
1,25(OH)2D3 has been verified by analyses using genetically engineered mouse models. 
Rachitic abnormalities observed in patients with type II hereditary rickets can be 
demonstrated by ablation of the Vdr gene in mice (conventional Vdr knockout (VDR-
KO) mice) (Li et al., 1997; Yoshizawa et al., 1997). Rachitic abnormalities in patients 
and mutant mice looked similar to those induced by nutritional vitamin D deficiency. 
However, 1,25(OH)2D3 supplements were not effective at ameliorating rachitic 
abnormalities. Moreover, impaired bone formation or growth in Vdr mutants could not be 
reversed by administration of 1,25(OH)2D3 (Bouillon et al., 2008). Feeding diets with a 
reduced phosphate content and high mineral content improved bone growth and 
formation in conventional VDR-KO mice (Li et al., 1998; Masuyama et al., 2003). Those 
findings implied that the positive effects of 1,25(OH)2D3 in bone development and 
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mineral deposition are mediated by indirect actions, such as increases in serum mineral 
levels. The concept that 1,25(OH)2D3 might have indirect beneficial actions in bone 
homeostasis in intact animals has been hampered by in vitro findings. In contrast to its 
beneficial actions in vivo, 1,25(OH)2D3 induces RANKL in vitro (Suda et al., 1999; 
Kitazawa et al., 2008; Pike, 2011). Thus, the action of 1,25(OH)2D3 on the skeleton has 
been enigmatic because of the contrast between in vivo and in vitro findings. In skeletal 
tissue, the direct action of 1,25(OH)2D3 in vivo is poorly understood for several reasons. 
First, activated VDR prevents Ca release from bone to serum through its stimulation of 
intestinal Ca absorption and renal reabsorption. Second, serum Ca homeostasis is 
maintained as a result of tightly regulated ion transport by the kidney, intestine, and bone. 
Finally, conventional genetic approaches using VDR-KO mice could not identify VDR 
action in bone because of the animals’ systemic defect in Ca metabolism. 
 
2.3.4.3. Osteocalcin  
Osteocalcin (OC), a 49-amino acid, γ-carboxyglutamic acid-containing protein 
produced by the osteoblast, has been shown to be a good marker for bone turnover 
(Beresford et al., 1984; Bronkers et al., 1985). OC contains three glutamic acid residues 
that can be carboxylated by a vitamin K dependent carboxylase (Lian and Gundberg, 
1988). The results are an activated form of the protein that can be involved in the 
formation of bone by binding available Ca in an arrangement similar to hydroxyapatite 
for ease of incorporation into the structural lattice of bone. It has been detected in the 
calcified tissues of many species (Hauschka et al., 1989). In addition to the OC found in 
bone, OC is also found in serum or plasma. Serum OC arises from newly synthesized OC 
that does not bind to the mineral phase of bone but is released directly into the circulation 
(Price and Nishimoto, 1980; Price et al., 1981). The serum concentration of OC can 
therefore be used as a measure of osteoblast activity (Lian et al., 1985; Gerstenfeld et al., 
1987). An overview of the OC, vitamin K, and Ca interaction is depicted in Figure 2.10. 
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Figure 2.10. OC γ-carboxylation pathway. Lipoproteins containing apolipoprotein E 
transport vitamin K to bone where it acts as a co-factor for OC γ-carboxylation. 
Carboxylated OC is responsible for the Ca uptake in bone. The action of vitamin K on 
bone depends on apoE affinity to osteoblast. ApoE mutations lead to different affinities 
for the lipoprotein receptor on osteoblasts. ApoE = apolipoprotein E; Ca = Ca; LPP = 
lipoprotein; OC = OC; Vit K = vitamin K. (Rodrigues et al., 2012) 
 
The aim of research with respect to OC has mainly been to evaluate its 
carboxylation state in response to a treatment. In humans the research has focused on 
bone health in subjects with osteoporosis. Shiraki (2000) evaluated bone mineral density 
with respect to vitamin K. The treatments consisted of a control group receiving 150 
mg/day elemental Ca and a test group receiving 45,000 µg menatetrenone (K2 with 4 side 
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chain units) + 150 mg/day elemental Ca and were applied to 241 osteoporotic humans. 
Bone mineral density was greater in patients receiving K2 and different from controls at 
6, 12, and 24 months of the study. OC serum levels and percent of carboxylation were 
higher (P < 0.05) in those receiving vitamin K. Binkley (2002) fed phylloquinone daily 
for 3 weeks to humans at 500, 1000, and 2000 µg to assess the ability of various doses of 
phylloquinone to facilitate OC γ-carboxylation. The percent carboxylated OC increased 
with phylloquinone supplementation. A greater increase was observed with 1000 and 
2000 µg than with 500 µg. There was not a difference between 1000 and 2000 µg so a 
second study was done to evaluate lower levels. Phylloquinone was supplemented at 250, 
375, 500, or 1000 µg/d for 2 weeks. The percent of carboxylated OC increased in all 
supplemented groups by week 1, which was sustained through week 2. Differences 
existed between the 250 µg and the placebo groups and between the 1000 and 500ug 
groups but not between the 250, 375, and 500 µg groups. It appears from this study that 
there is very little benefit of supplementing vitamin K over 1000 µg with respect to the 
percentage of carboxylated OC. However, Takeuchi et al. (2005) reported doses of MK-4 
up to 1500 μg/d could increase OC carboxylation. Also, other research indicated 
nutritional doses of MK-7 (45–90 μg/day) to be effective for carboxylation of OC (van 
Summeren et al., 2009; Brugè et al., 2001). The effect of natto derived MK-7 was 
attributed to its very long half-life in serum, providing a better carboxylation-grade of OC 
compared to phylloquinone (Schurgers et al., 2007). Therefore, the form, source, and 
chain length of vitamin K must be considered.  
 
2.3.4.4. Estrogens 
Estrogens also appear to be important for normal bone remodeling. This has been 
illustrated in states of estrogen deficiency where a loss of bone mass occurs. Estrogen 
therapy (Estradiol-17β) helped prevent osteoblast and osteocyte apoptosis (Plotkin et al., 
2005; Revankar et al., 2005; Krum, 2011; Erlandsson et al., 2013). Estrogens are believed 
to act via two nuclear receptors denoted estrogen receptor-a (ERa) and estrogen receptor 
b (ERb) (Kuiper et al., 1996; Mosselman et al., 1996). This is similar to how vitamin D 
acts on cells through the nuclear VDR. Studies have demonstrated that the two receptors 
have similar affinities for many estrogenic compounds (Kuiper et al., 1997; Tremble et 
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al., 1997). Estrogen resistance due to a point mutation in the ERa gene was reported in 
humans (Smith et al., 1994). These patients had increased bone turnover and osteopenia, 
indicating that ERa is important for normal bone remodeling in humans. The same effects 
were demonstrated in ER knockout mice (Windahl et al., 2002; Erlandsson et al., 2013). 
Similar effects have also been described in patients deficient in estrogen due to failure of 
the aromatase enzyme which converts testosterone into estrogen (Morishima et al., 1995). 
The similarities between the ERa mutation in humans and aromatase deficiency suggest 
that ERa is important for normal bone metabolism in humans. One of ERa’s specific 
functions is to protect against cortical bone resorption (Almeida et al., 2013). ERb 
immunoreactivity has been reported in rat tissues including brain, ovary, uterus, lung, 
heart, prostate, and testis (Li et al., 1997; Saunders et al., 1997; Simonian and Herbison, 
1997). However, little is presently known about the expression of ERb protein in bone. A 
number of studies have demonstrated effects of estrogens on cells of the osteoblast 
lineage (Slootweg et al., 1992; Robinson et al., 1997; Kassem et al., 1998). It is still 
unclear whether these effects are mediated by ERa, ERb, or both receptor subtypes. ERa 
has previously been reported to be expressed in murine, rat, and human osteosarcoma cell 
lines as well as in cultured human osteoblast-like cells (Bellido et al., 1993; Davis et al., 
1994; Ikegami et al., 1994). The ratio between ERa and ERb might determine the 
downstream activities of estrogens in target tissues (Pace et al., 1997; Pettersson et al., 
1997).  
 
2.4. Mycotoxins in swine 
2.4.1. Mycotoxin overview 
Mycotoxins are secondary metabolites produced by fungi and microbes that 
parasitize living plants externally or live in the tissues of the plants as endophytes. These 
compounds are not utilized by the host metabolism and it is estimated that around 300 of 
these compounds exist (Akande et al., 2006). Brase et al. (2009) hypothesized that the 
purpose of these compounds was to eliminate competition for food by creating an 
environment in which other microorganisms can not exist. The compounds we call 
antibiotics are one group of secondary metabolites produced that have been proven 
beneficial in the medical field. However, not all of them are beneficial and some can be 
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harmful, even toxic, to animal species. Forgacs et al. (1955) described the health 
condition resulting from mycotoxin exposure as mycotoxicosis. 
Both fungal growth and mycotoxin production are dependent on environmental 
factors and the optimum condition for mycotoxin production is usually within a narrower 
range than those for fungal growth only (Bennett and Klich, 2003). Factors that influence 
mycotoxin production include physical (temperature, water content, mechanical damage), 
chemical (atmosphere, substrate composition, pH, fungicides), and biological (fungal 
plant pathogens, microbial composition) factors (Cao et al., 2013; Marin et al., 2013; 
Silva et al., 1998). These factors are not exclusive. Often the correct combination of the 
factors must be achieved for optimum mycotoxin production (Marin et al., 2013) 
Animal research has primarily focused on 5 groups of mycotoxins because their 
presence in animal feed reduces performance and causes health issues. These mycotoxins 
are aflatoxins, trichothecenes, zearalenone, fumonisins, and ochratoxins.  These toxins 
will be the main focus for the remainder of this section. 
 
2.4.2. Aflatoxins 
Aflatoxins are a group of difuranocumarinic derivatives (Mejía et al., 2011). 
Aflatoxin has been implicated in causing hemorrhaging in pigs (Osweiler et al., 1970) 
due to its coumarin like structure which may reduce reductase enzyme activity and 
prevent vitamin K 2,3-epoxide from being converted back to its quinone form. Aflatoxin 
has also been shown to influence DNA modification leading to cell deregulation and cell 
death or transformation (Eaton and Gallagher, 1994). Aspergillus flavus, A. parasiticus, 
and A. nomius are some of the most common aflatoxin producers (Yiannikouris and 
Jouany, 2002). Chemical structures of B₁, B₂, G₁, G₂, M₁, and M₂ are shown in Figure 
2.11. 
 
 
 
33 
 
CH3O
OO
O O
O
                  CH3O
OO
O O
O
 
                                  B1                                                                                        B2 
O
CH3O
O
O O
O O
                
O
CH3O
O
O O
O O
 
                                 G1                                                                  G2 
OH
CH3O
OO
O O
O
                 
OH
CH3O
OO
O O
O
 
                                  M1                                                                M2 
 
Figure 2.11 Chemical structures of aflatoxins B₁, B₂, G₁, G₂, M₁, and M₂. 
The most common forms of aflatoxin in animal feeds are B₁, B₂, G₁, and G₂.  
 
Aflatoxin B₁ is the most toxic of all the known types, and it is associated with 
immune suppression and liver damage. In humans high doses of B1 (> 6000 mg/day) are 
lethal and small doses for a prolonged period cause cancer (Groopman and Kensler, 
1999). Aflatoxin B1 has been found in many crops including cotton, corn, nuts, peanuts, 
and wheat. B₂ and G₂ are relatively non-toxic unless they are metabolically oxidized into 
B₁ and G₁ in vivo (Kensler et al., 2011). Aflatoxin M1 and M2 are hydroxylated forms of 
B1 and B2. Aflatoxin M1 is a carcinogenic metabolite commonly found in the milk of 
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humans and animals (Smith, 1997). Aflatoxin M2 has been found in milk of cattle fed on 
contaminated feed (Scudamore, 1994; Pittet, 1998; Garrido et al., 2003). 
The FDA (2011) has set guidelines on the suggested upper limit of aflatoxin 
inclusion in animal feed in the U.S. Cottonseed meal intended for beef cattle, swine, or 
poultry should not exceed 300 ppb. Corn and peanut products intended for finishing 
swine of 45.4 Kg or greater should not exceed 200 ppb. Corn and peanut products 
intended for breeding beef cattle and swine, or mature poultry, should not exceed 100 
ppb. When considering the inclusion rate of these ingredients the total aflatoxin 
concentration (B₁ + B₂ + G₁ + G₂) should not exceed 20 ppb. The upper limit varies 
between countries. For example, 4 ppb of total aflatoxins is the limit set by the European 
Union (European Commission, 1998). 
 
2.4.3. Trichothecenes 
When ingested, trichothecenes inhibit protein synthesis in a wide range of 
organisms including animals, fungi, and plants (Cundliff et al., 1974). In addition they 
disrupt cytokine regulation, alter cell proliferation, and cause cell death (Rotter et al., 
1996a). The Fusarium-produced trichothecenes are the most studied with Fusarium 
sporotrichioides, F. graminearum, F. culmorum, F. poae, F. roseum, F. tricinctum, and 
F. acuminatum being the common trichothecene producers (Yiannikouris and Jouany, 
2002). The three most commonly produced toxins are T-2, diacetoxyscirpenol, and 
deoxynivalenol (DON) (Lauren et al., 1987). Figure 2.12 depicts the structure of T-2, 
diacetoxyscirpenol, and deoxynivalenol. Early trichothecene research indicated that 
metabolites vary in both the position and number of hydroxylations and the amount of 
esterification (Bamburg, 1976). Wu et al. (2013) reviewed how trichothecene toxicity 
changes when the chemical structure is altered. 
The main effect of trichothecenes when fed to pigs is reduced feed intake (Pollmann 
et al., 1985; Dorner, 2008). DON feed concentrations from 1 to 12 ppm in the diet were 
inversely related to feed intake (Young et al., 1983). In another study pigs receiving a diet 
with 15 ppm DON only ate 38% of the feed the control pigs ate (Trenholm et al., 1994). 
Prelusky et al. (1994) showed reductions in feed intake and gain with DON levels as low 
as 3 ppm. When T-2 was fed at 0 to 3.2 ppm to growing pigs for 35 days, feed intake was 
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significantly reduced (2.47 vs. 2.26 kg/day) at the highest inclusion, but daily gain was 
only numerically lower (Friend et al., 1992). The FDA (2010) suggests that grain and 
grain by-products destined for swine should not contain more than 5 ppm 
deoxynivalenol. These ingredients should also not exceed 20% of the complete diet. 
Recommendations for other trichothecenes have not been made.  
In addition to reducing feed intake, DON might reduce nutrient digestibility. 
Nursery and growing pigs fed concentrations of DON ranging from 0 to 4.6 ppm did not 
differ in nutrient digestibility (Dänicke et al., 2004b). The same results were found in 
finishing pigs fed 0.2 and 3.7 ppm DON (Dänicke et al., 2004a). However, nutrient 
digestibility of growing pigs (26 to 100 kg) fed 0 and 18.5 ppm was different (Goyarts 
and Dänicke, 2005). Metabolizable energy, digestibility of organic matter, crude protein, 
crude fat, and N-retention increased by 4, 3, 6, 11 and 10% respectively in pigs fed the 
DON-contaminated feed. The same study tested the same levels of DON allowing ad 
libitum feed intake but no differences were detected between treatments. DON’s ability 
to affect nutrient digestibility appears to be dependent on the concentration in the diet and 
volume of feed consumed. 
 
 
 
                
 
Figure 2.12. Structure of T-2 toxin, diacetoxyscirpenol, and deoxynivalenol (DON) 
(Mohamed, 2011). 
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2.4.4. Zearalenone  
Zearalenone is a cytosolic estrogen receptor and causes hyperestrogenism 
(McLachlan, 1993). Fusarium graminearum, F. culmorum, and F. crookwellense are 
common zearalenone producers (Yiannikouris and Jouany, 2002; Riley and Petska, 2005) 
that colonize corn, barley, oats, wheat, and other grains (Bennett and Klich, 2003). The 
chemical structure is similar to that of estrogen (Figure 2.13). Zearalenone in the liver is 
converted to α- and/or β-zearalenol (Zinedine et al., 2007). Pig livers convert zearalenone 
mainly to α-zearalenol which has been shown to bind to estrogen receptors in greater 
proportions compared to β-zearalenol (Malekinejad et al., 2006). Zearalenone binds to 
estrogen receptors located in the uterus, liver, mammary gland, and hypothalamus 
(Fitzpatrick et al., 1989).  
Signs of toxicity in swine include swelling of the vulva, increased size of the 
uterus, mammary enlargement, prolapse (rectal and vaginal), prolonged estrus, ovarian 
atrophy, pseudopregnancy, abortion, increased embryo mortality, stillbirths, and weak 
and/or small pigs at farrowing in sows and gilts (Etienne and Dourmad, 1994). These 
effects of hyperestrogenism have been observed in as little as 7 days with toxin levels as 
low as 1.5 ppm (Rainey et al., 1990; Oliver et al., 2012). Long  and  Diekman  (1984)  
reported  that  feeding  of  5,  15  or  30  ppm  zearalenone  from  12  to  15  d  postmating  
had no effect. It is likely that both length of exposure and time of administration play 
some role in detecting a response in female swine. Testis atrophy, nipple enlargement, 
rectal prolapse, reduced libido, and low sperm motility have been reported in boars 
(Diekman and Green, 1992; Etienne and Dourmad, 1994). 
Feed intake and gain of growing boars fed diets containing 0, 3, 6, or 9 ppm of 
zearalenone for 280 days were unaffected (Young and King, 1986). Diets containing 0 or 
50 ppm of zearalenone did not affect feed intake or gain in 5 week old gilts (Smith, 
1980). The same conclusions were made in another study using gilts 28 days old fed a 
diet containing 0 or 1.5 ppm (Oliver et al., 2012). In contrast, Young et al. (1990) fed 
purified zearalenone (0, 5, and 10 ppm) to 48 parity 1 lactating sows. Feed intake from 
day 7 to 28 of lactation decreased (3.93, 3.80, and 3.69 kg/d) as zearalenone inclusion 
level increased. The sow studies did not report weight change during the experimental 
periods so it is unclear if there was also an effect on body weight. 
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There is little evidence to make conclusions on zearalenone’s effects on nutrient 
digestibility. Jiang et al. (2012) fed 1 ppm zearalenone to weanling pigs (8.8 kg) for 3 
weeks. Nutrient digestibility in these pigs was unaffected. In contrast, Jiang et al. (2010) 
did find that zearalenone can affect digestibility of some nutrients. Energy (85.9, 84.0, 
83.4, 83.1%,) and crude protein (85.6, 83.4, 81.8, and 81.2%,) digestibility decreased  as 
zearalenone in the diet increased from 0 to 3 ppm in 1 ppm increments. 
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Figure 2.13. Chemical structures of zearalenone and estrogen. 
2.4.5. Fumonisins 
Fumonisins consist of an 18-carbon backbone and are differentiated by their 
varying side-groups. Previously, four types of fumonisins had been identified and were 
known as A, B, C, and P (Bartok et al., 2006). Partially hydrolyzed B (PHFB) was 
recently identified as a fifth type (Bartok et al., 2008). The B-series fumonisins are the 
most common with the B₁ subtype as the most toxic (Marasas, 2001; Nelson et al., 
1993). Fusarium moniliforme, F. verticillioides, and F. proliferatum are common 
fumonisin producers (Leslie et al., 1992; Yiannikouris and Jouany, 2002). 
 Fumonisins disrupt lipid metabolism and possibly lipid bilayer structure (Plattner 
and Shackelford, 1992; Riley et al., 1996). This is because they are structurally similar to 
sphingolipids (Figure 2.14). Fumonisins inhibit ceramide synthase causing metabolic 
intermediates to build up and cause the toxicity associated with fumonisins (Merrill et al., 
2001). The lack of metabolic products also interferes with the normal function of 
membrane proteins that require sphingolipids (Marasas et al., 2004). 
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A number of studies have documented the effects on feed intake using naturally 
contaminated feed or purified sources of fumonisin (FB₁). Rossi et al. (2011) conducted 
2 experiments, each for 35 days, evaluating fumonisin B₁ (FB1) levels using weanling 
pigs. In the first experiment (0.4 vs. 2.5 ppm) FB1 level did not significantly affect feed 
intake. However, there was a sex effect with male pigs eating more (+59 g/d) than 
females. Experiment 2 (2.2 vs. 5.5 ppm) was similar to experiment 1 in that feed intake 
was not affected as a whole by contamination level. Again, male pigs consumed more 
feed (+82 g/d) regardless of FB1 concentration. Another study using pig with a similar 
initial weight and age found a linear decrease in feed intake in male (-18 g/d) and female 
(-5 g/d) pigs fed FB₁ from 0 to 10 ppm (Rotter et al., 1996b). Diets with FB₁ 
concentrations of 0, 0.11, 0.33, and 1 ppm did not affect feed intake of barrows from 25 
to 101 kg of body weight (Rotter et al., 1997). In one study, feed intake was higher 
overall (+96 g/d) from pigs fed 2.5 ppm FB₁ compared to the control (Prelusky et al., 
1996). Slightly higher FB₁ concentrations of 10, 20 and 40 ppm did not affect feed intake 
of nursery pigs (Kovacs et al., 2000). It appears that at low concentrations of FB1 the 
effects of feed intake are widely variable.  
The health effects of FB1 become more pronounced as the concentration in the 
diet increases. Colvin et al. (1993) fed a diet modified to have 200 ppm FB1. After 3 days 
all pigs stopped consuming feed and began to lose weight. They also detected liver 
necrosis and edema. Liver damage and edema have also been detected at levels lower 
than 200 ppm. Motelin et al. (1994) fed diets containing <1, 5, 23, 39, 101, and 175 ppm 
total fumonisins. Feed intake decreased as toxin level increased with the largest decrease 
at 175 ppm total fumonisins (-5.6%). Evidence of liver damage was detected in pigs fed 
as low as 23 ppm fumonisin. With the help of this research the FDA (2001) recommends 
that the total fumonisin (FB1 + FB2 + FB3) level in corn and corn by-products intended 
for swine not be higher than 20 ppm and these ingredients should not exceed an inclusion 
rate of 50% of the diet on a dry matter basis. 
Gbore and Egbunike (2007) investigated the effect of fumonisin B₁ on nutrient 
digestibility in pigs from 8 to 32 weeks of age and digestibility was measured at three 
time points (end of nursery, grower, and finisher phases). Diets contained 0.2, 5.0, 10.0, 
and 15.0 ppm of FB₁. At the end of the nursery phase, ether extract digestibility was 
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lower (67.91, 63.93, 62.83, and 61.14%) in pigs receiving FB1. The trend of decreased 
ether extract digestibility in FB1 pigs continued through the grower phase. Digestibility 
for animals on the control diet during the finishing phase was generally higher than those 
on diets with FB₁. Ash digestibility was numerically lower and nitrogen-free extract 
digestibility was significantly lower (51.3 vs. 55.7%, P < 0.05) in FB₁ pigs compared to 
the control. No effects on ether extract digestibility were detected during this period. 
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Figure 2.14. Chemical structure of fumonisin B1, sphinganine, and sphingosine. 
 
 
2.4.6. Ochratoxin 
Ochratoxins are isocoumarin derivatives linked to L-phenylalanine by an amide 
bond (Figure 2.15). The major forms of ochratoxin are A, B, C, 4-hydroxy-A, and α with 
ochratoxin A considered the most toxic (Walbeek et al., 1969). The side chains for each 
type of ochratoxin are defined in Table 2.1. Ochratoxins are produced by Penicillium 
verrucosum, P. cyclopium, P. variabile, Aspergillus clavatus, A. melleus, and A. 
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sclerotiorum (Yiannikouris and Jouany, 2002). Ochratoxin A has a potent toxicity and its 
nephrotoxic, hepatotoxic and carcinogenic effects have been demonstrated in all 
mammalian species (Karlovsky, 1999). The main effects of ochratoxins are related to the 
reduction of protein, DNA and RNA synthesis as a competitive inhibitor of 
phenylalanine-tRNA ligase (Xiao et al., 1996). 
Szczech et al. (1973) were among the first to evaluate the effects of ochratoxin A 
fed to pigs. Four gilts at 4 weeks of age were administered ochratoxin A at 1.8% of diet 
and all died within 22 days. Twelve other gilts of the same age were given daily doses of 
1 or 2 mg of ochratoxin A per kg of body weight. Those receiving 1 mg/kg all died 
within 6 days. Those receiving 2 mg/kg all died within 3 days. In all cases, an immediate 
reduction in feed was observed and accompanied by a loss of body weight. Necropsy of 
these pigs showed ochratoxin A has nephrotoxic effects including necrosis of renal 
tubular epithelium (principally in the proximal convoluted tubules), tubular dilation, 
fibrosis, and infiltration of the interstitial tissue by inflammatory cells. Mild mycotoxic 
nephropathy has been induced in pigs by a diet containing ochratoxin A at concentrations 
as low as 800 ppb (Stoev et al., 2002). Lippold et al. (1991) fed 0, 0.5, and 2.5 ppm 
ochratoxin A to 15 kg barrows. Feed intake, daily gain, and feed efficiency all decreased 
as toxin level increased. Malagutti et al. (2005) demonstrated the same results with a diet 
containing only 25 ppb ochratoxin A in 45 kg pigs. 
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Figure 2.15. Basic structure of ochratoxins. 
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Table 2.1. Designation of side chains for ochratoxins1 
Ochratoxin R1 R2 R3 
A H Cl  -NH-CH(COOH)-CH2-phenyl 
B H H  -NH-CH(COOH)-CH2-phenyl 
C H Cl  -NH-CH(COOC2H5)-CH2-phenyl 
4-hydroxyochratoxin A OH Cl  -NH-CH(COOH)-C2H-phenyl 
 α H Cl  -OH 
1Adapted from Ringot et al. (2006). 
 
2.4.7. Mycotoxin interactions 
Ingredients used for animal feed that have been contaminated typically have been 
done so by multiple organisms and, therefore, contain more than one mycotoxin. This 
makes the evaluation of individual mycotoxins more difficult when using naturally 
contaminated feed ingredients. In this situation, animals eating the contaminated feed 
might show a combination of the symptoms described above due to synergistic (effect is 
greater than the sum of the two), additive (effect is equal to the sum of each component), 
and/or antagonistic (effects act in opposition) effects. Figure 2.16 depicts some of the 
currently know synergistic and additive effects of mycotoxins in pigs.  
 
 
Figure 2.16. Mycotoxin interactions in swine (Borutova and Pedrosa, 2011). 
Abbreviations: AFB1, Aflatoxin B1; FB1, Fumonisin B1; DON, Deoxynivalenol; OTA, 
Ochratoxin A; ZON, Zearalenone; FA, Fusaric acid; DAS, Diacetoxyscirpenol; CPA, 
Cyclopiazonic acid; MON, Moniliformin. 
Synergistic 
 Additive 
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Table 2.2 shows synergistic and additive effects of mycotoxins in pigs. The 
primary mycotoxin interactions studied in pigs have been between deoxynivalenol and 
fusaric acid, deoxynivalenol and fumonisin B₁, aflatoxin and ochratoxin, and aflatoxin 
and T-2 ( Huff et al., 1988; D'Mello et al., 1999). Creppy et al. (2004) observed negative 
health effects (pulmonary edema, and kidney and liver lesions) common to FB1 and 
ochratoxin when both mycotoxins were detected in the feed. In contrast, Speijers and 
Speijers (2004) demonstrated suppression of antibody formation when ochratoxin and 
FB₁ or deoxynivalenol were combined. Zielonka et al. (2009) reported histopathological 
lesions caused by deoxynivalenol when in combination with zearalenone. The antibody 
suppression and histopathological lesions presented in the previous two studies do not 
typically occur when the mycotoxins involved are individually consumed. 
   
 
Table 2.2. Mycotoxin interactions in swine1,2 
Mycotoxin Species tested Effect Reference 
AFB1+ OTA Pigs Synergistic (D'Mello et al., 1999; Huff et al., 1988) 
AFB₁ + FB₁ Growing pigs Synergistic (Harvey et al., 1995) 
AFB₁ + FB₁ Pigs Synergistic (Liu et al., 2002) 
AFB₁ + T₂ Pigs Synergistic (D'Mello et al., 1999) 
DON + FA Pigs Synergistic (D'Mello et al., 1999; Raymond et al., 2005) 
MON + FB₁ Pigs Additive (D'Mello et al., 1999) 
MON + DON Pigs Additive (D'Mello et al., 1999) 
OTA + DON Weaned piglets Synergistic (Speijers and Speijers, 2004) 
OTA + FB₁ Weaned piglets Synergistic 
(Creppy et al., 2004; Speijers and Speijers, 
2004) 
OTA + T₂ Weaned piglets Additive (Speijers and Speijers, 2004) 
DON + ZON Pigs Synergistic (Zielonka et al., 2009) 
FB₁ + DAS Pigs Additive (D'Mello et al., 1999) 
FB₁ + DON Pigs Synergistic (D'Mello et al., 1999; Huff et al., 1988; Speijers and Speijers, 2004) 
1 Adapted from Borutova and Pedrosa, 2011 
2 Abbreviations: AFB₁ – Aflatoxin B₁; FB₁ – Fumonisin B₁; DON – Deoxynivalenol; OTA – Ochratoxin 
A; ZON – Zearalenone; FA – Fusaric acid; DAS – Diacetoxyscirpenol; MON – Moniliformin 
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Reduced feed intake is a primary symptom of many mycotoxins as previously 
described. DON is arguably one of the most potent feed intake-reducing mycotoxins in 
pigs. One exception is zearalenone which does not appear to affect feed intake. However, 
when DON and zearalenone are present in feed at the same time the reduction in feed 
intake appears to be greater than DON alone. Table 2.3 gives some examples of the 
additive effects of DON and zearalenone on feed intake when fed to pigs. DON and 
zearalenone might have an additive effect on feed intake but it appears that most of the 
reduction in feed intake is primarily from the presence of DON.
 
 
Table 2.3. Feed intake in response to deoxynivalenol (DON) and zearalenone (ZEA) 
contaminated feed in swine.1 
Source of 
DON 
DON, 
ppm 
ZEA, 
ppm Sex 
Age or 
BW 
Feed 
intake2 Reference 
Purified 
3.6 1 
Not stated 20-24 Kg 
-20% 
(Forsyth et al., 
1977) 7.2 1 -44% 
40 1 -90% 
Natural (corn) 3.6 6.7 Gilts 3 wk -23% (Young et al., 1981) 
Natural (corn) 0.75-2 0.03-0.28 Barrows, gilts 3-7 wk -8% 
(Trenholm et al., 
1984) 
Natural 
(wheat) 3.7 0.4 Boars, gilts 23-53 kg -25% (Friend et al., 1986) 
Natural (corn) 4.2 0.2 Boars, gilts 23-53 kg -25% (Friend et al., 1986) 
1Adapted from Diekman and Green, 1992. 
2Feed intake of pigs on contaminated feed compared to a control. 
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2.5. Conclusion 
Vitamin K is an under-represented vitamin in the literature with respect to swine. 
The classic function of vitamin K, decreasing prothrombin time, has been validated. 
However, more recent information from rodent and human research has become available 
and possibly links vitamin K to the cell life cycle (protein C and gelatinase A) and 
changes in bone characteristics (OC). The results from these studies are not consistent 
and it is unknown whether the same effects can be shown in swine.  
Therefore, the objectives of the present research were to: 1) compare the growth 
performance of weanling pigs offered diets with and without corn containing mycotoxins 
in combination with three levels of vitamin K, 2) compare the growth performance of 
pigs fed three levels of vitamin K in the growing and finishing phases, 3) determine the 
effects of vitamin K on blood parameters, bone mineral density, and physical bone 
parameters during the growing and finishing stages of production. 
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CHAPTER 3. Effects of supplemental vitamin K on growth performance, bone health, 
and related blood parameters of pigs from weaning to finish.  
 
3.1. Introduction 
Vitamin K consists of phylloquinone, menaquinones, and menadione. 
Phylloquinone in forage, along with menaquinones synthesized by intestinal microbes, 
are the main sources for horses and assumed to meet the requirement (NRC, 2007). 
Phylloquinone and menaquinone-4 are often used as vitamin K supplements for humans 
(Cornelissen et al., 1997; Knapen et al., 2007). Cereal grains are relatively low in vitamin 
K (McDowell, 2000; Siciliano et al., 2000). Therefore, vitamin K is supplemented 
primarily as menadione to pigs (NRC, 2012) and poultry (NRC, 1994). Availability of 
microbial vitamin K for pigs is most likely to be low due to modern housing and waste 
management and the use of antibiotics in feed.  
There are currently twelve known proteins that are dependent upon the gamma-
carboxylation process by vitamin K to be fully active. Historically, impairment of blood 
coagulation is the major clinical sign of vitamin K deficiency. Vitamin K status with 
respect to blood clotting is typically established through evaluating prothrombin time 
(conversion of prothrombin to thrombin). This method for evaluating vitamin K status 
has been validated in many species including humans, mice, and swine (Hall et al., 1991; 
Sato et al., 2002; Simon et al., 2002).  
The current requirement estimate for vitamin K in swine is 0.5 mg of vitamin K 
(as menadione) per kg of diet (NRC, 2012). Vitamin K had no effect on gain, feed intake, 
or feed conversion, but decreased prothrombin time when fed to growing pigs for 16 
weeks at levels ranging from 1.1 to 110 mg/kg diet (Seerley et al., 1976). Growth 
performance characteristics were also not affected in another study where 7, 38, and 55 
kg pigs were fed 1 mg/kg diet (Brooks et al., 1973).  
Vitamin K has been implicated in diseases affecting bone health. OC, a protein 
produced by osteoblast cells of the bone, is dependent on vitamin K gamma-
carboxylation to bind Ca and deposit it in bone tissue (Beresford et al., 1984; Lian and 
Gundberg, 1988; Vermeer et al., 2004). In humans, vitamin K stimulates bone formation 
by human osteoblasts (Koshihara et al., 1996) and bone mineral density increased in 
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osteoporotic test subjects receiving vitamin K supplementation in as little as 6 months 
(Shiraki et al, 2000). Craciun et al. (1998) showed that dietary vitamin K increased bone 
formation and decreased bone resorption in long-distance runners. Vitamin K deficiency 
decreases bone mass and bone strength in rats and mice (Takeuchi et al., 2000; Simon et 
al., 2002). The effect of vitamin K administration on bone quality has not been reported 
in pigs. 
Stress from weaning is accompanied by body weight loss as a result of reduced 
feed intake caused by many factors including a change in diet, a new environment, and 
establishing social status (Weary et al., 2008; Meulen et al., 2010; McLamb et al., 2013). 
Exposure to mycotoxin contaminated corn at this stage of production can exacerbate the 
effects of weight loss post weaning possibly as a result of feed refusal and/or altered 
nutrient content of the contaminated feed (Friend et at., 1992). Some mycotoxins, such as 
aflotoxin, can cause systemic hemorrhages (Miller et al. 1981, 1982). The effects of 
aflatoxins in pigs vary, depending on age, diet, toxin concentration, and length of 
exposure (Andretta et al., 2012). Swine appear to be resistant to dietary levels of 
aflatoxins up to 300 ppb fed from time of weaning to marketing when adequate protein is 
available (Monegue et al. 1977). Administration of dietary vitamin K may be able to 
counter aflotoxin-related hemorrhaging. No information is available on the effects of 
vitamin K on other mycotoxins. 
Two experiments were conducted with the objectives being: 1) to compare the 
growth performance of weanling pigs offered diets with and without corn containing 
mycotoxins in combination with three levels of vitamin K, 2) to compare the growth 
performance of pigs fed three levels of vitamin K in the growing and finishing phases, 
and 3) to determine the effects of vitamin K on blood parameters, bone mineral density, 
and physical bone parameters during the growing and finishing stages of production. 
 
3.2. Materials and methods  
3.2.1. Experimental animals and treatments  
 All experiments were conducted under protocols approved by UK’s 
Institutional Animal Care and Use Committee (IACUC). Exp. 1 (experimental ID: UK 
1110) was carried out from July 1st to November 1st of 2011 and utilized a total of 80 
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crossbred pigs [45 barrows, 35 gilts; Yorkshire x Duroc, (Yorkshire x Landrace) x 
Duroc] with an initial BW of 8.35 ± 0.03 kg. Pigs were allotted to 5 dietary treatments on 
the basis of sex, initial BW, and breed of sire in a randomized complete block design. 
The experiment was conducted as a 2 x 2 factorial +1 arrangement of treatments 
with main effects of corn quality (good corn vs. bad corn) and vitamin K level (0, 0.5, 
and 2.0 ppm). This experimental design allowed for 4 replicates of the 5 treatments with 
4 pigs/pen (15 pens consisted of 2 barrows and 2 gilts and 5 pens of 3 barrows and 1 gilt). 
Treatments for Exp. 1 were: 1) good corn + 0 ppm K, 2) good corn + 0.5 ppm K, 3) bad 
corn + 0 ppm K, 4) bad corn + 0.5 ppm K, and 5) bad corn + 2.0 ppm K. 
Exp. 2 (experimental ID: UK 1210) was carried out from July 7th to November 
19th of 2012 and utilized a total of 36 crossbred pigs [18 barrows, 18 gilts; (Yorkshire x 
Landrace x Duroc) x Chester White] with an initial BW of 6.11 ± 0.99 kg. The gilts from 
Exp. 1 (Appendix 2) were bred and used as a source of pigs to conduct Exp. 2. Pigs 
maintained the level of vitamin K fed to the dam and were allotted to pens on the basis of 
sex, initial BW, and litter in a randomized complete block design with vitamin K 
inclusion level as the main effect. This allowed for 3 replicates of the 3 treatments with 4 
pigs/pen (9 pens consisting of 2 barrows and 2 gilts). Treatments for Exp. 2 were: 1) good 
corn + 0 ppm K, 2) good corn + 0.5 ppm K, and 3) good corn + 2.0 ppm K. 
During the nursery period for both experiments pigs were housed in elevated 
nursery pens (1.22 m x 1.22 m) with plastic coated, welded wire flooring. Each pen was 
equipped with a nipple waterer and a single sided, three–hole plastic and metal feeder. At 
4 weeks of age all pigs were moved to grow-finish pens (1.22 m x 2.44 m) with concrete 
slats, with access to 2 water nipples, and a two-hole metal feeder. The pigs were allowed 
ad libitum access to feed and water during the entire experimental period.  
 
3.2.2. Experimental diets 
The diets were formulated to meet or exceed NRC (1998) requirement estimates 
for pigs based on body weight with the exception of vitamin K. Prior to the start of Exp. 1 
all pigs were fed a common diet with no vitamin K supplementation (Trt 1) for 7 days as 
an attempt to deplete the pig’s vitamin K reserves and create a common, baseline level of 
vitamin K. Following the pre-trial phase, nursery diets were fed using a two phase 
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feeding system. Phase I and II diets (Table 3.1) were fed for 14 days each. At 
approximately 45.5 and 68.2 kg of body weight grower and finisher diets were fed 
respectively (Table 3.2). These diets only contained good corn and the same formulation 
was used in both Exp. 1 and 2. The vitamin K-free vitamin premix and vitamin K source 
(MSBC, 33% vitamin K) used in this study were provided by DSM (DSM Nutritional 
Products North America, Parsippany, NJ). The inclusion levels of MSBC provided 0.50 
and 2.00 ppm vitamin K which are the current requirement estimate and 4 times the 
requirement respectively (NRC, 2012). Mycotoxin level was used to distinguish between 
“good” and “bad” corn (Table 3.3). An antibiotic (Mecadox, Phibro Animal Health, 
Fairfield, NJ) was added to the diet in an effort to reduce the fecal concentration of 
vitamin K and therefore limiting the pig’s exposure to the vitamin from gut microbes 
through coprophagy. 
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Table 3.1. Ingredient composition of nursery diets 
(%, as-fed basis) 
 
Phase1 
Ingredient I II 
Corn2 49.70 55.46 
Dehulled soybean meal (48% CP) 26.00 22.25 
Dried whey 10.00 10.00 
Spray dried animal plasma 3.00 2.00 
Fish meal, menhaden 3.00 2.00 
Lactose 4.00 4.00 
Corn oil 2.00 2.00 
DiCa phosphate 0.61 0.80 
Limestone 0.85 0.65 
Salt 0.40 0.40 
Trace mineral premix3 0.075 0.075 
Vitamin premix4 0.10 0.10 
Antibiotic5 0.25 0.25 
Antioxidant6 0.02 0.02 
Total: 100 100 
1Treatments within each Phase made through addition of vitamin K as 
MSBC (menadione sodium bisulfate complex, 33% vitamin K): Trt 1 - 
good corn + 0 ppm vit K, Trt 2 - good corn + 0.5 ppm vit K, Trt 3 - 
bad corn + 0 ppm vit K, Trt 4 - bad corn + 0.5 ppm vit K, Trt 5 - bad 
corn + 2.0 ppm vit K. Phases I and II fed for 14 days each. 
2Good and bad corn diets included 100% of their respective corn type 
as corn source. 
3Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as 
FeSO4·H2O; Mn, 45 mg as MnO; Cu, 13 mg as CuSO4·5H2O; I, 1.5 
mg as CaI2O6; Co 0.23 mg as CoCO3; Se, 0.28 mg as Na2SeO3. 
4Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; 
vitamin E, 44 IU; thiamin, 4.0 mg; riboflavin, 8.8 mg; pyridoxine, 4.4 
mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic 
acid, 22mg; D-biotin, 0.22 mg. 
5Mecadox - 10 (Phibro Animal Health, Fairfield, NJ) supplied 55 mg 
carbadox per kg of diet. 
6Santoquin (Monsanto, St. Louis, MO) supplied 130 mg ethoxyquin 
per kg of diet. 
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Table 3.2. Ingredient composition of grower and 
finisher diets (%, as-fed basis) 
 
Phase1 
Ingredient Grower Finisher 
Corn 72.27 84.92 
Dehulled soybean meal (48%) 25.25 13.00 
DiCa phosphate 0.675 0.425 
Limestone 0.900 0.750 
Salt 0.400 0.400 
Lysine HCl 0.080 0.080 
Trace mineral premix2 0.075 0.075 
Vitamin premix3 0.100 0.100 
Antibiotic4 0.250 0.250 
Total: 100 100 
1Treatments within each Phase made through addition of vitamin K as 
MSBC (menadione sodium bisulfate complex, 33% vitamin K): Trt 1 
and 3 - good corn + 0 ppm vit K, Trt 2 and 4 - good corn + 0.5 ppm 
vit K,  Trt 5 - good corn + 2.0 ppm vit K. Grower diets fed from 
approximatelly 45.5 to 68.2 kg of body weight. Finisher diet fed from 
approximately 68.2 to 113.6 kg of body weight. 
2Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as 
FeSO4·H2O; Mn, 45 mg as MnO; Cu, 13 mg as CuSO4·5H2O; I, 1.5 
mg as CaI2O6; Co 0.23 mg as CoCO3; Se, 0.28 mg as Na2SeO3. 
3Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; 
vitamin E, 44 IU; thiamin, 4.0 mg; riboflavin, 8.8 mg; pyridoxine, 4.4 
mg; vitamin B12, 33 µg; folic acid, 1.3 mg; niacin, 44 mg; pantothenic 
acid, 22mg; D-biotin, 0.22 mg. 
4Mecadox - 10 (Phibro Animal Health, Fairfield, NJ) supplied 55 mg 
carbadox per kg of diet. 
 
 
Table 3.3. Mycotoxin analysis of corn sources for Exp. 1 
 
Concentration (ppm)1 
Mycotoxin Bad corn Good corn 
Vomitoxin 5.9 0.6 
15-acetyl DON 0.5 <0.5 
Zearalenone 3.0 <0.5 
Fumonisin B1 7.0 <2.0 
Aflatoxin B1 <0.02 <0.02 
Other <0.5 <0.5 
1The practical quantitation limit (PQL) is 0.5 ppm for vomitoxin, 15-acetyl DON, and 
zearalanone. The aflatoxin PQL is 0.02 ppm and the fumonisin PQL is 2.0 ppm. 
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3.2.3. Growth performance response measures 
 Pig and feeder weights were recorded weekly to calculate ADG, ADFI, 
and G:F. Feed was added to the feeders when there was approximately 2.5 kg left. The 
feeders were checked twice daily to remove waste in the feeder trough and to make sure 
the feed had not become blocked preventing normal flow. When diets were changed at 
the end of each phase, the feeders were emptied completely before the new diet was 
added. Water nipple heights were adjusted on an as-needed basis based on the growth of 
the pigs in each pen to ensure easy access. 
 
3.2.4. Collection, preparation, and storage of blood 
All blood was collected from pigs by jugular puncture. Two blood samples were 
taken at each collection time.  Plasma was collected in a plastic tube containing sodium 
citrate and serum was collected in a second plastic tube containing a gel for serum 
separation (BD Vacutainer®, Franklin Lakes, NJ) During the nursery phase, samples 
were taken from 1 male and 1 female per pen at day 0, from all pigs at day 14, and all 
pigs at day 28. During the growing and finishing phases, blood was collected from 10 
barrows (Exp. 1) or 6 barrows and 6 gilts (Exp. 2) chosen at each time of slaughter (45.4, 
79.5, 113.6 kg). Animals were sacrificed by sodium pentobarbital overdose. Blood was 
centrifuged (607 x g at 4°C for 20 min.) to separate plasma and serum. All samples were 
frozen at -20°C until analysis. 
 
3.2.5. Prothrombin time analysis 
Prothrombin time was determined using plasma from nursery d 0 and 28, and all 
grow-finish samplings by the Quick one-stage procedure (Quick et al., 1935). In this 
procedure, 0.1 ml of citrated plasma was incubated in a 37°C water bath for 30 seconds. 
Rabbit brain thromboplastin (Sigma-Aldrich) reconstituted in CaCl2 was added as the 
extrinsic factor (0.1 ml), the mixture was gently mixed, and the time to clot was recorded 
(Appendix 4). All samples were analyzed in duplicate. 
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3.2.6. Blood Ca and OC analysis 
Total Ca in plasma was determined using procedures previously described (Hall 
et al., 1991). In this procedure 0.1 ml of plasma was combined with 4.9 ml of a 9:l 
mixture of nitric:perchloric acid. Samples were heated to 35°C in a water bath overnight, 
diluted further, and analyzed. Simultaneously, free plasma Ca was measured using 
plasma samples from the same aliquots but without acid digestion. Ca content of digested 
and undigested plasma samples was analyzed by atomic absorption spectrophotometry 
(Mode1 560 spectrophotometer, Perkin-Elmer Corp., Norwalk, CT). Serum OC was 
determined using a commercially available ELISA kit (MicroVue™ OC EIA, Quidel 
Corp.). 
 
3.2.7. Bone measurements 
Thirty barrows From Exp. 1 were selected and sacrificed to collect bone samples. 
Barrows were selected in groups of 10 (2 per trt based on nursery trt) when average pen 
weights reached 45.4, 79.5, and 113.6 kg. These weights were selected because it creates 
3 equal timepoints at which to evaluate response parameters between leaving the nursery 
and reaching market weight. Six barrows and 6 gilts (2 of each sex per trt) were selected 
at the same average weights in Exp. 2. Left and right front feet and femurs were removed 
at time of slaughter. This was done by cutting the feet off at the carpal bones between the 
metacarpals and radius and ulna. Left and right femurs were extracted from the hams. All 
bones were rinsed with warm water, placed in plastic bags, labeled either left or right side 
of the animal, and frozen. The 3rd and 4th metacarpal bones were removed from the feet 
and refrigerated overnight to thaw prior to additional measurements. The 3rd and 4th 
metacarpals from the front left foot were used for all analyses. Wet weight and length 
were recorded after excess tissue was removed from the bones. Length of femur was 
measured from the anterior-posterior grove on the distal articular surface proximally to 
the groove between the greater trochanter and the base of the femoral neck. Length of 
metacarpals was measured similarly.  
Bone breaking strength (load at failure) was conducted using an Instron 
Instrument (Model TM, Instron Corp., Canton, MA) similar to procedures described 
previously (Cromwell et al., 1972; Crenshaw, 1986; Hall et al., 1991). The instrument 
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measures kilograms of force required to break bones when placed in a horizontal position 
on supports. Fulcrum width was 3.5 and 8.5 cm for metacarpals and femurs respectively. 
The maximum force of the machine was set at 50 and 500 kg for metacarpals and femurs 
respectively. Force was applied to the shaft of the bone by an instrument moving at 5 
cm/min and measured by a pressure sensitive cell that records on a graph recorder. 
Thawed, wet bones were used as this more accurately resembles the bone in its natural 
physiological state compared to a dry bone (Crenshaw, 1981).  
A sample 1 cm in width was cut at mid shaft from both femurs. Metacarpals were 
cut in half at mid shaft. Bone marrow was physically removed from samples. Bones were 
additionally defatted in ethyl ether for 2 days, or until ether maintained a clear color, 
removing saturated, and adding new, ether every 8 hours. The extracted samples were 
dried overnight at 105°C. Bone wall area of these samples was measured using digital 
analysis software (Pickle and Gould, 2011) by taking a picture of each bone that included 
a known scale. Each individual picture was calibrated to the included scale. Inner and 
outer diameters were measured to calculate the respective areas through pixel count and 
used to calculate bone wall area by subtraction. 
Dry, fat-free femur and metacarpal samples were ashed in a muffle furnace at 
600°C for 16 h. Bone ash Ca was determined by atomic absorption of acid digested ash 
samples and P was determined using a gravimetric procedure (AOAC, 1995). 
 
3.2.8. Statistical analysis  
 Prior to analyses, all data was evaluated to identify any potential statistical 
outliers. Growth performance data was evaluated and pens having a within-pen CV 
greater than 20% for ADG, ADFI, and/or G:F were further examined. Then individual 
pig performances within the selected pens were evaluated to identify the pig most 
divergent from its pen mates. This performance was then compared with littermates on 
other treatments in the experiment to determine whether the observed abnormalities were 
simply a genetic response. Lab measurements for bone properties and composition, OC, 
prothrombin time, and plasma Ca having CV’s greater than 10, 10, 5, and 25% 
respectively were reanalyzed. Proc Univariate of SAS® (SAS Inst. Inc., Cary, NC) was 
used to aid in evaluating data and identifying outliers.   
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 The experimental data was analyzed using the least squares analysis of 
variance (Proc GLM) procedure of SAS® (SAS Inst. Inc., Cary, NC). The experimental 
unit was pen for all nursery data and grow-finish performance data. Pig was the 
experimental unit for grow-finish blood Ca, OC, prothrombin time, and bone 
measurements. The statistical model included treatment and replicate. Linear, quadratic, 
and single degree of freedom comparisons were made for level of K inclusion within and 
between corn types to evaluate any possible interactions. Treatment least squares means 
were calculated using the LSMEANS function of SAS. Proc IML was used to determine 
linear and quadratic contrast coefficients for treatments with unequal spacing. Linear and 
quadratic contrasts evaluated the 3 levels of vitamin K (0, 0.5, and 2.0 ppm) in the “bad 
corn” diets. The data from Exp. 2 was analyzed for an interaction between treatment and 
sex (Appendix 3). With the exception of plasma Ca (Table A3.1), no sex effects were 
detected. The differences in plasma Ca between gilts and barrows are thought to be due to 
high analytical error and are false positives.  Differences were considered significant at P 
< 0.05 and having a tendency for significance at P < 0.10. 
 
3.3. Results 
No animals were removed from the data pool prior to analysis. A feed mixing 
error was discovered after animals had already begun the nursery period in Exp. 1. The 
nursery phase I diet was mixed with 0.5% trace mineral premix rather than the suggested 
0.075% (6.67 x). While this exceeded the planned level of inclusion, none of the minerals 
were at toxic levels (NRC, 2012). Phase 2 nursery and grow-finish diets were mixed with 
the appropriate amount of mineral premix.  No hemorrhaging from mycotoxin exposure 
was observed (coughing up blood or blood in the feces). Common to zearalonone 
exposure, we observed that barrows receiving bad corn had swollen teats and gilts had 
swollen teats and vulvas after just 5 days of receiving the treatments and existed for the 
entirety of Exp. 1. 
 
3.3.1. Growth performance 
Growth performance results for Exp. 1 are shown in Tables 3.4 and 3.5 for 
nursery and grower-finisher phases of the study, respectively. During the nursery phase in 
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Exp. 1 (Table 3.4) ADG (P = 0.005) and ADFI (P = 0.015) were greater for pigs 
receiving good corn than compared to pigs receiving bad corn throughout the entire 28 
day period demonstrating that there was a corn effect. When vitamin K was added to the 
diets the decrease in ADG and ADFI is no longer present (P ≥ 0.10). Within good corn 
treatments those receiving vitamin K had numerically lower ADG and ADFI. Those same 
pigs were also numerically less efficient. 
Within pigs on the bad corn diets, those receiving 0.5 ppm K were gaining the 
most (+21 g/d) at the end of the nursery period. However, pigs receiving good corn with 
the same amount of supplemental vitamin K gained less (-21 g/d) than the control. These 
were not significantly different from control values. Similar to ADG, within the bad corn 
diets ADFI was greatest in pigs receiving 0.5 ppm K (+39 g/d). Feed efficiency did not 
differ between corn types or vitamin K inclusion level. However, inclusion of 2 ppm 
resulted in the greatest feed efficiency in Phases I and II individually as well as in the two 
phases combined.  While there were no significant quadratic effects, there appears to be a 
quadratic nature to ADG, ADFI, and feed efficiency in response to inclusion of vitamin K 
within bad corn diets. There were several instances where response measures increased 
from 0 to 0.5 ppm vitamin K, but then decreased from 0.5 to 2 ppm vitamin K. 
The grower and finisher phases (Table 3.5) show a loss of most of the corn type 
effect. This was expected since all pigs were switched to good corn at the beginning of 
the grower phase. There is some residual effect of corn type in total trial ADG (P = 
0.045). There may be a small amount of compensatory gain shown in pigs on Treatments 
3-5 since their switch to the good corn because, by the end of the finisher phase, pigs that 
were on bad corn diets in the nursery phase have matched or exceeded the BW, ADG, 
and ADFI of pigs offered good corn since weaning. Therefore, in the current study there 
appears to be no long term effects on growth performance in pigs fed these levels of 
toxins in corn.  
Growth performance results for Exp. 2 are shown in Tables 3.6 and 3.7 for 
nursery and grower-finisher phases of the study respectively. Nursery body weight 
differences are due to heavier pigs at weaning from gilts receiving 0.5 ppm vitamin K 
(Appendix 2). Those pigs gained more and ate more compared to pigs on the other two 
treatments. This is a typical observation from larger pigs. Vitamin K level did not affect 
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daily gain, feed intake, or feed efficiency in the nursery (P > 0.10). Vitamin K level did 
not affect daily gain or feed efficiency of growing and finishing pigs (Table 3.7). Feed 
intake of pigs receiving 0.5 ppm K decreased (-0.10 kg), but intake increased (+0.13 kg) 
in pigs receiving 2.0 ppm K compared to the control from d69-103 (linear = 0.044, 
quadratic = 0.062). 
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Table 3.6. Effects of dietary vitamin K inclusion on growth performance of nursery pigs 
(Exp. 2) 
 
Vitamin K (ppm) 
 
P-values1 
Performance trait (n=3)2 0 0.5 2 SE Trt Vit. K L Q 
Body weight, kg 
        Initial 5.55 6.96 5.79 0.10 0.001 0.003 0.27 0.001 
Final 18.75 21.76 18.81 0.72 0.067 0.16 0.43 0.031 
         Daily gain, g 
        Phase I 370 408 334 19 0.13 0.96 0.13 0.13 
Phase II  573 649 596 32 0.33 0.27 0.98 0.16 
Phase I & II 471 529 465 23 0.21 0.41 0.47 0.11 
         Daily feed, g 
        Phase I 517 538 476 23 0.26 0.74 0.18 0.34 
Phase II  984 1079 995 37 0.25 0.30 0.75 0.12 
Phase I & II 751 809 736 29 0.29 0.58 0.44 0.17 
         Gain:feed 
        Phase I 0.713 0.759 0.703 0.028 0.42 0.63 0.56 0.25 
Phase II  0.582 0.601 0.599 0.012 0.53 0.29 0.50 0.39 
Phase I & II 0.627 0.654 0.633 0.013 0.39 0.36 0.92 0.20 
1 Contrasts include Vit. K (Compares 0 ppm vs. 0.5 + 2 ppm), L (linear), and Q (quadratic). 
2 Nursery Phases I and II were conducted for 14 days each. 
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Table 3.7. Effects of vitamin K inclusion on growth performance of growing and 
finishing pigs (Exp. 2) 
 
Vitamin K (ppm) 
 
P-values1 
Performance trait2 0 0.5 2 SE Trt Vit. K L Q 
Body weight, kg 
        Initial 18.75 21.76 18.81 0.72 0.067 0.16 0.43 0.031 
Final 112.48 113.73 113.84 - - - - - 
         Daily gain, kg 
        d28-68 0.73 0.74 0.71 0.02 0.47 0.77 0.31 0.53 
d69-103 1.00 0.98 1.04 0.02 0.21 0.51 0.14 0.34 
d104-129 1.07 0.93 1.02 - - - - - 
         Daily feed, kg 
        d28-68 2.18 2.21 2.28 0.11 0.79 0.64 0.52 0.99 
d69-103 2.76 2.66 2.89 0.03 0.053 0.71 0.044 0.062 
d104-129 3.19 3.42 3.94 - - - - - 
         Gain:feed 
        d28-68 0.338 0.336 0.314 0.019 0.66 0.62 0.39 0.87 
d69-103 0.361 0.370 0.361 0.007 0.63 0.65 0.78 0.41 
d104-129 0.335 0.272 0.259 - - - - - 
1Contrasts include Vit. K (Compares 0 ppm vs. 0.5 + 2 ppm), L (linear), and Q (quadratic). 
2The nursery phase ended and the grower phase started on d28. One complete rep was sacrificed on days 68 and 103 
to collect bone samples. n = 3, 2, 1 and 1 for d29-68, d69-103, d104-129, and final body weight respectively. 
 
 
3.3.2. Blood metabolites 
 Prothrombin time results for Exp. 1 are shown in Table 3.8. The effects of 
vitamin K on prothrombin time were similar in both the nursery and grow-finish phases. 
The addition of 0.5 ppm of vitamin K decreased prothrombin time by approximately 1.8 
seconds by the end of the nursery phase (P < 0.0001) and 2.2 seconds by the end of the 
grow-finish phase (P ≤ 0.006) compared to no vitamin K. Increasing the inclusion level 
of vitamin K beyond 0.5 ppm to 2.0 ppm did not result in an additional decrease in 
prothrombin time. Corn type did not affect prothrombin time. Pigs harvested at 
approximately 113.6 kg had an increased prothrombin time compared to the previous 2 
slaughter groups of 45.4 and 79.5 kg. This may indicate a biological change in 
coagulation reagent concentrations. It appears that the current dietary vitamin K 
recommendation of 0.5 ppm is adequate for activating the coagulation cascade in pigs 
during these stages of production.  
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Prothrombin time results for Exp. 2 are shown in Table 3.9. The effects of vitamin 
K on prothrombin time were similar in both the nursery and grow-finish phases. The 
addition of 0.5 ppm of vitamin K decreased prothrombin time by approximately 1.7 
seconds by the end of the nursery phase (P < 0.0001) and by the end of the grow-finish 
phase (P < 0.0001) compared to no vitamin K. Increasing the inclusion level of vitamin K 
beyond 0.5 pm to 2.0 ppm did not result in an additional decrease in prothrombin time 
similar to Exp. 1.  
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Table 3.9. Effects of vitamin K on prothrombin time (seconds) of nursery, growing, and 
finishing pigs (Exp. 2) 
  
Vitamin K (ppm) 
 
P-values1 
    0 0.5 2 SE Trt Vit. K L Q 
Nursery 
         Initial (n=6) 18.15 18.46 18.19 0.13 0.22 0.28 0.78 0.09 
Final (n=12) 18.41 16.71 16.55 0.13 <.0001 <.0001 <.0001 <.0001 
Grow-finish (n=4) 
        45.4 kg 
 
18.33 16.56 16.60 0.15 <.0001 <.0001 0.0001 <.0001 
79.5 kg 
 
18.49 16.69 17.19 0.29 0.005 0.002 0.060 0.003 
113.6 kg   18.73 17.03 17.00 0.12 <.0001 <.0001 <.0001 <.0001 
1Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic). 
 
 
Serum OC results for Exp. 1 are shown in Table 3.10. Vitamin K did not affect 
OC concentrations with the exception of 2 ppm vitamin K increasing soncentrations in 
final nursery samples. Corn type did not affect OC concentrations. Biologically, OC 
concentrations numerically increased over time in the nursery and generally decreased as 
pigs grew during the growing and finishing periods. OC was numerically the lowest in 
nursery pigs fed 0.5 ppm vitamin K within both good and bad corn groups. 
 Serum OC results for Exp. 2 are shown in Table 3.11. Initial OC 
concentrations were not the same across treatments. There was a quadratic response (P = 
0.029) with concentrations the lowest in pigs fed 0.5 ppm K. At the end of the nursery 
phase OC linearly increased (P = 0.035) with increasing dietary K. A similar response is 
seen in 45.4 kg barrows (P = 0.009, linear). However, in 79.5 and 113.6 kg barrows there 
was no response to K level. 
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Table 3.11. Effects of dietary vitamin K on serum OC concentrations (ng/ml) of nursery, 
growing, and finishing pigs (Exp. 2) 
 
Vitamin K (ppm) 
 
P-values1 
  0 0.5 2 SE Trt Vit. K L Q 
Nursery (n=3) 
        Initial 620 493 522 30 0.043 0.04 0.13 0.029 
Final 386 410 458 23 0.09 0.16 0.035 0.82 
Grow-finish (n=4) 
        45.4 kg 319 291 497 44 0.019 0.20 0.009 0.23 
79.5 kg 332 343 276 56 0.67 0.75 0.42 0.73 
113.6 kg 415 410 366 59 0.81 0.71 0.53 0.93 
1Contrasts include Vit. K (Compares 0 vs. 0.5 + 2.0 ppm K), L (linear), and Q (quadratic). 
 
 
Plasma Ca concentrations for Exp. 1 are shown in Tables 3.12 and 3.13 for the 
nursery and grow-finish periods respectively. Plasma Ca concentrations at weaning were 
not the same across treatments. Total plasma Ca has been reported in the range of 8-12 
mg/dl for pigs (Carter et al., 1996). In this study, total plasma Ca was greater than 12 
mg/dl in 45.4 and 79.5 kg barrows. Total Ca at the end of the nursery period was higher 
in pigs receiving vitamin K than those receiving no vitamin K (P = 0.043). Free Ca 
concentrations were not affected by treatment so the extra Ca detected must be in the 
bound form. At all sampling time points approximately half of the Ca in the plasma was 
in the bound form leaving the remaining half in the free or ionized form. Corn type did 
not affect the plasma Ca concentration in the nursery. Similarly, corn type in the nursery 
did not affect Ca concentrations during the grow-finish period.  
Plasma Ca concentrations for Exp. 2 are shown in Table 3.14. Nursery plasma Ca 
concentrations were unaffected by dietary treatment. At 45.4 kg, total Ca decreased 
linearly (P = 0.017) while free Ca and % free increased linearly (P = 0.003) with 
increased vitamin K. At 113.6 kg, total Ca did not differ between treatments. Free Ca (P 
= 0.0002) and % free (P = 0.0012) decreased linearly as dietary vitamin K increased. 
Plasma Ca concentrations at 79.5 kg were not affected by vitamin K level. Total Ca 
concentrations at the beginning of nursery and at 113.6 kg were numerically higher than 
the upper limit of normal plasma Ca levels.  
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Table 3.14. Effects of vitamin K on plasma Ca concentrations (mg/dl) of nursery, 
growing, and finishing pigs (Exp. 2) 
 
Vitamin K (ppm) 
 
P-values1 
Period 0 0.5 2 SE Trt Vit. K L Q 
Nursery 
        Initial (n=6) 
        Total  13.72 14.16 14.18 0.42 0.68 0.39 0.51 0.55 
Free  6.34 6.94 6.72 0.34 0.46 0.25 0.61 0.26 
Free (%) 46.3 49.1 47.5 2.3 0.69 0.48 0.89 0.40 
Final (n=12) 
        Total  10.12 9.51 10.19 0.30 0.24 0.47 0.53 0.12 
Free  3.31 3.74 3.49 0.19 0.30 0.20 0.81 0.13 
Free (%) 33.0 40.3 34.9 2.5 0.11 0.14 0.96 0.039 
Grow-finish (n=4) 
        45.4 kg 
        Total  14.09 12.48 11.74 0.50 0.028 0.012 0.017 0.15 
Free  6.49 6.71 7.46 0.17 0.010 0.024 0.003 0.90 
Free (%) 46.4 54.2 63.5 2.8 0.007 0.006 0.003 0.34 
79.5 kg 
        Total  11.4 11.2 10.8 0.51 0.71 0.50 0.44 0.85 
Free  5.71 5.41 5.64 0.26 0.70 0.58 0.95 0.42 
Free (%) 50.0 48.4 52.9 3.5 0.66 0.88 0.46 0.61 
113.6 kg 
        Total  15.5 15.7 15.4 0.31 0.84 0.86 0.79 0.61 
Free  8.2 7.2 6.6 0.16 0.0003 0.0002 0.0002 0.018 
Free (%) 53.0 46.0 42.8 1.3 0.0018 0.0007 0.0012 0.028 
1Contrasts include K (Compares 0 vs. 0.5 + 2.0 ppm K), L (linear), and Q (quadratic). 
 
 
3.3.3. Bone properties 
The physical and chemical properties of bones from barrows at 45.4, 79.5, and 
113.6 kg of body weight in response to dietary vitamin K inclusion level are shown in 
Tables 3.15 through 3.20. Breaking strength of femurs from all slaughter periods and 
treatments of both Exp. 1 and Exp. 2 exceeded the maximum capacity of the machine 
(500 kg). Therefore, femur breaking strength is not reported. 
 In 45.4 kg barrows from Exp. 1, (Table 3.15) metacarpal P was less (P = 0.038, 
linear) in barrows fed 2 ppm vitamin K. Femur P tended to be higher (P = 0.056, linear) 
 
69 
 
in barrows fed 2.0 ppm vitamin K. All other metacarpal and femur characteristics were 
unaffected by treatment. It is worth noting the high Ca:P in the metacarpals (3.1, 2.8, and 
2.4) which decreased as vitamin K level in the diet increased. At 79.5 kg (Table 3.16) 
length (7.3, 7.2, and 6.9 cm; P = 0.002, linear) and dry fat-free metacarpal weights (11.8, 
11.6, 10.1 g; P = 0.016, linear) decreased linearly with increasing dietary inclusion of 
vitamin K. Femur P was significantly lower in barrows fed 0.5 ppm vitamin K (19.8, 
17.9, and 19.4 %, P = 0.004, quadratic). Other metacarpal and femur properties were not 
affected by treatment. At 113.6 kg (Table 3.17), the vitamin K treatment did not affect 
metacarpal and femur properties. However, metacarpal wet (37.5, 36.7, and 33.7 g) and 
dry, fat-free (15.9, 15.6, and 15.0 g) weights decreased in a seemingly linear manner as 
dietary vitamin K inclusion increased, similar to what was seen in 79.5 kg barrows. 
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Table 3.15. Physical and chemical properties of bones from 45.4 kg barrows in response 
to dietary vitamin K (Exp. 1) 
 
Vitamin K (ppm)1 
 
P-value 
Item2 0 0.5 2 RMSE3 Trt L Q 
Metacarpal 
       Breaking strength (kg) 80.6 85.5 75.8 12.8 0.68 0.56 0.49 
Wet wt. (g) 18.3 18.8 18.9 1.9 0.90 0.77 0.75 
Dry, fat-free wt. (g) 7.5 7.4 7.8 0.3 0.48 0.33 0.42 
Length (cm) 6.1 6.5 6.5 0.2 0.10 0.15 0.11 
Bone wall area (mm2) 75.5 76.3 82.2 8.1 0.64 0.36 0.88 
Ash (%) 43.8 45.4 43.7 2.0 0.50 0.73 0.26 
Ca (%) 56.1 49.8 41.2 10.4 0.32 0.17 0.72 
P (%) 18.0 18.0 17.1 0.4 0.09 0.038 0.43 
Ca:P 3.1 2.8 2.4 0.6 0.43 0.26 0.68 
Femur        
Wet wt. (g) 172.6 187.5 183.6 14.4 0.39 0.58 0.24 
Length (cm) 15.7 15.3 15.7 0.4 0.44 0.76 0.22 
Bone wall area (mm2) 129.4 153.5 170.9 24.0 0.32 0.18 0.49 
Ash (%) 68.1 67.2 66.3 1.8 0.65 0.40 0.73 
Ca (%) 39.7 38.7 38.7 1.5 0.73 0.60 0.55 
P (%) 20.1 19.7 20.8 0.3 0.055 0.056 0.10 
Ca:P 2.0 2.6 1.9 1.1 0.65 0.76 0.43 
1n = 3, 3, and 2 for 0, 0.5, and 2 ppm vitamin K respectively. 
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
3RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Table 3.16. Physical and chemical properties of bones from 79.5 kg barrows in response 
to dietary vitamin K (Exp. 1) 
 
Vitamin K (ppm)1 
 
P-value 
Item2 0 0.5 2 RMSE3 Trt L Q 
Metacarpal 
       Breaking strength (kg) 120.3 143.0 117.0 29.3 0.49 0.69 0.26 
Wet wt. (g) 29.1 28.4 24.8 2.4 0.19 0.080 0.82 
Dry, fat-free wt. (g) 11.8 11.6 10.1 0.6 0.044 0.016 0.63 
Length (cm) 7.3 7.2 6.9 0.1 0.004 0.002 0.46 
Bone wall area (mm2) 99.9 104.3 73.6 17.2 0.18 0.09 0.36 
Ash (%) 50.6 51.3 50.9 2.3 0.93 0.97 0.72 
Ca (%) 27.3 32.8 33.3 7.8 0.57 0.51 0.46 
P (%) 15.8 16.6 17.3 2.6 0.80 0.56 0.84 
Ca:P 1.7 2.0 1.9 0.3 0.55 0.65 0.36 
Femur        
Wet wt. (g) 280.4 278.1 247.1 18.3 0.16 0.07 0.63 
Length (cm) 18.1 18.0 17.6 0.4 0.45 0.22 0.78 
Bone wall area (mm2) 214.4 206.0 174.6 26.5 0.29 0.13 0.93 
Ash (%) 68.4 68.8 69.3 0.6 0.29 0.17 0.58 
Ca (%) 38.5 36.8 38.4 1.1 0.15 0.74 0.063 
P (%) 19.8 17.9 19.4 0.6 0.012 0.82 0.004 
Ca:P 2.0 2.1 2.0 0.1 0.29 0.99 0.13 
1n = 3, 3, and 2 for 0, 0.5, and 2 ppm vitamin K respectively. 
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
3RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Table 3.17. Physical and chemical properties of bones from 113.6 kg barrows in 
response to dietary vitamin K (Exp. 1) 
 
Vitamin K (ppm)1 
 
P-value 
Item2 0 0.5 2 RMSE3 Trt L Q 
Metacarpal 
       Breaking strength (kg) 144.3 159.2 163.5 19.7 0.50 0.40 0.48 
Wet wt. (g) 37.5 36.7 33.7 3.2 0.45 0.23 0.95 
Dry, fat-free wt. (g) 15.9 15.6 15.0 1.0 0.66 0.39 0.95 
Length (cm) 7.9 7.7 7.8 0.3 0.61 0.77 0.38 
Bone wall area (mm2) 119.0 112.4 110.8 13.4 0.73 0.59 0.63 
Ash (%) 53.1 52.9 55.6 1.8 0.30 0.15 0.51 
Ca (%) 32.7 32.9 33.3 2.3 0.96 0.78 0.99 
P (%) 15.6 15.8 15.6 1.7 0.99 0.93 0.91 
Ca:P 2.1 2.1 2.1 0.1 0.82 0.57 0.83 
Femur        
Wet wt. (g) 381.6 381.4 358.5 31.2 0.69 0.42 0.80 
Length (cm) 20.4 20.2 19.9 0.5 0.51 0.29 0.80 
Bone wall area (mm2) 225.6 240.3 220.4 27.7 0.68 0.70 0.43 
Ash (%) 70.3 69.7 71.0 1.1 0.43 0.35 0.32 
Ca (%) 38.9 37.7 37.0 1.5 0.39 0.26 0.53 
P (%) 18.2 18.7 18.0 0.4 0.30 0.49 0.16 
Ca:P 1.9 2.0 1.9 0.3 0.89 0.97 0.65 
1n = 3, 3, and 2 for 0, 0.5, and 2 ppm vitamin K respectively. 
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
3RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
 
 
Physical characteristics of metacarpals and femurs from 45.4 kg pigs of Exp. 2 are 
shown in Table 3.18. Metacarpal mineral content did not differ between treatments. 
Femur P was 1.5% greater (P = 0.015) and Ca was 0.9 % lower in pigs fed 2 ppm K 
compared to controls which resulted in a lower Ca:P ratio (1.4; P = 0.004, linear). At 79.5 
kg (Table 3.19) metacarpal wet weight (P = 0.005) and length (P = 0.008) increased 
linearly as dietary vitamin K increased. The addition of 0.5 ppm K did not affect femur P 
but 2.0 ppm K increased it by 1.5 % (P = 0.04). Other metacarpal and femur responses at 
79.5 kg were unaffected by treatment.  At 113.6 kg (Table 3.20) metacarpals from pigs 
receiving 2 ppm K were heavier, longer, and had a greater bone wall area, numerically, 
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compared to the other two treatments. The same bones also required a numerically 
greater force to be broken. However, the treatment means are not statistically different. 
Metacarpal Ca increased (P = 0.042, linear) as dietary vitamin K increased. Femur length 
decreased (P = 0.010, linear) and Ca decreased (P = 0.038, linear) as dietary vitamin K 
increased. Ca:P was significantly lower in femurs from pigs receiving vitamin K (1.8 vs. 
1.5, P = 0.019). It is worth noting that femur Ca:P is lower than that of metacarpals at all 
weights in Exp. 2. 
 
Table 3.18. Physical and chemical properties of bones from 45.4 kg barrows and gilts in 
response to dietary vitamin K (Exp. 2) 
 
Vitamin K (ppm) 
 
P-value1 
Item2 (n=4) 0 0.5 2 SE Trt Vit. K L Q 
Metacarpal 
        Breaking strength (kg) 50.5 54.5 38.6 2.7 0.007 0.27 0.004 0.07 
Wet wt. (g) 16.7 18.1 17.4 0.7 0.45 0.29 0.79 0.23 
Dry, fat-free wt. (g) 6.7 7.9 6.7 0.2 0.006 0.049 0.29 0.002 
Length (cm) 6.2 6.6 6.5 0.1 0.16 0.07 0.27 0.11 
Bone wall area (mm2) 47.8 52.9 44.1 1.4 0.006 0.69 0.018 0.009 
Ash (%) 46.4 43.7 43.0 0.9 0.08 0.030 0.059 0.17 
Ca (%) 34.7 35.9 36.1 0.7 0.37 0.18 0.27 0.38 
P (%) 18.5 19.2 18.0 0.4 0.13 0.88 0.16 0.13 
Ca:P 1.9 1.9 2.0 0.03 0.031 0.16 0.012 0.41 
Femur 
        
Wet wt. (g) 161.0 182.4 160.0 4.7 0.014 0.11 0.26 0.006 
Length (cm) 14.9 15.6 14.9 0.1 0.013 0.08 0.35 0.005 
Bone wall area (mm2) 133.7 164.1 118.2 4.7 0.0002 0.23 0.003 0.0003 
Ash (%) 68.6 67.3 63.2 2.1 0.23 0.23 0.09 0.99 
Ca (%) 31.2 30.1 28.3 1.1 0.20 0.16 0.08 0.82 
P (%) 18.2 18.2 19.7 0.4 0.038 0.15 0.015 0.50 
Ca:P 1.7 1.7 1.4 0.05 0.011 0.027 0.004 0.91 
1Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
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Table 3.19. Physical and chemical properties of bones from 79.5 kg barrows and gilts in 
response to dietary vitamin K (Exp. 2) 
 
Vitamin K (ppm) 
 
P-value1 
Item2 (n=4) 0 0.5 2 SE Trt Vit. K L Q 
Metacarpal 
        Breaking strength (kg) 128.6 127.3 101.0 12.9 0.28 0.38 0.13 0.75 
Wet wt. (g) 23.3 24.7 27.9 0.9 0.015 0.024 0.005 0.86 
Dry, fat-free wt. (g) 11.2 11.3 12.6 0.6 0.22 0.32 0.10 0.75 
Length (cm) 6.9 7.1 7.4 0.1 0.024 0.025 0.008 0.65 
Bone wall area (mm2) 64.7 72.1 75.4 3.3 0.12 0.056 0.07 0.30 
Ash (%) 51.3 48.7 47.0 1.9 0.34 0.18 0.18 0.56 
Ca (%) 34.7 36.5 37.0 1.2 0.41 0.20 0.28 0.44 
P (%) 16.8 17.7 17.9 0.4 0.14 0.058 0.11 0.22 
Ca:P 2.1 2.1 2.1 0.04 0.99 0.92 0.96 0.93 
Femur 
        
Wet wt. (g) 236.1 260.1 264.0 11.5 0.23 0.10 0.18 0.27 
Length (cm) 17.0 17.6 17.3 0.2 0.15 0.09 0.57 0.07 
Bone wall area (mm2) 189.8 199.9 201.3 13.4 0.81 0.53 0.62 0.68 
Ash (%) 69.0 69.6 69.1 0.4 0.63 0.53 0.93 0.35 
Ca (%) 29.7 29.6 30.1 0.5 0.81 0.86 0.58 0.77 
P (%) 18.8 18.2 18.1 0.2 0.10 0.040 0.07 0.20 
Ca:P 1.6 1.6 1.7 0.04 0.40 0.23 0.21 0.63 
1Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
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Table 3.20. Physical and chemical properties of bones from 113.6 kg barrows and gilts 
in response to dietary vitamin K (Exp. 2) 
 
Vitamin K (ppm) 
 
P-value1 
Item2 (n=4) 0 0.5 2 SE Trt Vit. K L Q 
Metacarpal 
        Breaking strength (kg) 139.3 141.8 154.3 14.1 0.73 0.63 0.44 0.95 
Wet wt. (g) 30.9 31.7 32.9 2.0 0.78 0.59 0.50 0.93 
Dry, fat-free wt. (g) 15.6 15.2 15.7 0.9 0.90 0.90 0.82 0.69 
Length (cm) 7.6 7.5 7.7 0.2 0.69 0.98 0.55 0.54 
Bone wall area (mm2) 82.2 82.3 95.2 3.3 0.033 0.14 0.013 0.47 
Ash (%) 50.0 50.0 49.6 0.5 0.79 0.73 0.51 0.87 
Ca (%) 35.4 36.8 37.2 0.5 0.057 0.022 0.042 0.15 
P (%) 17.5 17.7 17.7 0.1 0.60 0.32 0.49 0.47 
Ca:P 2.0 2.1 2.1 0.03 0.21 0.09 0.13 0.36 
Femur 
        
Wet wt. (g) 321.3 321.3 320.5 13.0 0.99 0.98 0.96 0.99 
Length (cm) 19.2 19.5 18.3 0.2 0.017 0.29 0.010 0.15 
Bone wall area (mm2) 201.9 214.2 230.3 13.2 0.36 0.24 0.17 0.77 
Ash (%) 70.2 69.8 69.6 0.5 0.68 0.43 0.43 0.74 
Ca (%) 33.4 28.6 27.1 1.6 0.052 0.020 0.038 0.15 
P (%) 18.4 19.0 18.1 0.2 0.016 0.40 0.08 0.012 
Ca:P 1.8 1.5 1.5 0.09 0.055 0.019 0.07 0.08 
1Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
 
 
Tables 3.21 and 3.22 show the biological changes in bones from 45.4 to 113.6 kg 
for Exp. 1 and Exp. 2 respectively. Metacarpal breaking strength, wet weight, dry fat-free 
weight, length, bone wall area, and % ash increased linearly (P < 0.0001) as weight 
increased. Metacarpal Ca (P = 0.0002), P (P = 0.026), and Ca:P (P = 0.001) decreased as 
animals grew in Exp. 1. In Exp. 2 (Table 3.22) metacarpal Ca was unchanged, P 
decreased (P = 0.002), and Ca:P increased (P < 0.0001). Similar to metacarpals, femur 
wet weight, length, and bone wall area increased linearly (P < 0.0001) in both 
experiments. Femur ash (P = 0.0001) and P (P = 0.0023) also increased linearly in Exp. 1. 
Femur ash increased (P = 0.003) in Exp. 2. Femur Ca and Ca:P were not different 
between weight groups in either experiment.  
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Table 3.21. Physical and chemical properties of bones from barrows sacrificed at three 
different weights (Exp. 1) 
 
Slaughter wt. (kg)1 
 
P-value 
Item2 45.4 79.5 113.6 RMSE3 Weight L Q 
Metacarpal 
       Breaking strength (kg) 69.8 139.5 147.3 23.9 <.0001 <.0001 0.15 
Wet wt. (g) 18.8 27.2 36.4 2.6 <.0001 <.0001 0.86 
Dry, fat-free wt. (g) 7.8 11.0 15.7 0.7 <.0001 <.0001 0.23 
Length (cm) 6.5 7.0 7.8 0.3 <.0001 <.0001 0.57 
Bone wall area (mm2) 75.8 95.3 115.4 13.9 <.0001 <.0001 0.98 
Ash (%) 44.9 50.6 53.5 2.0 <.0001 <.0001 0.44 
Ca (%) 49.7 30.8 32.8 8.0 0.0008 0.0002 0.15 
P (%) 17.0 17.2 15.2 1.6 0.033 0.0262 0.43 
Ca:P 2.9 1.8 2.2 0.4 0.0027 0.001 0.049 
Femur 
       Wet wt. (g) 183.2 265.8 379.0 21.7 <.0001 <.0001 0.43 
Dry, fat-free wt. (g) 1.9 3.8 4.7 0.5 <.0001 <.0001 0.23 
Length (cm) 15.6 17.8 20.3 0.5 <.0001 <.0001 0.65 
Bone wall area (mm2) 156.5 195.9 233.4 26.8 <.0001 <.0001 0.97 
Ash (%) 67.0 69.0 70.0 1.2 0.0004 0.0001 0.67 
Ca (%) 38.8 38.0 37.9 1.2 0.35 0.16 0.77 
P (%) 19.7 19.5 18.3 0.8 0.0035 0.0023 0.52 
Ca:P 2.1 2.1 1.9 0.6 0.64 0.46 0.73 
1n = 12, 12, and 6 for 45.4, 79.5, and 113.6 kg slaughter weight groups respectively. 
2Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
3RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Table 3.22. Physical and chemical properties of bones from barrows and gilts sacrificed 
at three different weights (Exp. 2) 
 
Slaughter wt. (kg) 
 
P-value 
Item1 (n=12) 45.4 79.5 113.6 SE Weight L Q 
Metacarpal 
       Breaking strength (kg) 47.9 119.0 145.1 6.3 <.0001 <.0001 0.007 
Wet wt. (g) 17.4 25.3 31.8 0.7 <.0001 <.0001 0.44 
Dry, fat-free wt. (g) 7.1 11.7 15.5 0.3 <.0001 <.0001 0.35 
Length (cm) 6.4 7.1 7.6 0.08 <.0001 <.0001 0.31 
Bone wall area (mm2) 48.3 70.7 86.6 1.7 <.0001 <.0001 0.13 
Ash (%) 44.4 49.0 49.9 0.7 <.0001 <.0001 0.048 
Ca (%) 35.5 36.1 36.5 0.4 0.35 0.15 0.92 
P (%) 18.5 17.5 17.6 0.2 0.002 0.003 0.02 
Ca:P 1.92 2.06 2.07 0.02 <.0001 <.0001 0.011 
Femur 
       
Wet wt. (g) 167.8 253.4 321.0 5.5 <.0001 <.0001 0.19 
Length (cm) 15.1 17.3 19.0 0.1 <.0001 <.0001 0.16 
Bone wall area (mm2) 138.6 197.0 215.5 6.9 <.0001 <.0001 0.026 
Ash (%) 66.4 69.2 69.9 0.7 0.006 0.003 0.24 
Ca (%) 29.9 29.8 29.7 0.7 0.98 0.86 0.96 
P (%) 18.7 18.4 18.5 0.2 0.62 0.55 0.44 
Ca:P 1.60 1.62 1.61 0.05 0.94 0.97 0.74 
1Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
 
 
 
3.4. Discussion 
3.4.1. Animals and vitamin K status 
Pigs chosen for this study all came from sows that had received a diet with a 
vitamin premix including vitamin K (MSBC) formulated to meet their estimated 
requirement. The only source of nutrition prior to weaning for these pigs was the dam’s 
milk (i.e. no creep feed). Vitamin K levels have been reported to be very low in 
colostrum and mature milk of humans (Canfield et al., 1991). Pig access to maternal 
feces was not restricted so there is a possibility that nursing pigs were exposed to 
bacterially produced vitamin K. Schendel and Johnson (1962) were the first to report a 
vitamin K deficiency in pigs at birth which remains until the pig is fed a diet meeting 
their vitamin K requirement. Their data suggests that vitamin K is not a trans-placental 
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nutrient. Therefore, we believe that this information in combination with our pretrial 
period of a vitamin K deficient diet containing an antibiotic (attempt to reduce fecal 
vitamin K content) was sufficient to create a potential vitamin K deficient status in our 
pigs prior to applying treatments. 
 
3.4.2. Growth performance 
Vitamin K inclusion level did not affect growth performance. A performance 
response to vitamin K was not expected because that is not one of the vitamins known 
functions. However, no such data has been reported in the past for swine. If differences in 
bone growth had occurred, there might be an increase in muscle and other tissues 
surrounding the bone in response to vitamin K intake resulting in a small increase in body 
weight. Corn type did affect gain and feed intake. It is well documented that feed 
containing fumonisin B1 (Colvin et al., 1993; Motelin et al., 1994; Rotter et al., 1996) 
and vomitoxin (Young et al., 1983; Dorner, 2008; Friend et al., 1992) have the potential 
to alter pig performance. These two toxins in combination produce a synergistic effect 
further exacerbating performance (Zielonka et al., 2009). Diets in the present study 
contained 7.0 and 5.9 ppm fumonisin B1 and vomitoxin respectively. Fumonisin B1 
levels < 40 ppm are not typically associated with reduced feed intake (Prelusky et al., 
1996; Rotter et al., 1997; Rossi et al., 2011). Vomitoxin concentrations as low as 1 and 
3.2 ppm have decreased growth performance by reducing feed intake (Young et al., 1983; 
Friend et al., 1992; Dorner, 2008). Reduced performance in the current study can 
primarily be attributed to vomitoxin. 
While the increased mineral level in the nursery Phase I diets (fed for 14 days) of 
Exp. 1 was not intended, it demonstrated that the minerals included in the premix at 6.67 
times the recommended level were not harmful to newly weaned pigs. Furthermore, it did 
not alleviate negative growth effects in response to feeding mycotoxin contaminated corn 
which was a possible response. Some minerals, such as Cu, stimulate growth in pigs 
(Kornegay et al., 1989; Cromwell, 1997) when fed at higher levels of inclusion. This has 
been attributed to the antimicrobial actions of Cu (Fuller et al., 1960) but these findings 
are not conclusive. Zn is another mineral linked to increased growth at high levels of 
inclusion (Han and Thacker, 2009). The literature reports the effects of high levels of Cu 
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and Zn are sometimes additive (Perez et al., 2011) while others found them to not be 
additive (Hill et al., 2000). In either case, there is a possibility that the high mineral level 
could be masking any potential vitamin K benefits in the early post weaning period. That 
is unlikely however since no growth response was detected in the growing and finishing 
phases of Exp. 1 or at any point of production in Exp. 2. 
 
3.4.3. Prothrombin time 
Prothrombin time has been the classic method for determining blood clotting and 
detecting vitamin K activity in response to dietary alterations or medication such as blood 
thinners in patients with cardiovascular complications. Prothrombin time varies within 
the literature primarily due to reagents used and method of detection. The reagent used 
(citrate or EDTA) used to bind plasma Ca, and its concentration in the reaction, can affect 
reported prothrombin time values (Duncan et al., 1984; Adcock et al., 1997; Horsti, 
2000). For this reason caution must be taken when comparing results between studies. 
The International Normalized Ratio (INR) has been used to standardize prothrombin time 
results for oral anticoagulant therapy in humans (ICHS, 1985). Regardless of the reagent, 
instrument, or method used, the results should be the same when the INR system is used. 
The current study utilized prothrombin time as an indicator of vitamin K activity within 
the animal. Prothrombin time was decreased in pigs receiving diets including vitamin K. 
These results validate the treatments. Certain mycotoxins have a coumarin-like structure 
(e.g., aflatoxin B1) and interfere with blood clotting (Osuna and Edds, 1982). Analysis of 
the corn used in this study reported an aflatoxin B1 level below the limit of detection 
(0.02 ppm) which, according to the results of this study, is also too low a concentration to 
affect blood clotting or cannot be detected by the current methods and treatments. 
 
3.4.4. OC and plasma Ca 
The goal of measuring serum OC concentration was to evaluate bone turnover in 
response to dietary inclusion of vitamin K. Neither the 0.5 nor 2.0 ppm levels of vitamin 
K inclusion affected serum OC concentrations. Binkely et al. (2000) showed γ-
carboxylation of OC is dependent on vitamin K status. Other research in humans 
associates uncarboxylated OC with low bone mass (Szule et al., 1993) and increased risk 
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of fracture (Szule et al., 1996; Vergnaud et al., 1997). Periods of vitamin K insufficiency 
have been associated with both unchanged (Fiore et al., 1990) and decreased (Sato et al., 
1997) serum OC concentrations. OC concentrations were not affected by vitamin K level 
in this study. If the percentage of carboxylated OC is increased due to vitamin K 
inclusion then there should be a similar increase in the amount of bound Ca (decreased 
free Ca) in the plasma. A comparison of Ca and OC (Tables 3.10, 3.11, 3.12, 3.13, and 
3.14) from the same bone at the same time period did not reflect that in this study. The 
differences detected in plasma Ca concentration do not follow a pattern suggesting a 
treatment effect and might be due to the high variability (CV > 20%) in the current study 
associated with the analysis procedure leading to false positives. The method used to 
measure plasma Ca had an average coefficient of variation of 20%. Ca supply might also 
be a limiting factor. Since OC is a measurement of osteoblast activity, and therefore bone 
remodeling, decreased concentrations would indicate less bone mass turnover. These 
results indicate that at these levels of dietary vitamin K there is no significant correlation 
between K and osteoblast activity. 
 
3.4.5. Bones 
Previous techniques used to describe properties of swine bones included diameter 
and bone wall thickness measured by hand (Cromwell et al., 1972; Carter et al., 1996). 
However, the cross section of any given bone is not a perfect circle. Multiple 
measurements must be taken at many angles and averaged to determine an approximate 
diameter. Furthermore, the same problems exist with respect to bone wall thickness. Dual 
energy X-ray absorptiometry (DXA) is a newer method used to determine bone mineral 
density, strength, and other bone characteristics (Peterson et al., 1995; Aiyangar et al., 
2010). Availability of the machine, its cost, and its inability to scan larger animals are 
limiting factors of its use. In this study bone wall area was reported by a newer, more cost 
effective method utilizing digital pixel count. While differences in these methods have 
not been evaluated, it is possible that this newer method is more accurate and more 
sensitive method in describing bones in response to a treatment than methods previously 
used.  
 
81 
 
The addition of vitamin K at the current levels of inclusion does not appear to affect 
bone properties of barrows from 45.4 to 113.6 kg. It is possible the explanation for these 
results is that Ca is the limiting factor in vitamin K related biological reactions. Vitamin 
K carboxylates circulating OC which then ultimately binds available Ca, returns to bone 
tissue, and deposits the Ca forming hydroxyapatite crystals. Both the diet and bones 
(resorption) would be likely sources of Ca. However, additional Ca was not included in 
the diet. Cromwell et al. (1970) and Maxson and Mahan (1983) found that the dietary 
levels of Ca and P necessary to maximize bone strength were much greater than the 
levels required to maximize growth performance. Therefore, the same might be true 
about vitamin K and Ca if a response is to be detected. The differences detected in 
metacarpal weights and lengths are probably not real and due to human error in the 
laboratory, unaccounted for biological differences in the animals, and/or the low sample 
used for analysis. 
The current study followed bone breaking procedures from previous research in pigs 
(Carter et al., 1996). The test for load at failure in that study and the current were 
conducted on the same machine, using the same fulcrum distance, and bones were stored 
and prepared in the same manner. Their pigs had an average final weight of 39.7 kg 
which is similar to the first group of pigs slaughtered in this study at 45.4 kg. They 
reported loads between 125 and 283 kg needed to break femurs.  This is well within the 
maximum possible load (500 kg) the machine is capable of applying. However, femurs 
from this study exceeded the maximum load. Mineral density and other properties of the 
femurs do not support this increase in strength. Furthermore, their metacarpal breaking 
strengths were half of that reported here when the dietary Ca and P concentration were 
similar. Extrapolating that to the reported values for femurs and they would have most 
likely been over the 500 kg limit as well. Carter et al. (1996) did not report the length of 
the femurs from their pigs. It is possible that, since pigs in the current study were on 
average 5.7 kg heavier, the femurs in the current study were longer and required a longer 
fulcrum distance to be accurately broken by this machine. The machine itself could also 
be experiencing mechanical problems and not actually be applying the force set by the 
operator.    
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Table 3.23 shows the average daily intake of vitamin K for Exp. 1 and 2. 
Compared to studies using humans the daily intake of vitamin K in the current study is 
too low to see a response. Shiraki et al. (2000) showed an oral dose of 45 mg/day 
(menatetranone) reduced the risk of fracture, increases bone mineral density, and 
increased blood OC levels in adult women. Cracium et al. (1998) injected 10 mg of 
synthetic K1 (phytonadione) per day and observed similar results. The maximum intake 
of vitamin K in the current study was in the grow-finish phase of Exp. 1 at 5.14 mg/day.  
 
Table 3.23. Average vitamin K intake  
Period and treatment1 ADFI (g)2 VKI (mg)3 
Exp. 1 
  Nursery 
  0.5 843 0.42 
2.0 754 1.51 
Grow-finish 
  0.5 2619 1.31 
2.0 2572 5.14 
Exp. 2 
  Nursery 
  0.5 529 0.26 
2.0 465 0.93 
Grow-finish 
  0.5 2350 1.18 
2.0 2372 4.74 
1Treatment is supplemental vitamin K concentration in 
the diet as mg/kg or parts per million (ppm) 
2ADFI = average daily feed intake 
3VKI = vitamin K intake per day  
 
 
3.4.6. Conclusion and implications 
Detailed effects of vitamin K on multiple aspects of swine physiology and during 
multiple stages of production have not been documented. The current studies demonstrate 
that MSBC as a source of vitamin K at dietary inclusions of 0.5 and 2.0 ppm does not 
affect growth performance or blood parameters (Ca, OC) in nursery and growing pigs 
from 45.5 to 113.6 kg of body weight compared to a diet that did not have any vitamin K 
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added. Vitamin K did affect a few bone characteristics but the results were inconsistent. 
Also, the results show pigs do not require a supplemental source of vitamin K to survive. 
Prothrombin time as an indicator of vitamin K activity is evidence that the experimental 
system was successful.  
In hypothesis testing there are two types of errors that can be made. Type I error 
is the rejection of a true null hypothesis and α is the probability of committing this error 
so it is desirable to keep this value low to reduce the risk of a false positive. The standard 
level of significance (α) used in biological data is 0.05. Type II error is the acceptance of 
a false null hypothesis and β is the probability of committing this error so it is desirable to 
keep this value low to reduce the risk of a false negative. Variance and sample size affect 
the probability of committing one of these errors. The smaller the difference between the 
experimental mean and the hypothesized mean the researcher wants to detect 
significantly, the larger the sample size (n) needs to be to avoid Type I error. This is also 
referred to as increasing the power of the test. Decreasing the variance (i.e., using an 
improved measurement technique) decreases the probability of committing a Type II 
error. Many of the significant differences observed in the current research are believed to 
be Type I errors due to low sample size and large inherent variability of some of the 
parameters measured. 
There are still many questions that need answers. Other vitamin K sources 
(phylloquinone or other synthetic forms), dietary inclusions higher than 4 times the 
current recommendation, longer exposure time, and Ca:vitamin K are all possible items 
for future investigation. Despite the lack of evidence with respect to vitamin K’s efficacy, 
this research provides a relatively detailed look at the biological changes in bones and 
associated blood markers over a large portion of the typical lifespan of pigs. The majority 
of previously published data on this topic is greater than a decade old. Also, the bone data 
suggests that not all bones share the same characteristics as there might be differences in 
the Ca:P ratio between bones and that difference might be related to the animal’s age. 
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Appendix 1. Metacarpal harvest instructions 
Front feet were removed from the animal at the joint comprised of carpal bones 
between the metacarpals and radius and ulna. The result is shown here in an anterior and 
posterior picture below. Feet were removed, placed in a labeled bag with an 
accompanying label/tag inside the bag and frozen for storage at -20 C. 
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- Location of bones within 
the feet 
Radius and 
Ulna 
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- Further separation 
of the bones 
located in the feet 
- Green arrow 
indicates the 3rd 
and 4th metacarpals 
used for breaking 
strength, Ca, P, etc. 
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Appendix 2. Reproductive performance and related blood parameters of gilts fed three 
levels of vitamin K (MSBC) from weaning. 
 
Experimental animals and treatments  
 All experiments were conducted under protocols approved by UK’s 
Institutional Animal Care and Use Committee. This experiment (experimental ID: UK 
1110b) was carried out from July 2011 to November 2012 using 40 crossbred gilts 
[Yorkshire x Duroc, (Yorkshire x Landrace) x Duroc] previously allotted to dietary 
treatments as described in Chapter 3. All gilts maintained their respective vitamin K 
treatment level throughout gestation and lactation. At 6 months of age gilts were moved 
to gestation crates and exposed to boars to stimulate estrus. Heat checking began at 8 
months of age. Gilts in heat were bred by artificial insemination (AI) immediately and 
again 24 hours later. All bred gilts were pregnancy checked around day 60 of gestation by 
ultrasound. Approximately 1 week before the projected due date, gilts were moved to 
farrowing crates. Gilts were allowed ad libitum access to feed and water during the entire 
experimental period. Dietary treatments in the gestation and lactation periods consisted 
of: 1) 0 ppm K, 2) 0.5 ppm K, and 3) 2.0 ppm K. 
 
Experimental diets 
The experimental diet was formulated to meet or exceed NRC (1998) requirement 
estimates for gestating swine. The same diet was fed throughout gestation and lactation 
(Table A2.1). Therefore, the nutrient levels were below the suggested requirements 
during lactation. At 6 months of age the gilts began receiving this diet. The vitamin K 
free vitamin premix and vitamin K source (MSBC, 33% vitamin K) used in this study 
were provided by DSM (DSM Nutritional Products North America, Parsippany, NJ). The 
inclusion levels of MSBC provide 0.50 and 2.00 ppm supplemental vitamin K which are 
the current suggested requirement and 4 times the requirement respectively (NRC, 1998). 
Integral, a glucomannan containing brewers dried yeast and an anticaking agent, was 
included in the diet as a mycotoxin binder. 
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Gilt and litter response measures 
Gilts were weighed at breeding, late gestation, farrowing, and weaning. Pig 
weight was recorded at farrowing, and weaning. Litter size was recorded at farrowing 
(alive and stillborn) and weaning. When litter size exceeded gilt teat number pigs were 
cross fostered to another gilt on the same treatment.  
 
Collection, preparation, and storage of Blood 
All blood was collected from gilts by jugular puncture. Serum and plasma 
samples were taken from each gilt at breeding, late gestation, farrowing and weaning. 
Blood was centrifuged (607 x g at 4°C for 20 min.) to separate plasma and serum. All 
samples were frozen at -20°C until analysis. 
 
Prothrombin time analysis 
Prothrombin time was determined using citrated plasma by the Quick one-stage 
procedure (Appendix 4). In this procedure, 0.1 ml of citrated plasma was incubated in a 
37°C water bath for 30 seconds. Rabbit brain thromboplastin (Sigma-Aldrich) 
reconstituted in CaCl2 was added as the extrinsic factor (0.1 ml), the mixture was gently 
mixed, and the time to clot was recorded. All samples were analyzed in duplicate. 
 
Blood Ca and OC analysis 
Total Ca in plasma was determined using procedures previously described (Hall 
et al., 1991). In this procedure 0.1 ml of plasma was combined with 4.9 ml of a 9:l 
mixture of nitric:perchloric acid. Samples were heated to 35°C in a water bath overnight, 
diluted further, and analyzed. Simultaneously, free plasma Ca was measured using 
plasma samples from the same aliquots but without acid digestion. Ca content of digested 
and undigested plasma samples was analyzed by atomic absorption spectrophotometry 
(Mode1 560 spectrophotometer, Perkin-Elmer Corp., Norwalk, CT). Bound plasma Ca 
was calculated as the difference between total and free Ca. Serum OC was determined 
using a commercially available ELISA kit (MicroVue™ OC EIA, Quidel Corp.). 
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Statistical analysis  
 Prior to analyses, all data was evaluated to identify any potential statistical 
outliers. Litter data was evaluated for variation (CV) greater than 20% within litter and 
within litters of the same treatment. OC, prothrombin time, and plasma Ca data having 
CV’s greater than 10, 5, and 25% respectively were reanalyzed. Proc Univariate of SAS® 
(SAS Inst. Inc., Cary, NC) was used to aid in evaluating data and identifying outliers.  
Out of the 40 gilts used, only 28 showed signs of estrus and were bred. Of those 28, 13 
were removed prior to analysis. This included 5 that were determined “open” at 
pregnancy checking (d60 of gestation), 6 that had fewer than 5 live pigs at farrowing, and 
2 that died shortly after farrowing. 
 The experimental data was analyzed using the least squares analysis of 
variance (Proc GLM) procedure of SAS® (SAS Inst. Inc., Cary, NC). Gilt was the 
experimental unit for all data. The statistical model included treatment. Linear and 
quadratic contrasts were made for level of K inclusion. Treatment least squares means 
were calculated using the LSMEANS option and when necessary separated using the 
PDIFF function of SAS. Proc IML was used to determine linear and quadratic 
comparison coefficients for treatments with unequal spacing. Differences were 
considered significant at P < 0.05 and having a tendency for significance at P < 0.10. 
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Table A2.1. Ingredient composition of experimental diets 
used for gestation and lactation (as-fed basis) 
Item Ingredient, % 
Corn 85.62 
Soybean meal, 48% CP 10.05 
Grease, choice white 1.0 
DiCa Phosphate 1.55 
Limestone 0.83 
Salt 0.5 
Trace mineral premix1 0.05 
Vitamin premix2 0.1 
Choline, 50%3 0.1 
Integral4 0.2 
Calculated nutrient composition  
ME, kcal/kg            3,682 
Crude protein, % 12.11 
Lysine, % 0.54 
Ca, % 0.75 
P, % 0.6 
1 Supplied per kg of diet: Zn, 131 mg as ZnO; Fe, 131 mg as FeSO4·H2O; Mn, 45 
mg as MnO; Cu, 13 mg as CuSO4·5H2O; I, 1.5 mg as CaI2O6; Co 0.23 mg as 
CoCO3; Se, 0.28 mg as Na2SeO3. 
2 Supplied per kg of diet: vitamin A, 6,600 IU; vitamin D3, 880 IU; vitamin E, 44 
IU; thiamin, 4.0 mg; riboflavin, 8.8 mg; pyridoxine, 4.4 mg; vitamin B12, 33 µg; 
folic acid, 1.3 mg; niacin, 44 mg; pantothenic acid, 22 mg; D-biotin, 0.22 mg. 
Vitamin K (as menadione sodium bisulfate complex) was added to the diet to 
create 0, 0.5, and 2.0 ppm K treatments. 
3 Supplies 0.5 g of choline per kg of diet as choline chloride. 
4Glucomannan containing brewers dried yeast and anticaking agent. 
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Table A2.2. Gilt numbers during reproduction based on nursery 
and grow-finish treatments 
 
Nursery treatment 
 
GF treatment 
Corn1: G G B B B  G G G 
Vit K2: 0 0.5 0 0.5 2   0 0.5 2 
Total 8 8 8 8 8  16 16 8 
Heat 4 6 6 6 6  10 12 6 
Bred 4 6 6 6 6  10 12 6 
Open 0 0 0 3 2  0 3 2 
Farrowed 4 6 6 3 4  10 9 4 
2nd parity 1 4 1 0 2   2 4 2 
          Farrowing rate3 100 100 100 50 66.67   100 75 66.67 
1 Corn type: G = good corn, B = bad corn. 
2 Vitamin K concentrations are in parts per million (ppm). 
3 Farrwoing rate is percentage of gilts farrowed that were bred. 
 
 
 
Table A2.3. Effects of vitamin K on plasma Ca concentrations of gilts at farrowing 
and weaning 
 
Treatment1 
 
P-values2 
Period 0 0.5 2 RMSE3 Trt Vit. K L Q 
Farrowing 
        Total 9.88 12.08 12.33 2.07 0.26 0.11 0.24 0.27 
Free 4.84 6.62 6.35 0.68 0.01 0.005 0.065 0.013 
Free (%) 46.96 54.69 49.19 3.92 0.06 0.08 0.99 0.021 
Weaning 
        Total 11.56 11.77 11.48 1.48 0.97 0.95 0.90 0.82 
Free 6.64 6.51 5.61 0.70 0.19 0.23 0.08 0.78 
Free (%) 55.28 57.53 48.72 9.58 0.50 0.73 0.31 0.54 
1 Vitamin K inclusion level units are parts per million (ppm). n = 4, 4, and 3 for 0, 0.5, and 2 ppm K 
respectively. Ca concentration means are mg/dl. 
2 Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
3 RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Table A2.4. Effects of vitamin K on prothrombin time (seconds) in gilts at 
farrowing and weaning 
 
Treatment1 
 
P-values2 
  0 0.5 2 RMSE3 Trt Vit. K L Q 
Farrowing 19.11 17.45 17.47 0.46 0.0014 0.006 0.0027 0.0004 
Weaning 19.61 18.59 17.90 0.85 0.075 0.043 0.305 0.034 
1 Vitamin K inclusion level units are parts per million (ppm). n = 4, 4, and 3 for 0, 0.5, and 2.0 ppm K 
respectively. 
2 Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
3 RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
 
 
 
Table A2.5. Effects of vitamin K on OC (ng/ml) in gilts at farrowing and weaning 
 
Treatment1 
 
P-values2 
  0 0.5 2 SE Trt Vit. K L Q 
Farrowing 115.0 95.4 102.8 12.2 0.55 0.33 0.68 0.33 
Weaning 134.9 118.9 103.1 8.9 0.11 0.07 0.052 0.50 
1 Vitamin K inclusion level units are parts per million (ppm), n = 3. 
2 Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
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Table A2.6. Effects of vitamin K on reproduction (all parities) 
 
Treatment1 
 
P-value2 
  0 0.5 2 RMSE3 Trt Vit. K L Q 
n 8 8 6      
Day of Gest. Farrowed 114.1 115.0 114.4 1.2 0.38 0.32 0.98 0.17 
Days Farrowing -
Wean 20.3 20.7 19.1 2.6 0.29 0.44 0.68 0.13 
Pigs/Litter         
Total 13.9 7.4 8.8 2.3 0.0005 0.0002 0.018 0.0005 
Born live 12.3 6.3 8.1 2.4 0.002 0.0007 0.072 0.0009 
Post transfer 10.75 6.38 8.67 2.28 0.0043 0.0049 0.47 0.0014 
Wean 9.6 6.0 7.3 2.4 0.051 0.026 0.32 0.024 
Litter Weight, kg         
Total 22.0 14.4 15.8 4.4 0.018 0.007 0.11 0.014 
Born live 19.6 12.8 14.9 4.5 0.047 0.022 0.27 0.024 
Post transfer 17.3 12.4 15.7 4.3 0.09 0.11 0.95 0.031 
Wean 51.3 46.7 43.4 13.9 0.63 0.38 0.38 0.72 
Piglet Weight, kg         
    Total 1.59 1.92 1.84 0.2 0.060 0.025 0.24 0.035 
    Born live 1.61 2.00 1.97 0.2 0.010 0.005 0.18 0.005 
    Post transfer 1.62 1.95 1.85 0.2 0.019 0.0084 0.21 0.011 
    Wean 5.41 8.11 6.34 0.8 0.0001 0.0006 0.72 <.0001 
Sow Feed, kg         
Total farrowing - 
wean 98.9 92.8 89.2 36.5 0.60 0.42 0.85 0.33 
ADFI  4.67 4.47 4.64 1.6 0.99 0.94 0.92 0.99 
Sow Weight, kg         
Breeding 178.4 169.0 164.2 23.6 0.59 0.33 0.37 0.63 
Farrowing 227.3 205.7 226.6 19.4 0.11 0.27 0.61 0.044 
Weaning 209.5 154.0 204.9 45.9 0.09 0.21 0.65 0.032 
Gestation gain 48.9 40.5 62.4 15.1 0.07 0.74 0.07 0.14 
Lactation loss 17.8 39.1 21.7 28.1 0.37 0.38 0.89 0.17 
1 Vitamin K inclusion level units are parts per million (ppm). 
2 Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
3 RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Table A2.7. Effects of vitamin K on reproduction (parity 1) 
 
Treatment1 
 
P-value2 
  0 0.5 2 RMSE3 Trt Vit. K L Q 
n 6 4 4      
Day of Gest. Farrowed 113.7 114.8 114.3 0.9 0.21 0.11 0.62 0.11 
Days Farrowing -
Wean 21.0 24.5 18.3 2.0 0.004 0.73 0.009 0.005 
Pigs/Litter         
Total 11.8 6.5 10.5 2.4 0.016 0.026 0.90 0.005 
Born live 11.5 5.0 9.8 2.4 0.005 0.009 0.94 0.002 
Post transfer 10.3 5.0 9.8 2.1 0.006 0.47 0.0016 0.024 
Wean 9.2 5.0 8.5 2.3 0.047 0.081 0.71 0.016 
Litter Weight, kg         
Total 19.3 12.0 18.5 4.4 0.059 0.11 0.64 0.020 
Born live 19.0 9.9 17.4 4.6 0.031 0.057 0.73 0.010 
Post transfer 16.7 9.9 17.4 4.0 0.039 0.30 0.015 0.19 
Wean 54.0 41.9 46.8 14.4 0.44 0.24 0.67 0.26 
Piglet Weight, kg         
    Total 1.65 1.84 1.78 0.3 0.48 0.25 0.61 0.31 
    Born live 1.66 1.99 1.79 0.2 0.12 0.079 0.76 0.050 
    Post transfer 1.63 1.99 1.80 0.2 0.11 0.66 0.048 0.066 
    Wean 5.97 8.68 5.47 0.7 <.0001 0.015 0.013 <.0001 
Sow Feed, kg         
Total farrowing - 
wean 75.6 70.3 68.0 28.5 0.91 0.68 0.73 0.85 
ADFI  3.57 2.86 3.74 1.3 0.56 0.62 0.32 0.68 
Sow Weight, kg         
Breeding 208.0 181.0 193.2 17.8 0.10 0.052 0.51 0.051 
Farrowing 233.3 213.8 228.6 18.6 0.30 0.26 0.93 0.13 
Weaning 199.5 170.9 182.0 24.9 0.23 0.12 0.55 0.13 
Gestation gain 25.2 32.7 35.5 7.3 0.11 0.046 0.09 0.28 
Lactation loss 33.8 42.8 46.6 16.6 0.48 0.25 0.32 0.57 
1 Vitamin K inclusion level units are parts per million (ppm). 
2 Contrasts include Vit. K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
3 RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Table A2.8. Effects of vitamin K on reproduction (parity 2) 
 
Treatment1 
 
P-value2 
  0 0.5 2 RMSE3 Trt Vit. K L Q 
n 2 4 2      
Day of Gest. Farrowed 114.5 115.3 114.5 1.8 0.85 0.80 0.89 0.60 
Days Farrowing -Wean 19.5 19.1 20.0 2.3 0.60 0.65 0.81 0.37 
Pigs/Litter         
Total 16.0 8.3 7.0 2.2 0.026 0.010 0.024 0.036 
Born live 13.0 7.7 6.5 2.2 0.08 0.033 0.062 0.10 
Post transfer 12.0 7.8 6.5 1.9 0.063 0.025 0.047 0.1 
Wean 10.0 7.0 6.0 2.5 0.35 0.18 0.24 0.38 
Litter Weight, kg         
Total 24.7 16.7 13.2 4.4 0.13 0.060 0.079 0.228 
Born live 20.3 15.6 12.5 4.3 0.29 0.16 0.16 0.47 
Post transfer 19.0 14.9 12.5 3.9 0.32 0.16 0.18 0.44 
Wean 48.6 51.5 39.9 12.4 0.62 0.80 0.44 0.64 
Piglet Weight, kg         
    Total 1.55 1.98 1.89 0.1 0.02 0.008 0.061 0.009 
    Born live 1.57 2.02 1.95 0.1 0.036 0.016 0.076 0.024 
    Post transfer 1.59 1.91 1.95 0.2 0.21 0.09 0.18 0.18 
    Wean 4.84 7.52 7.20 1.1 0.12 0.056 0.18 0.08 
Sow Feed, kg         
Total farrowing - 
wean 122.1 115.3 110.4 52.5 0.75 0.62 0.98 0.47 
ADFI  6.26 5.71 5.53 0.7 0.55 0.30 0.38 0.49 
Sow Weight, kg         
Breeding 148.9 157.0 135.2 35.0 0.80 0.93 0.63 0.70 
Farrowing 221.4 197.7 224.5 21.3 0.39 0.60 0.63 0.23 
Weaning 219.5 137.1 227.7 78.7 0.43 0.61 0.67 0.25 
Gestation gain 72.5 48.2 89.3 26.7 0.33 0.88 0.37 0.25 
Lactation loss 1.8 35.4 -3.2 46.9 0.63 0.74 0.74 0.41 
1 Vitamin K inclusion level units are parts per million (ppm). 
2 Contrasts include K (Compares 0 vs. 0.5 + 2 ppm K), L (linear), and Q (quadratic).  
3 RMSE - Root mean square error; when divided by the square root of the number of observations provides the 
standard error associated with each mean.  
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Appendix 3. Effects of vitamin K on growth performance, bone characteristics, and blood 
metabolites by sex for Chapter 3. 
 
Table A3.1. Effects of vitamin K on plasma Ca concentrations (mg/dl) of nursery, 
growing, and finishing gilts and barrows (Exp. 2) 
 
Sex 
 
P-values 
Period  Gilt Barrow SE Sex Trt(sex) 
Nursery 
     Initial (n=8) 
     Total  14.32 13.85 0.25 0.11 0.11 
Free  6.66 6.67 0.26 0.94 0.79 
Free (%) 46.59 48.16 1.68 0.31 0.69 
Final (n=18) 
     Total  10.28 9.59 0.27 0.91 0.29 
Free  3.34 3.69 0.16 0.92 0.30 
Free (%) 32.56 39.59 2.20 0.72 0.057 
Grow-finish (n=6) 
     45.4 kg 
     Total  12.26 13.28 0.39 0.12 0.12 
Free  6.76 7.01 0.15 0.62 0.054 
Free (%) 55.43 53.98 2.08 0.24 0.07 
79.5 kg 
     Total  11.17 11.11 0.41 0.84 0.91 
Free  5.47 5.70 0.22 0.88 0.92 
Free (%) 48.94 51.97 2.83 0.72 0.86 
113.6 kg 
     Total  15.39 15.65 0.22 0.24 0.50 
Free  7.09 7.57 0.14 0.52 0.47 
Free (%) 46.04 48.52 1.14 0.22 0.03 
 
 
 
 
 
 
 
 
97 
 
Table A3.2. Physical and chemical properties of bones from 45.4 kg gilts and barrows 
(Exp. 2) 
 
Sex 
 
P-value 
Item1 (n=6) Gilt Barrow SE Sex Trt(sex) 
Metacarpal 
     Breaking strength (kg) 51.42 44.33 1.78 0.030 0.99 
Wet wt. (g) 16.74 18.01 0.64 0.21 0.93 
Dry, fat-free wt. (g) 6.89 7.28 0.20 0.21 0.90 
Length (cm) 6.32 6.55 0.09 0.12 0.93 
Bone wall area (mm2) 46.43 50.09 0.92 0.030 0.77 
Ash (%) 44.24 44.50 0.94 0.85 0.99 
Ca (%) 35.47 35.62 0.59 0.86 0.26 
P (%) 18.70 18.39 0.36 0.57 0.80 
Ca:P 1.90 1.94 0.03 0.36 0.51 
Femur 
     Wet wt. (g) 15.08 15.19 0.12 0.56 0.75 
Length (cm) 162.1 173.5 3.0 0.036 0.49 
Bone wall area (mm2) 142.4 134.9 3.8 0.21 0.56 
Ash (%) 64.99 67.75 1.77 0.31 0.55 
Ca (%) 29.67 30.05 1.03 0.80 0.91 
P (%) 18.63 18.72 0.35 0.86 0.40 
Ca:P 1.59 1.62 0.05 0.78 0.94 
1Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
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Table A3.3. Physical and chemical properties of bones from 79.5 kg gilts and barrows 
(Exp. 2) 
 
Sex 
 
P-value 
Item1 (n=6) Gilt Barrow SE Sex Trt(sex) 
Metacarpal 
     Breaking strength (kg) 107.6 130.3 10.3 0.17 0.63 
Wet wt. (g) 24.59 25.98 0.78 0.26 0.79 
Dry, fat-free wt. (g) 11.35 12.05 0.46 0.32 0.41 
Length (cm) 7.09 7.14 0.09 0.72 0.51 
Bone wall area (mm2) 66.91 74.58 2.39 0.064 0.74 
Ash (%) 48.00 49.96 1.43 0.37 0.21 
Ca (%) 37.21 34.92 0.90 0.12 0.54 
P (%) 17.63 17.30 0.34 0.50 0.45 
Ca:P 2.11 2.02 0.03 0.049 0.58 
Femur 
     Wet wt. (g) 17.38 17.23 0.19 0.60 0.70 
Length (cm) 249.6 257.2 10.7 0.63 0.74 
Bone wall area (mm2) 195.0 199.0 12.9 0.83 0.82 
Ash (%) 69.07 69.36 0.31 0.53 0.15 
Ca (%) 29.76 29.87 0.41 0.86 0.34 
P (%) 18.36 18.39 0.18 0.89 0.28 
Ca:P 1.62 1.63 0.04 0.96 0.44 
1Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
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Table A3.4. Physical and chemical properties of bones from 113.6 kg gilts and barrows 
(Exp. 2) 
 
Sex 
 
P-value 
Item1 (n=6) Gilt Barrow SE Sex Trt(sex) 
Metacarpal 
     Breaking strength (kg) 132.6 157.6 8.2 0.07 0.09 
Wet wt. (g) 30.32 33.34 1.49 0.20 0.33 
Dry, fat-free wt. (g) 14.60 16.41 0.65 0.10 0.43 
Length (cm) 7.54 7.68 0.12 0.45 0.12 
Bone wall area (mm2) 82.74 90.43 2.40 0.064 0.85 
Ash (%) 50.12 49.65 0.52 0.55 0.87 
Ca (%) 36.83 36.11 0.39 0.24 0.66 
P (%) 17.72 17.52 0.13 0.31 0.89 
Ca:P 2.08 2.06 0.03 0.68 0.90 
Femur 
     Wet wt. (g) 18.90 19.13 0.14 0.30 0.059 
Length (cm) 306.1 336.0 6.2 0.015 0.07 
Bone wall area (mm2) 200.3 230.6 7.9 0.035 0.24 
Ash (%) 69.68 70.05 0.44 0.57 0.45 
Ca (%) 30.62 28.74 1.35 0.36 0.49 
P (%) 18.58 18.40 0.14 0.40 0.56 
Ca:P 1.65 1.56 0.08 0.48 0.59 
1Ash % is on a dry, fat-free bone basis. Ca and P % are on an ash basis. 
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Table A3.5. Effects of dietary vitamin K on serum OC (ng/ml) of growing and finishing 
gilts and barrows (Exp. 2) 
 
Sex 
 
P-values 
(n=6) F M SE Trt Trt(sex) 
Weight 
     45.4 kg 353 385 43 0.62 0.18 
79.5 kg 338 295 52 0.58 0.85 
113.6 kg 391 403 38 0.83 0.19 
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Appendix 4. Procedure for determination of prothrombin time. 
 
Reagents: 
1) CaCl2 – Fisher Scientific, 10 MM solution made using Nano water 
2) Rabbit brain thromboplastin – 4 ml vial, Sigma Aldrich (product number: 44213) 
 
Procedure: 
• Reconstitute thromboplastin with 4 ml of a 10MM CaCl2 solution 
• Thaw frozen plasma samples in 37°C water bath for 30 seconds 
• Vortex thawed sample 
• Pipet 0.1 of thawed plasma into a new micro centrifuge tube 
• Pipet 0.1 ml reconstituted thromboplastin into tube with plasma 
• Start timer simultaneously 
• Swirl gently to mix and observe for clot to form 
• Stop timer when clot is observed 
• All samples run in duplicate simultaneously 
 
 
 
 
 
 
 
 
 
 
 
102 
 
REFERENCES 
 
Adcock, D. M., D. C. Kressin, and R. A. Marlar. 1997. Effect of 3.2% vs. 3.8% sodium 
citrate concentration on routine coagulation testing. Am. J. Clin. Pathol. 107:105-
110. 
Akande, K. E., M. M. Abubakar, T. A. Adegbola, and S. E. Bogoro. 2006. Nutritional 
and health implications of mycotoxins in animal feeds: a review. Pakistan J. Nutr. 
5:398-403. 
Anderson, H. C. 2003. Matrix vesicles and calcification. Curr. Rheumatol. Rep. 5:222 
226. 
Andretta, I., M. Kipper, C. R. Lehnen, L. Hauschild, M. M. Vale, and P. A. Lovatto. 
2012. Meta-analytical study of productive and nutritional interactions of 
mycotoxins in growing pigs. Animal 6:1476-1482. 
Anil, S.S. 2011. Nutritional Intervention to Minimize Claw Lesions and to Improve 
Performance and Longevity in Breeding Female Pigs. Dissertation, Minnesota, 
USA. 
Anil, S. S., L. Anil, and J. Deen. 2009. Effect of lameness on sow longevity. J. Am. Vet. 
Med. Assoc. 235:734–738. 
Anil, S. S., L. Anil, J. Deen, S. K. Baidoo, and R. D. Walker. 2007. Factors associated 
with claw lesions in gestating sows. J. Swine Health Prod. 15:78–83. 
Almeida, M., S. Iyer, M. Martin-Millan, S. M. Bartell, L. Han, E. Ambrogini, M. Onal, J. 
Xiong, R. S. Weinstein, R. L. Jilka, C. A. O’Brien, and S. C. Manolagas. 2013. J. 
Clin. Invest. 123:394-404. 
AOAC. 1995. Official Methods of Analysis (16th Ed.). Association of Official Analytical 
Chemists, Arlington, VA. 
Arthur, S.R., E. T. Kornegay, H. R. Thomas, H. P. Veit, D. R. Notter, and R. A. 
Barczewski. 1983. Restricted energy intake and elevated Ca and P intake for gilts 
during growth. III. Characterization of feet and limbs and soundnesss scores of 
sows during three parities. J. Anim. Sci. 56:876-886. 
Bai, M. 2004. Structure–function relationship of the extracellular Ca sensing 
receptor. Cell Ca. 35:197-207. 
 
103 
 
Bamburg, J. R. 1976. Chemical and biochemical studies of trichothecene mycotoxins. 
Adv. Chem. Ser. 149:144-162. 
Bartok, T., A. Szecsi, A. Szekeres, A. Mesterhazy, and M. Bartok. 2006. Detection of 
new fumonisin mycotoxins and fumonisin-like compounds by reversed-phase 
high-performance liquid chromatography/electrospray ionization ion trap mass 
spectrometry. Rapid. Commun. Mass. Sp 20:2447-2462. 
Bartok, T., A. Szekeres, A. Szecsi, M. Bartok, and A. Mesterhazy. 2008. A new type of 
fumonisin series appeared on the scene of food and feed safety. Cereal. Res. 
Commun. 36:315-319. 
Baxter, E., L. Boyle, S. Edwards, R. Geers, M. Harris, M. C. Meunier-Salaun, L. Juul-
Pedersen, M. Sutherland, A. Valros, and B. Wechsler. 2011. Preparatory work for 
the future development of animal based measures for assessing the welfare of 
sow, boar, and piglet including aspects related to pig castration. In: Sub-Report A: 
Welfare of Sow, Boar, and Piglet. Available online: http:// 
www.efsa.europa.eu/en/supporting/pub/178e.htm. 
Bellido, T., G. Girasole, G. Passeri, X. P. Yu, H. Mocharla, R. L. Jilka, A. Notides, and 
S. C. Manolagas. 1993. Demonstration of estrogen and vitamin D receptors in 
bone marrow-derived stromal cells: Up-regulation of the estrogen receptor by 
1,25-dihydroxyvitamin-D3. Endocrinology. 133:553-562. 
Bennett, J. W., and M. Klich. 2003. Mycotoxins. Clin Microbiol Rev 16:497-516. 
Beresford, J. N., J. A. Gallagher, J. W. Poser, and R.G.G. Russell. 1984. Production of 
OC by human bone cells in vitro: Effects of 1,25(OH)2D3, 24,25(OH)2D3, 
parathyroid hormone, and glucocorticoids. Metab. Bone Dis. Relat. Res. 5:229-
234. 
Berge, S. 1948. Genetical researches on the number of vertebrae in pigs. J. Anim. Sci. 
7:233-238. 
Bergsjo, B., T. Matre, I. Nafstad. 1992. Effects of diets with graded levels of 
deoxynivalenol on performance in growing pigs. J. Vet. Med. 39:752-758.    
Bergsjo, B., W. Langseth, I. Nafstad, J.J. Hogset, H.J.S. Larsen. 1993. The effect of 
 
104 
 
naturally deoxynivalenol-contaminated oats on the clinical condition, blood 
parameters, performance and carcass composition of growing pigs. Vet. Res. 
Comm. 17:283-294. 
Bertazzo, S., and C. A. Bertran. 2006. Morphological and dimensional characteristics of 
bone mineral crystals. Bioceramics. 18:3-10.  
Beutler, B. 2002. Toll-like receptors: how they work and what they do. Curr. Opin. 
Hematol. 9:2–10. 
Binkely, S. B., R. W. McKee, S. A. Thayer, and E. A. Doisy. 1940. Structure of vitamin 
K2. J. Biol. Chem. 133:721-723. 
Binkley, N. C., D. C. Krueger, J. A. Engelke, A. L. Foley, and J. W. Suttie. 2000. 
Vitamin K supplementation reduces serum concentrations of under-γ-
carboxylated OC in healthy young and elderly adults. Am. J. Clin. Nutr. 72:1523-
1528. 
Binkley, N. C., D. C. Krueger, T. N. Kawahara, J. A. Engelke, R. J. Chappell, and J. W. 
Suttie. 2002. A high phylloquinone intake is required to achieve maximal OC γ-
carboxylation. Am. J. Clin. Nutr. 76:1055–1060. 
Blanaru, J. L., J. R. Kohut, S. C. Fitzpatrick-Wong, and H. A. Weiler. 2004. Dose 
response of bone mass to dietary arachidonic acid in piglets fed cow milk-based 
formula. Am. J. Clin. Nutr. 79:139-147. 
Bonde, M.K., T. Rousing, J. H. Badsberg, and J. T. Sorensen. 2004. Associations 
between lying-down behavior problems and body condition  limb disorders, and 
skin lesions of lactating sows housed in farrowing crates in commercial sow 
herds. Livest. Prod. Sci. 87:179–187. 
Bonewald, L., and G. R. Mundy. 1990. Role of transforming growth factor beta in bone 
remodeling. Clin. Orthop. Rel. Res. 2:35-40. 
Bonjour, J. P. 2005. Dietary protein: an essential nutrient for bone health. J. Am. Coll. 
Nutr. 24:526–536. 
Booth, S. L., J. A. Sadowski, J. L. Weihrauch, and G. Ferland. 1993. Vitamin K1 
(phylloquinone) content of foods: a provisional table. J. Food Composition Anal. 
6:109-120. 
Booth, S. L., K. W. Davidson, and J. A. Sadowski. 1994. Evaluation of an HPLC method 
 
105 
 
for the determination of phylloquinone (vitamin K1) in various food matrices. J. 
Agri. Food Chem. 42:295-300. 
Booth, S. L., J. A. T. Pennington, and J. A. Sadowski. 1996. Food sources and dietary 
intakes of vitamin K-1 (phylloquinone) in the American diet: data from the FDA 
Total Diet Study. J. Am. Diet. Assoc. 96:149-154. 
Boron, W. F., and E. L. Boulpaep. 2004. Endocrine system chapter. In: Medical 
Physiology: A Cellular And Molecular Approach. Elsevier/Saunders. 
Borutova, R., and K. Pedrosa. 2011. Synergistic effects of mycotoxins discussed. 
Feedstuff  83:1-3. 
Bouillon, R., W. H. Okamura, and A. W. Norman. 1995. Structure-function relationships 
in the vitamin D endocrine system. Endocr. Rev. 16:200-257. 
Bouillon, R., G. Carmeliet, L. Verlinden, E. van Etten, A. Verstuyf, H. F. Luderer, L. 
Lieben, C. Mathieu, and M. Demay. 2008. Vitamin D and human health: lessons 
from vitamin D receptor null mice. Endocr. Rev. 29:726-776. 
Boyle, W. J., W. S. Simonet, and D. L. Lacey. 2003. Osteoclast differentiation and 
activation. Nature. 423:337-342. 
Brase, S., A. Encinas, J. Keck, and C. F. Nising. 2009. Chemistry and biology of 
mycotoxins and related fungal metabolites. Chem. Rev. 109:3903-3990. 
Bronkers, A. L., S. Gay, M. T. Dimuzio, and W. T. Butler. 1985. Immunolocalization of 
γ-carboxyglutamic acid containing proteins in developing rat bones. Collagen 
Relat. Res. 5:273-281. 
Brooks, P.H., D. A. Smith, and V. C. R. Irwin. 1977. Biotin supplementation of diets; 
the incidence of foot lesions and the reproductive performance of sows. Vet. Rec., 
101:46-50. 
Brooks, C. C., R. M. Nalramura, and A. Y. Miyabnra. 1973. Effect of menadione and 
other factors on sugar-induced heart lesions and hemorrhagic syndrome in the pig. 
J. Anim. Sci. 37:1344-1350. 
Brown, E. M., G. Gamba, D. Riccardi, M. Lombardi, R. Butters. O. Klfor, A. Sun, M. A. 
Hedgler, J. Lytton, and S. C. Hebert. 1993. Cloning and characterization of an 
extracellular Ca(2+)-sensing receptor from bovine parathyroid. Nature. 366:575-
580. 
 
106 
 
Brown, R. G., H. U. Aeschbacher, and D. Funk. 1972. Connective tissue metabolism in 
swine IV: growth dependent changes in the composition of long bones in female 
swine. Growth. 36:389-406. 
Brugè, F., T. Bacchetti, F. Principi, G. P. Littarru, and L. Tiano. 2001. Olive oil 
supplemented with menaquinone-7 significantly affects OC carboxylation. Br. J. 
Nutr. 106:1058-1062. 
Bryant, K. L., E. T. Kornegay, J. W. Knight, K. E. Webb, Jr., and D. R. Notter. 1985a. 
Supplemental biotin for swine. I. Influence on feedlot performance, plasma biotin 
and toe lessions in developing gilts. J. Anim. Sci. 60:136-144. 
Bryant, K. L., E. T. Kornegay, J. W. Knight, H. P. Veit, and D. R. Notter. 1985b. 
Supplemental biotin for swine. III. Influence of supplementation to corn and 
wheat based diets on the incidence and severity of toe lesions, hair and skin 
characteristics and structural soundness of sows housed in confinement during 
four parities. J. Anim. Sci. 60:154-162. 
Bucay, N., I. Sarosi, C. R. Dunstan, S. Morony, J. Tarpley, C. Capparelli, S. Scully, H. 
Lin Tan, W. Xu, D. L. Lacey, W. J. Boyle, and W. S. Simonet. 1998. 
Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial 
calcification. Genes Dev. 12:1260-1268. 
Bullerman, L. B., L. L. Schroeder, and K. Y. Park. 1984. Formation and control of 
mycotoxins in food. J. Food Protect. 47:637-646. 
Burr, D. B. 2002. Targeted and nontargeted remodeling. Bone. 30:2-4. 
Burt, V.T., E. Bee, and J. F. Pennock. 1977. The formation of menaquinone-4 (Vitamin 
K) and its oxide in some marine invertebrates. Biochem. J. 162:297-302. 
Calabotta, D. F., E. T. Kornegay, H. R. Thomas, J. W. Knight, D. R. Notter, and H. P. 
Veit. 1982. Restricted energy intake and elevated Ca and P intake for gilts during 
growth. I. Feed lot performance and foot and leg measurements and scores during 
growth. J. Anim. Sci. 54:565-575. 
Calvo, M. S., and Y. K. Park. 1996. Changing P content of the U.S. diet: 
potential for adverse effects on bone. J. Nutr. 126:1168-1180. 
Canfield, L. M., and J. M. Hopkinson. 1989. State of the art vitamin K in Human milk. J 
Pediatr. Gastroenterol. Nutr. 8:430-441. 
 
107 
 
Canfield, L. M., J. M. Hopkinson, A. F. Lima, B. Silva, and C. Garga. 1991. Vitanim K 
in colostrum and mature human milk over the lactation period – A cross-sectional 
study. Am. J. Clin. Nutr. 53:730-735. 
Cao, A., R. Santiago, A. J. Ramos, S. Marin, L. M. Reid, and A. Butron. 2013. 
Environmental factors related to fungal infection and fumonisin accumulation 
during the development and drying of white maize kernels. International  J. Food 
Microbiology. 164:15-22. 
Carney, S. L. 1997. Calcitonin and human renal Ca and electrolyte transport. Miner. 
Electrolyte Metab. 23:43-47. 
Carter, S. D., G. L. Cromwell, T. R. Combs, G. Colombo, and P Fanti. 1996. The 
determination of serum concentrations of OC in growing pigs and its relationship 
to end-measures of bone mineralization. J. Anim. Sci. 74:2719-2729. 
Charles, O. W., and E. J. Day. 1968. The response of vitamin K deficient chicks 
subjected to heat stress. Poul. Sci. 47:1996-1999. 
Christakos, S., P. Dhawan, Y. Liu, X. Peng, and A. Porta. 2003. New insights into the 
mechanisms of vitamin D action. J. Cell Biochem. 88:695-705. 
Clarke, B. 2008. Normal bone anatomy and physiology. Clin. J. Am. Soc. Nephrol. 
3:131-139. 
Coelho, M. B. 1991. Vitamin stability. Feed Management 42:24-35. 
Colvin, B. M., A. J. Cooley, and R. W. Beaver. 1993. Fumonisin toxicosis in swine – 
clinical and pathological findings. J. Vet. Diagn. Invest. 5:232-241. 
Combs, F. C., Jr. 1999. The Vitamnis. Second Ed. Oxford, UK: Academic Press. 
Conly, J., and K. Stein. 1992. The production of menaquinones (vitamin K2) by intestinal 
bacteria and their role in maintaining coagulation homeostasis. Prog. Food Nutr. 
Sci. 16:307-343. 
Conly, J., and K. Stein. 1994. Redustion of vitamin K2 concentrations in human liver 
associated with the use of broad spectrum antimicrobials. Clin. Invest. Med. 
17:531-539. 
Cook, K. K., G. V. Mitchell, E. Grundel, and J. I. Rader. 1999. HPLC analysis for trans 
vitamin K1 and dihydro-vitamin K1 in margarines and margarine-like products 
using C30 stationary phase. Food Chem. 67:79–88. 
 
108 
 
Cornelissen, M., R. von Kries, P. Loughnan, and G. Schubiger. 1997. Prevention of 
vitamin K deficiency bleeding: Efficacy of different multiple oral dose schedules 
of vitamin K. Eur. J. Pediatr. 156:126–130. 
Corrigan, J. J., and F. I. Marcus. 1974. Coagulopathy associated with vitamin E ingestion.  
J. Am. Med. Assoc. 230:1300-1301. 
Corrigan, J. J. Jr. 1982. The effect of vitamin E on warfarin-induced vitamin K 
deficiency. Ann. NY Acad. Sci. 393:361-368. 
Corwin, R. L., T. J. Hartman, S. A. Maczuga, and B. I. Graudbard. 2006. Dietary 
saturated fat intake is inversely associated with bone density in humans: analysis 
of NHANES III. J. Nutr. 136:159-165. 
Costanzo, L. S. 2007. BRS Physiology. Lippincott, Williams, & Wilkins. pp. 263. 
Craciun, A. M., J. Wolf, M. H. Knapen, F. Brouns, and C. Vermeer. 1998. Improved 
bone metabolism in female elite athletes after vitamin K supplementation. Int. J. 
Sports Med. 19:479–484. 
Creppy, E. E., P. Chiarappa, P. Baudrimont, S. Moukha, and M. R. Carratu. 2004. 
Synergistic effects of fumonisin B-1 and ochratoxin A: are in vitro cytotoxicity 
data predictive of in vivo acute toxicity? Toxicology 201:115-123. 
Crenshaw, T. D., E. R. Peo, Jr., A. J. Lewis, and B. D. Moser. 1981. Bone strength as a 
trait for assessing mineralization in swine: a critical review of techniques 
involved. J. Anim. Sci. 53:827-835. 
Crenshaw, T. D. 1986 Reliability of dietary Ca and P levels and bone mineral content as 
predictors of bone mechanical properties at various time periods in growing 
swine. J. Nutr. 116:2155-2170. 
Cromwell, G. L., V. W. Hays, C. W. Scherer, and J. R. Overfield. 1970. Effects of dietary 
P and Ca level on performance, bone mineralization and carcass characteristics of 
swine. J. Anim. Sci. 30:519-525. 
Cromwell, G. L., V. W. Hays, C. W. Scherer, and J. R. Overfield. 1972. Effects of dietary 
Ca and P on performance and carcass, metacarpal and turbinate characteristics of 
swine. J. Anim. Sci. 34:746-751. 
Cromwell , G. L., M. D. Lindemann, and H. J. Monegue. 1997. Effects of phytase in low 
 
109 
 
Ca, low P diets on performance and bone strength of finishing pigs. 75: (Suppl. 1) 
69. 
Cundliff, E., M. Cannon, and J. Davies. 1974. Mechanism of inhibition of eukaryotic 
protein-synthesis by trichothecene fungal toxins. P. Natl. Acad. Sci. USA 71:30-
34. 
D'Mello, J. P. F., C. M. Placinta, and A. M. C. MacDonald. 1999. Fusarium mycotoxins: 
a review of global implications for animal health, welfare and productivity. Anim. 
Feed Sci. Tech. 80:183-205. 
Dagorn, J., and A. Aumaitre. 1978. Sow culling; reasons for and effect on productivity. 
Livestock Prod. Sci. 6:167-177. 
Dam, H. 1929. Cholestrine metabolism in hens and chickens. Biochemische Zeitschrift. 
215:475-492. 
Dam, H., and F. Schonheyder. 1934. A deficiency in chicks resembling scurvy. Biochem. 
J. 28:1355-1359. 
Dänicke, S., T. Goyarts, H. Valenta, E. Razzari, and J. Bohm. 2004a. On the effects of 
deoxynivalenol (DON) in pig feed on growth performance, nutrients utilization 
and DON metabolism. J. Anim. Feed. Sci. 13:539-556. 
Dänicke, S., H. Valenta, F. Klobasa, S. Döll, M. Ganter, G. Flachowsky. 2004b. Effects 
of graded levels of fusarium toxin contaminated wheat in diets for fattening pigs 
on growth performance, nutrient digestibility, deoxynivalenol balance and clinical 
serum characteristics. Arch. Anim. Nutr. 58:1-17. 
Davis, V. L., J. F. Couse, T. K. Gray, and K. S. Korach. 1994. Correlation between low 
levels of estrogen receptors and estrogen responsiveness in two rat osteoblast-like 
cell lines. J. Bone Miner. Res. 9:983-991. 
De Jong, M.F. and Sytsema, J.R., 1983. Field experience with d-biotin supplementation 
to gilt and sow feed. Vet. Q. 5:58-67. 
DeLuca, H. F. 2008. Evolution of our understanding of vitamin D. Nutr. Rev. 66:73-87. 
Dewey, C. E., R. M. Friendship,and M. R. Wilson. 1993. Clinical and postmortem 
examination of sows culled for lameness. Can. Vet. J. 34:555–556. 
 
 
110 
 
Dersjant-Li, Y., M. W. Verstegen, and W. J. Gerrits. 2003. The impact of low 
concentrations of aflatoxin, deoxynivalenol or fumonisin in diets on growing pigs 
and poultry. Nutr. Res. Rev. 16:223-239. 
Diekman, M. A., and M. L. Green. 1992. Mycotoxins and reproduction in domestic 
livestock. J. Anim. Sci. 70:1615-1627. 
Ding, J. W., X. H. Tong, J. Yang, Z. Q. Liu, Y. Zhang, J. Yang, S. Li, and L. Li. 2010. 
Activated protein C protects myocardium via activation of anti-apoptotic 
pathways of survival in ischemia-reperfused rat heart. J. Korean Med. Sci. 
25:1609-1615. 
Dorner, J. W. 2008. Management and prevention of mycotoxins in peanuts. Food. Addit.
 Contam. Part A Chem. Ana. l Control Expo. Risk Assess. 25:203-208. 
Dowd, P., and Z. B. Zheng. 1995. On the mechanism of the anticlotting action of vitamin 
E quinone. Proc. Natl. Acad. Sci. 92:8171-8175. 
Drake, T. A., J. H. Morrissey, and T. S. Edgington. 1989. Selective cellular expression of 
tissue factor in human tissues: implications for disorders of hemostasis and 
thrombosis. Am. J. Pathol. 134:1087–1097. 
Duncan, E. M., C. R. Casey, B. M. Duncan, and J. V. Lloyd.  1984. Effect of 
concentration of trisodium citrate anticoagulant on the calculation of the 
International Normalized Ratio and the International Sensitivity Index of 
thromboplastin. Thromb. Haemost. 72:84-88. 
Eaton, D. L., and E. P. Gallagher. 1994. Mechanisms of aflatoxin carcinogenesis. Annu. 
Rev. Pharmacol. Toxicol. 34:135-172. 
EFSA. 2007. Scientific opinion of the Panel on Animal Health and Welfare on a request 
from the Commission on animal health and welfare aspects of different housing 
and husbandry systems for adult breeding boars, pregnant, farrowing sows, and 
unweaned piglets. The EFSA Journal 572:1–13. 
Erickson, B., M. Fang, J. M. Wallace, B. G. Orr, C. M. Les, and M. M. B. Holl. 2013. 
Nanoscale structure of type I collagen fibrils: Quantitative measurement of D-
spacing. Biotechnol. J. 8:117-126.  
Eriksen, E. F., D. W. Axelrod, and F. Melsen. 1994. Bone Histomorphometry, New 
York, Raven Press. pp. 1–12. 
 
111 
 
Erlandsson, M. C., L. Bian, I. M. Jonsson, K. M. Andersson, and M. I. Bokarewa. 2013. 
Mol. Endo. 27:1311-1321. 
Esmon, C. T. 1989. The roles of protein C and thrombomodulin in the regulation of blood 
coagulation. J. Biol. Chem. 264:4743–4746. 
Esmon, C. T. 2001. Role of coagulation inhibitors in inflammation. Thromb. Haemost. 
86:51–56. 
Esmon, C. T. 2002a. New mechanisms for vascular control of inflammation mediated by 
natural anticoagulant proteins. J. Exp. Med. 196:561–564. 
Esmon, C. T. 2002b. Protein C pathway in sepsis. Ann. Med. 34:598–605. 
Esmon, C. T. 2003. Coagulation and inflammation. J. Endotoxin Res. 9:192–198. 
Etienne, E., and J. Y. Dourmad. 1994 Effects of zearalenone on glucosinolates in the diet 
on reproduction in sows: A review. Live. Prod. Sci. 40:99-113. 
European Commission. 1998. Commission Regulation (EC) No. 1525/98 of 16 July 1998 
amending Regulation (EC) No 194/97 of 31 January 1997 setting maximum 
levels for certain contaminants in foodstuffs. J. European Communities. 201:43-
46. 
FDA. 2001. Guidance for Industry: Fumonisin Levels in Human Foods and Animal 
Feeds; Final Guidance. Available online at http://www.fda.gov/Food/Guida-
nceRegulation/GuidanceDocumentsRegulatoryInformation/ChemicalContaminant
sMetalsNaturalToxinsPesticides/ucm109231.htm. Accessed on September 19, 
2013. 
FDA. 2010. Guidance for Industry and FDA: Advisory Levels for Deoxynivalenol 
(DON) in Finished Wheat Products for Human Consumption and Grains and 
Grain By-Products used for Animal Feed. Available online at 
http://www.fda.gov/downloads/Food/GuidanceRegulat-ion/UCM217558.pdf. 
Accessed on September 19, 2013. 
FDA. 2011. Animal Feed Safety System (AFSS). Available online at 
http://www.fda.gov/AnimalVeterinary/SafetyHealth/AnimalFeedSafetySystemAF
SS/default.htm. Accessed on September 19, 2013. 
Felix, R., M. G. Cecchini, H. Fleisch. 1990.  Macrophage colony stimulating factor 
 
112 
 
restores in vivo bone resorption in the op/op osteopetrotic mouse. Endocrinology. 
127:2592-2594. 
Field, R. A., M. L. Riley, F. C. Mello, M. H. Corbridge, and A. W. Kotula. 1974. Bone 
composition in cattle, pigs, sheep and poultry. J. of Anim. Sci. 39:493–499.  
Fiore, C. E., C. Tamburino, R. Foti, and D. Grimaldi. 1990. Reduced bone mineral 
content in patients taking an oral anticoagulant. South Med. J. 83:538–542. 
Fitzpatrick, D. W., C. A. Picken, L. C. Murphy, and M. M. Buhr. 1989. Measurement of 
the relative binding affinity of zearalenone, alpha-zearalenol and beta-zearalenol 
for uterine and oviduct estrogen receptors in swine, rats and chickens: an indicator 
of estrogenic potencies. Comp. Biochem. Physiol. C. 94:691-694. 
Forgacs, J., H. Koch, and W. T. Carll. 1955. Further mycotoxic studies on poultry 
hemorrhagic disease. Poultry. Sci. 34:1194. 
Forsyth, D. M., T. Yoshizawa, N. Morooka, and J. Tuite. 1977. Emetic and refusal 
activity of deoxynivalenol to swine. Appl. Environ. Microb. 34:547-552. 
Fredeen, H. T., and A. P. Sather. 1978. Joint damage in pigs reared under confinement. 
Can. J. Anim. Sci. 58:759–773. 
Friend, D. W., B. K. Thompson, H. L. Trenholm, H. J. Boermans, K. E. Hartin, and P. L. 
Panich. 1992. Toxicity of T-2 toxin and its interaction with deoxynivalenol when 
fed to young pigs. Can. J. Anim. Sci. 72:703-711. 
Friend, D. W., H. L. Trenholm, B. K. Thompson, P. S. Fiser, and K. E. Hartin. 1986. 
Effect of feeding diets containing deoxynivalenol (vomitoxin)-contaminated 
wheat or corn on the feed consumption, weight-gain, organ weight and sexual 
development of male and female pigs. Can. J. Anim. Sci. 66:765-775. 
Friendship, R. M., M. R. Wilson, G. W. Almond, I. McMillan, R. R. Hacker, R. Pieper, 
and S. S. Swaminathan. 1986. Sow wastage: Reasons for and effect on 
productivity. Can. J. Vet. Res. 50:205-208. 
Fukudome, K., X. Ye, N. Tsuneyoshi, O. Tokunaga, K. Sugawara, H. Mizokami, and M. 
Kimoto. 1998. Activation mechanism of anticoagulant protein C in large blood 
vessels involving the endothelial cell protein C receptor. J. Exp. Med. 187:1029–
1035. 
Fuller, R., L. G. M. Newland. C. A. E. Briggs, R. Braude, and K. G. Mitchell. 1960. The 
 
113 
 
normal intestinal flora of the pig. IV. The effect of dietary supplements of 
penicillin, chlortetracycline or copper sulphate on the fecal flora. J. Appl. Bact. 
23:195-205. 
Garrido, N. S., M. H. Iha, M. R. Santos Ortolani, and R. M. Duarte Favaro. 2003. 
Occurance of aflatoxins M1 and M2 in milk commercialized in Ribeirao Preto-SP, 
Brazil. Food Additives and Contaminants. 20:70-73. 
Gbore. F. A., and G. N. Egbunike 2007.  Influence of dietary fumonisin B1 on nutrient 
utilization by growing pigs. Livestock Research for Rural Development. 19:93. 
Gerstenfeld, L. C., S. D. Chipman, J. Glowacki, and J. B. Lian. 1987. Expression of 
differentiated function by mineralizing cultures of chicken osteoblasts. Dev. Biol. 
122:49-60. 
Gijsbers, B. L. M. G., K. S. G. Jie, and C. Vermeer. 1996. Effect of food composition on 
vitamin K absorption in Human volunteers. Br. J. Nutr. 76:223-229. 
Gjein, H., and R. B. Larssen.1995a.The effect of claw lesions and claw infections on 
lameness in loose housing of pregnant sows. Acta. Vet. Scand. 36:451–459. 
Gjein, H., and R. B. Larssen. 1995b. Housing of pregnant sows in loose and confined 
systems-a field study. 2. Claw lesions: morphology, prevalence, location and 
relation to age. Acta. Vet. Scand. 36:433–442. 
Goyarts, T., and S. Dänicke. 2005. Effects of deoxynivalenol (DON) on growth 
performance, nutrient digestibility and DON metabolism in pigs. Mycotoxin Res. 
21:139-142. 
Graff, I. E., R. Waagbø, C. Vermeer, O. Lie, and A. K. Lundebye. 2002. A multivariate 
study on the effects of dietary vitamin K, vitamin D3 and Ca, and water carbon 
dioxide on growth, bone minerals, vitamin status and health performance in 
smolting Atlantic salmon (Salmo salar L.). J. Fish Dis. 25:599-614. 
Grahl-Madsen, E., and O. Lie. 1997. Effects of different levels of vitamin K in diets for 
cod (Gadus morhua). Aquaculture. 151:269–274. 
Granghi, R. R., and J. H. Strain. 1980. Effect of biotin supplementation on reproductive 
performance and foot lesions in swine. Can. J. Anim. Sci. 60:961-969. 
Grey, S. T., A. Tsuchida, H. Hau, C. L. Orthner, H. H. Salem, and W. W. Hancock. 1994. 
 
114 
 
Selective inhibitory effects of the anticoagulant activated protein C on the 
responses of human mononuclear phagocytes to LPS, IFN-γ, or phorbol ester. J. 
Immunol. 153:3664–3672. 
Gray, S. L., B. R. Lackey, P. L. Tate, M. B. Riley, and N. D. Camper. 2004. Mycotoxins 
in root extracts of American and Asian ginseng bind estrogen receptors alpha and 
beta. Exp. Biol. Med. (Maywood) 229:560-568. 
Greer, E. B., J. M. Leibholz, D. I. Pickering, R. E. Macoun,. And W. L. Bryden. 1991. 
Effect of supplementary biotin on the reproductive performance, body condition 
and foot health of sows on three farms. Aust. Agric. Res. 42:1013-1021. 
Greer, F. R., S. Marshall, J. Cherry, and J. W. Suttie. 1991. Vitamin K status of lactating 
mothers, Human milk and breast-feeding infants. Pediatr., 88:751-756.  
Groenen-van, Dooren, M. M. C. L. 1995. Bio-availability of phylloquinone and 
menaquinones after oral and colorectal administration in vitamin K-deficient rats. 
Biochem. Pharmacol., 50: 797-801. 
Groopman, J. D., and T. W. Kensler. 1999. The light at the end of the tunnel for 
chemical-specific biomarker: daylight or headlight? Carcinogenesis 20:1-11. 
Grove, M. D., G. Y. Shelly, H. T. William, J. E. John, A. W. Ivan, R. K. Narayanarao, 
and R. E. Nichols. 1969. Mycotoxins produced by fusarium tricinctum and 
possibly involved in cattle disease. J. Agr. Food Chem. 18: 734-736. 
Haley, M., X. Cui, P. C. Minneci, K. J. Denas, C. Natanson, and P. Q. Eichacker. 2004. 
Activated protein C in sepsis: emerging insights regarding its mechanism of 
action and clinical effectiveness. Curr. Opin. Infect. Dis. 17:205–211. 
Hall, D. D., G. L. Cromwell and T. S. Stahly. 1991. Effects of dietary Ca, 
P, Ca: P ratio and vitamin K on performance, bone strength and blood clotting 
status of pigs. J. Anim. Sci. 69:646-655. 
Hamilton, C. R., and T. L. Veum. 1984. Response of sows and litters to added dietary 
biotin in environmentally regulated facilities. J. Anim. Sci. 59:151-157. 
Han, Y. K., and P. A. Thacker. 2009. Performance, nutrient digestibility and nutrient 
balance in weaned pigs fed diets supplemented with antibiotics or zinc oxide. J. 
Anim. and Vet. Adv. 8:868-875. 
Harvey, R. B., T. S. Edrington, L. F. Kubena, M. H. Elissalde, and G. E. Rottinghaus. 
 
115 
 
1995. Influence of aflatoxin and fumonisin B1-containing culture material on 
growing barrows. Am. J. Vet. Res. 56:1668-1672. 
Hauschka, P. V., J. B. Lian, D.E.C. Cole, and C. M. Gundberg. 1989. OC and 
matrix Gla protein: Vitamin K-dependent proteins in bone. Physiol. Rev. 69:990-
1047. 
Haussler, M. R., G. K. Whitfield, C. A. Haussler, J. C. Hsieh, P. D. Thompson, S. H. 
Selznick, C. E. Dominguez, and P.W. Jurutka. 1998. The nuclear vitamin D 
receptor: biological and molecular regulatory properties revealed. J. Bone Mineral 
Res. 13:325-349. 
Heaney, R. P., and D. K. Layman. 2008. Amount and type of protein influences bone 
health. Am. J. Clin. Nutr. 87:1567-1570. 
Heaney, R. P., and R. R. Recker. 1982. Effects of nitrogen, P, and caffeine on 
Ca balance in women.  J. Lab. Clin. Med. 99:46-55. 
Heinonen, M., J. Oravainen, T. Orro. L. Seppa-Lassila. E. Ala-Kurikka. J. V. Virolainen, 
A. Tast, and O. A. T. Peltoniemi. 2006. Lameness and fertility of sows and gilts in 
randomly selected loose-housed herds in Finland. Vet. Rec.159:383–387. 
Heinonen, M., O. Peltoniemi, and A. Varlos. 2013. Impact of lameness and claw lesions 
in sows on welfare, health, and production. Live. Sci. 156:2-9. 
Helson, L. 1984. The effect of intravenous vitamin E and menadiol sodium diphosphate 
on vitamin K dependent clotting factors. Thromb. Res. 35:11-18. 
Hill, G. M., G. L. Cromwell, T. D. Crenshaw, C. R. Dove, R. C. Ewan, D. A. Knabe, A. 
J. Lewis, G. W. Libal, D. C. Mahan, G. C. Shurson, L. L. Southern, and T. L. 
Veum. Growth promotion effects and plasma changes from feeding high dietary 
concentrations of zinc and copper to weanling pigs (regional study). J. Anim. Sci. 
78:1010-1016. 
Hirose, K., K. Okajima, Y. Taoka, M. Uchiba, H. Tagami, K.-Y. Nakano, J. Utoh, H. 
Okabe, and N. Kitamura. 2000. Activated protein C reduces the 
ischemia/reperfusion induced spinal cord injury in rats by inhibiting neutrophil 
activation. Ann. Surg. 232:272–280. 
Hock, J. M., M. Centrella, and E. Canalis. 2004. Insulin-like growth factor I (IGF-I) has 
 
116 
 
independent effects on bone matrix formation and cell replication. Endocrinology. 
122:254-260. 
Holick, M. F. 1996. Vitamin D and bone health. J. Nutr. 126:1159-1164. 
Hollander, D. 1973. Vitamin K1 absorption by everted intestinal sacs of the rat. Am. J. 
Physiol. 225:360-364. 
Hollander, D., K. S. Muralidhara, and E. Rim. 1976. Colonic absorption of bacterially 
synthesized vitamin K2 in the rat. Am. J. Physiol. 230:251-255. 
Hollinger, H. Z., and C. J. Pattee. 1956. A review of normal Ca and P 
metabolism. Canad. Med. Assoc. J. 74:912-921. 
Holst, W. F., and E. R. Halbrook. 1931. A “scurvy-like disease in chicks. Science. 354 
-354. 
Horsti, J. 2000. Measurement of prothrombin time in EDTA plasma with combined 
thromboplastin reagent. Clin. Chem. 46:1844-1846. 
Huff, W. E., L. F. Kubena, R. B. Harvey, and J. A. Doerr. 1988. Mycotoxin interactions 
in poultry and swine. J. Anim. Sci. 66:2351-2355. 
Ikegami, A., S. Inoue, T. Hosoi, M. Kaneki, Y. Mizuno, Y. Akedo, Y. Ouchi, and H. 
Orimo. 1994. Cell cycle-dependent expression of estrogen receptor and effect of 
estrogen on proliferation of synchronized human osteoblast-like osteosarcoma 
cells. Endocrinology. 135:782-789. 
Indyk, H. E., and D. C. Wollard. 1997. Vitamin K in milk and infant formulas: 
Determination of phylloquinone and menaquiinone-4. Analyst. 122:465–469. 
Institute of Medicine. 1997. Dietary Reference Intakes for Ca, P, 
Magnesium, Vitamin D, and Fluoride. National Academy Press. Pp.151-152. 
International Committee for Haematology Standardization (ICHS). 1985. International 
Committee on Thrombosis and Haemostastis. ICSH/ICTH recommendations for 
reporting prothrombin time in oral anticoagulant control. Thromb. Haemost. 
53:155-156. 
Itoh, T., M. Tanioka, H. Yoshida, T. Yoshioka, H. Nishimoto, and S. Itohara. 1998.  
Reduced Angiogenesis and Tumor Progression in Gelatinase A-deficient Mice. 
Cancer Research. 58:1048-1051. 
Jackson, C. J., M. Xue, P. Thompson, R. A. Davey, K. Whitmont, S. Smith, N. B. 
 
117 
 
Legendre, T. Sztynda, L. J. Furphy, A. Cooper, P. Sambrook, and L. March. 2005. 
Activated protein C prevents inflammation yet stimulates angiogenesis to promote 
cutaneous wound healing. Wound Repair Regen. 13:284-294. 
Jakob, E. and I. Elmadfa. 1996. Application of a simplified HPLC assay for 
determination of phylloquinone vitamin K1 in animal and plant food items. Food 
Chem. 56:87–91. 
Jiang, S. Z., Z. B. Yang, W. R. Yang, B. Q. Yao, H. Zhao, F. X. Liu, C. C. Chen, and F. 
Chi. 2010. Effects of feeding purified zearalenone contaminated diets with or 
without clay enterosorbent on growth, nutrient availability, and genital organs in 
post-weaning female pigs. Asian-Aust. J. Anim. Sci. 23:74-81. 
Jiang, S. Z., Z. B. Yang, W. R. Yang, S. J. Wang, F. X. Liu, L. A. Johnston, F. Chi, and 
Y. Wang. 2012. Effect of purified zearalenone with or without modified 
montmorillonite on nutrient availability, genital organs and serum hormones in 
post-weaning piglets. Livestock Sci. 144:110-118. 
Jolly, D. W., C. Craig, and T. E. Nelson Jr. 1977. Estrogen and prothrombin synthesis: 
effect of estrogen on absorption of vitamin K. Am. J. Physiol. 232:12-17. 
Joyce, D. E., L. Gelbert, A. Ciaccia, B. DeHoff, and B. W. Grinnell. 2001. Gene 
expression profile of antithrombotic protein C defines new mechanisms 
modulating inflammation and apoptosis. J. Biol. Chem. 276:11199–11203. 
Karlen, G. A. M., P. H. Hemsworth, H. W. Gonyou, E. Fabrega, A. Davidstrom, and R. J. 
Smits. 2007. The welfare of gestating sows in conventional stalls and large groups 
on deep litter. Appl. Anim. Behav. Sci. 105:87–101. 
Karlovsky, P. 1999. Biological detoxification of fungal toxins and its use in plant 
breeding, feed, and food protection. Nat. Toxins. 7:1-23. 
Kassem, M., R. Okazaki, S. A. Harris, T. C. Spelsberg, C. A. Conover, and B. L. Riggs. 
1998. Estrogen effects on insulin-like growth factor gene expression in a human 
osteoblastic cell line with high levels of estrogen receptor. Calcif. Tissue Int. 
62:60-66. 
Kato, S. 2000. The function of vitamin D receptor in vitamin D action. J. Biochem. 
127:717-722. 
 
118 
 
Kensler, T. W., B. D. Roebuck, G. N. Wogan, and J. D. Groopman. 2011. Aflatoxin: a 
50-year odyssey of mechanistic and translational toxicology. Toxicol. Sci. 120: 
S28-S48. 
Kilbride, A. L., C. E. Gillman, and L. E. Green. 2010. A cross-sectional study of 
prevalence and risk factors for foot lesions and abnormal posture in lactating sows 
on commercial farms in England. Anim. Welfare. 19:473–480. 
Kilbride, A. L., C. E. Gillman, and L.E. Green. 2009. A cross-sectional study of the 
prevalence of lamenesss in finishing pigs, gilts, and pregnant sows and 
associations with limb lesions and floor types on commercial farms in England. 
Anim. Welfare. 18:215–224. 
Kimura, S., H. Satoh, and M. Komai. 1992. The roles of intestinal flora and intestinal 
function on vitamin K metabolism. J. Nutr. Sci. Vitaminol. 38:425-428. 
Kindberg, C. G. and J. W. Suttie. 1989. Effect of various intakes of phylloquinone on 
signs of vitamin K deficiency and serum liver phylloquinone concentrations in the 
rat. J. Nutr. 119:175-180. 
Kindberg, C., J. W. Suttie, K. Uchida, K. Hirauchi, and H. Nakao. 1987. Menaquinone 
production and utilization in germ-free rats after inoculation with specific 
organisms. J. Nutr. 117:1032-1035. 
Kitazawa, R., K. Mori, A. Yamaguchi, T. Kondo, and S. Kitazawa. 2008. Modulation of 
mouse RANKL gene expression by Runx2 and vitamin D3. J. Cell Biochem. 
105:1289-1297. 
Knapen, M. H., L. J. Schurgers, and C. Vermeer. 2007. Vitamin K2 supplementation 
improves hip bone geometry and bone strength indices in postmenopausal 
women. Osteoporos. Int. 18:963–972. 
Knauer, M., K. J. Stalder, L. Karriker, T. J. Baas, C. Johnson, T. Serenius, L. Layman, 
and J. D. McKean. 2007. A descriptive e-survey of lesions from cull sows 
harvested at two Midwestern U.S. facilities. Prev. Vet. Med. 82:198–212. 
Kong, Y. Y., U. Feige, I. Sarosi, B. Bolon, A. Tafuri, S. Morony, C. Capparelli, J. Li, R. 
Elliott, S. McCabe, T. Wong, G. Campagnuolo, E. Moran, E. R. Bogoch, G. Van, 
L. T. Nguyen, P. S. Ohashi, D. L. Lacey, E. Fish, W. J. Boyle, and J. M. 
 
119 
 
Penninger. 1999. Activated T cells activate bone loss and joint destruction in 
adjuvant arthritis through osteoprotegrin ligand. Nature. 402:304-309. 
Kornegay, E. T. 1986. Biotin in swine production: A review. Live. Prod. Sci. 14:65-89. 
Kornegay, E. T., and H. R. Thomas,1981. P in swine. II. Influence of dietary 
Ca and P levels and growth rate on serum minerals, soundness scores and bone 
development in barrows, gilts and boars. J. Anim. Sci. 52:1049-1059. 
Kornegay, E. T., P. H. G. van Heugten, M. D. Lindemann, and D. J. Blodgett. 1989. 
Effects of biotin and high copper levels on performance and immune response of 
weanling pigs. J. Anim. Sci. 67:1471-1477. 
Koshihara, Y., K. Hoshi, H. Ishibashi, and M. Shiraki. 1996. Vitamin K2 promotes 
1,25(OH)2 vitamin D3-induced mineralization in human periosteal osteoblasts. 
Calcif. Tissue Int. 59:466 473. 
Kovacs, M. Z., F. Vetesi, F. Kovacs, A. Bata, I. Repa, and P. Horn. 2000. Investigations 
on the tolerable limit values and the perinatal toxic effect of mycotoxins produced 
by Fusarium moniliforme. Magy. Allatorvosok. 122:168-175. 
Kroneman, A., L. Vellenga, W. D. Van, and H. M. Vermeer. 1993. Field research on 
veterinary problems in group-housed sows - a survey of lameness. J. Vet. Med. 
40:704–712. 
Krum, S. A. 2011. Direct transcriptional targets of sex steroid hormones in bone. J. Cell. 
Biochem. 112:401-408. 
Kuiper, G. G., B. Carlsson, K. Grandien, E. Enmark, J. Haggblad, S. Nilsson, and J. A. 
Gustafsson. 1997. Comparison of the ligand binding specificity and transcript 
tissue distribution of estrogen receptors alpha and beta. Endocrinology. 138:863-
870. 
Kuiper, G. G., E. Enmark, M. Pelto-Huikko, S. Nilsson, and J. A. Gustafsson. 1996. 
Cloning of a novel receptor expressed in rat prostate and ovary. Proc. Natl. Acad. 
Sci. 93:5925-5930. 
Laszik, Z., A. Mitro, F. B. Taylor, Jr., G. Ferrell, and C. T. Esmon. 1997. Human protein 
C receptor is present primarily on endothelium of large blood vessels: 
implications for the control of the protein C pathway. Circulation. 96:3633–3640. 
Lay, A. J., Z. Liang, E. D. Rosen, and F. J. Castellino. 2005. Mice with a severe 
 
120 
 
deficiency in protein C display prothrombotic and proinflammatory phenotypes 
and compromised maternal reproductive capabilities. J. Clin. Inves. 115:1552-
1561. 
Lauren, D. R., A. Ashley, B. A. Blackwell, R. Greenhalgh, J. D. Miller, G. A. Neish. 
1987. Trichothecenes produced by fusarium-crookwellense daom 193611. J. Agr. 
Food Chem. 35:884-889. 
Legros, R., N. Balmain, and G. Bonel. 1987. Age-related changes in mineral of rat and 
bovine cortical bone. Calcified Tissue International. 41:137-144.  
Leslie, J. F., R. D. Plattner, A. E. Desjardins, and C. J. R. Klittich. 1992. Fumonisin B1 
production by strains from different mating populations of gibberella-fujikuroi 
(fusarium section liseola). Phytopathology. 82:341-345. 
Li, J., X. Yan, H. Hsu, J .Juan, Y. Sun, H. Tan, I. Solovyev, X. Xia, F. Fletcher, D.  L. 
Lacey, and W. J. Boyle. 2000. Structural features of the RANK intracellular 
domain required for osteoclastogenesis and bone density regulation. J. Bone Min. 
Res. 15:173-174. 
Li, X., P. E. Schwartz, and E. F. Rissman. 1997. Distribution of estrogen receptor-beta 
like immunoreactivity in rat forebrain. Neuroendocrinology. 66:63-67. 
Li, Y. C., A. E. Pirro, M. Amling, G. Delling, R. Baron, R. Bronson, and M. B. Demay. 
1997. Targeted ablation of the vitamin D receptor: an animal model of vitamin D 
dependent rickets type II with alopecia. Proc. Natl. Acad. Sci. USA. 94:9831-
9835. 
Li, Y. C., M. Amling, A. E. Pirro, M. Priemel, J. Meuse, R. Baron, G. Delling, and M. B. 
Demay. 1998. Normalization of mineral ion homeostasis by dietary means 
prevents hyperparathyroidism, rickets, and osteomalacia, but not alopecia in 
vitamin D receptor-ablated mice. Endocrinology. 139:4391-4396. 
Lian, J. B., M. C. Couttes, and E. Canalis. 1985. Studies of hormonal regulation of 
OC synthesis in cultured fetal rat calvariae. J. Biol. Chem. 260:8706-8710. 
Lian, J. B., and C. M. Gundberg. 1988. OC: Biochemical considerations and 
clinical applications. Clin. Orthop. Relat. Res. 226:267-291. 
Lippold, C. C., S. C. Stothers, A. A. Frohlich, R. J. Boila, and R. R. Marquardt. 1992. 
 
121 
 
Effects of periodic feeding of diets containing ochratoxin A on the performance 
and clinical chemistry of pigs from 15 to 50 kg body weight. Can. J. Anim. Sci. 
72:135-146. 
Lipsky, J. J. 1994. Nutritional sources of vitamin K. Mayo Clin. Proc. 69:462-466. 
Liu, B. H., F. Y. Yu, M. H. Chan, and Y. L. Yang. 2002. The effects of mycotoxins, 
fumonisin B1 and aflatoxin B1, on primary swine alveolar macrophages. Toxicol. 
Appl. Pharm. 180:197-204. 
Liu, D., H. P. Veit, and D. M. Denbow. 2004. Effects of long-term dietary lipids on 
mature bone mineral content, collagen, crosslinks, and prostaglandin E2 
production in Japanese quail. Poultry Sci. 83:1876-1883. 
Locklin, R. M., R. O. Oreffo, and J. T. Triffitt. 1999.  Effects of TGF beta and bFGF on 
the differentiation of human bone marrow stromal fibroblasts. Cell Biol. Int. 
23:185-194. 
Long, G. G., and M. A. Diekman. 1984. Effect of purified zearalenone on early gestation 
in gilts. J. Anim. Sci. 59:1662-1670. 
Lutz, J. 1984. Ca balance and acid-base status of women as affected by increased 
protein intake and by sodium bicarbonate ingestion. Am. J. Clin. Nutr. 39:281-
288. 
Malagutti, L., M. Zannotti, A. Scampini, and F. Sciaraffia. 2005. Effects of Ochratoxin A 
on heavy pig production. Anim. Res. 54:179-184. 
Malekinejad, H., R Maas-Bakker, and J. Fink-Gremmels. 2006. Species differences in the 
hepatic biotransformation of zearalenone. Vet.  J. 172:96-102. 
Mann, K. G., M. E. Nesheim, W. R. Church, P. Haley, and S. Krishnaswamy. 1990. 
Surface dependent reactions of the vitamin K-dependent enzyme complexes. 
Blood. 76:1–16. 
Marasas, W. F. O. 2001. Discovery and occurrence of the fumonisins: a historical 
perspective. Environ. Health. Persp. 109:239-243. 
Marasas, W. F. O., R. Riley, K. Hendricks, V. Stevens, T. Sadler, J. Gelineau-van Waes, 
S. Missmer, J. Cabrera, O. Torres, W. Gelderblom, J. Alleqood, C. Martinez, J. 
Maddox, J. Miller, L. Starr, M. Sullards, A. Roman, K. Voss, E. Wang, and A. 
Merrill Jr. 2004. Fumonisins disrupt sphingolipid metabolism, folate transport, 
 
122 
 
and neural tube development in embryo culture and in vivo: A potential risk 
factor for human neural tube defects among populations consuming fumonisin-
contaminated maize. J. Nutr. 134:711-716. 
Marin, P., A. deOry, A. Cruz, N. Magan, and M. T. Gonzalez-Jaen. 2013. Potential 
effects of environmental conditions on the efficiency of the antifungal 
tebuconazole controlling Fusarium verticillioides and Fusarium proliferatum 
growth rate and fumonisin biosynthesis. International J. Food Microbiology. 
165:251-258. 
Masuyama, R., Y. Nakaya, S. Katsumata, Y. Kajita, M. Uehara, S. Tanaka, A. Sakai, S. 
Kato, T. Nakamura, and K. Suzuki. 2003. Dietary Ca and P ratio regulates bone 
mineralization and turnover in vitamin D receptor knockout mice by affecting 
intestinal Ca and P absorption. J. Bone Miner. Res. 18:1217-1226. 
Matschiner, J. T. and G. R. Bell. 1973. Effect of sex and sex hormones on plasma 
prothrombin and vitamin K deficiency. Proc. Soc. Exp. Biol. Med. 144:316-320. 
Matsumoto, T., M. Ito, Y. Hayashi, T. Hirota, Y. Tanigawara, T. Sone, M. Fukunaga, M. 
Shiraki, and T. Nakamura. 2011. A new active vitamin D3 analog, eldecalcitol, 
prevents the risk of osteoporotic fractures: a randomized, active comparator, 
double-blind study. Bone. 49:605-612. 
Matta, V. C. and B. C. Johnson. 1960. Effect of feeding vitamin K deficient diets to 
female rats. J. Nutr. 72:455-458. 
Maxson, P. F., and Mahan. 1983. Dietary Ca and P levels for growing 
swine from 18 to 57 kilograms body weight. J. Anim. Sci. 56:1124-1134. 
Mellen, I. M. 1952. The Natural History of the Pig.Exposition Press, New York. 
Mellette, S. J. and L. A. Leone. 1960. Influence of age, sex, strain of rat and fat soluble 
vitamins on hemorrhagic syndromes in rats fed irradiated beef. Fed. Proc. 
19:1045-1049. 
Mensink, C. G., J. P. Koeman, J. Veling, and E. Gruys.1990. Haemorrhagic claw lesions 
in new born piglets due to selenium toxicosis during pregnancy. Vet. Rec. 
126:620-622. 
Merrill, A. H., M. C. Sullards, E. Wang, K. A. Voss, and R. T. Riley. 2001. Sphingolipid 
 
123 
 
metabolism: roles in signal transduction and disruption by fumonisins. 
Environmental Health Perspectives. 109:283-289. 
McCormick, S. P., A. M. Stanley, N. A. Stover, and N. J. Alexander. 2011. 
Trichothecenes: from simple to complex mycotoxins. Toxins (Basel) 3:802-814. 
McDowell, L. R. 2000. Vitamins in Animal and Human Nutrition. 2nd ed. Ames: Iowa 
State Press. 
McLachlan, J. A. 1993. Functional toxicology: a new approach to detect biologically 
active xenobiotics. Environ. Health. Perspect. 101:386-387. 
Mejía, L., A. Chapa, M. Vazquez, I. Torres, and R. Guevara. 2011. Aflatoxins 
biochemistry and molecular biology - biotechnological approaches for control in 
crops. In: Aflatoxins - Detection, Measurement and Control. I. Torres-Pacheco ed. 
Mexico. Pp. 317-354. 
Mentaverri, R., S. Yano, N. Chattopadhyay, L. Petit, O. Kifor, S. Kamel, E. F. 
Terwilliger, M. Brazier, and E. M. Brown. 2006. The Ca sensing receptor is 
directly involved in both osteoclast differentiation and apoptosis. FASEB J 
20:2562-2564. 
Merrill, A. H., M. C. Sullards, E. Wang, K. A. Voss, and R. T. Riley. 2001. Sphingolipid 
metabolism: roles in signal transduction and disruption by fumonisins. Environ. 
Health Persp. 109:283-289. 
Meulen, J. V. D., S. J. Koopmans, R. A. Dekker, and A. Hoogendoorn. 2010. Increasing 
weaning age of piglets from 4 to7 weeks reduces stress, increases post-weaning 
feed intake but does not improve intestinal functionality. Animal. 4:1653-1661. 
McKee, R. W., S. B. Binkley, S. A. Thayer, D. W. MacCorquodale, and E. A. Doisy. 
1939. The isolation of vitamin K2. J. Biol. Chem. 131:327-344. 
McLamb, B. L., A. J. Gibson, E. L. Overman, C. Stahl, and A. J. Moeser. 2013. Early 
weaning stress in pigs impairs innate mucosal immune responses to 
enterotoxigenic E. coli challenge and exacerbates intestinal injury and clinical 
disease. Plos One. 8:1-12. 
Miller, D. M., B. P. Stuart, and W. A. Crowell. 1981. Experimental aflatoxicosis in 
swine: Morphological and clinical pathological results. Can. J. Comp. Med. 
45:343–351. 
 
124 
 
Miller, D. M., W. A. Crowell, and B. P. Stuart. 1982. Acute aflatoxicoses in swine: 
Clinical pathology, histopathology, and electron microscopy. Am. J. Vet. Res. 
43:273–277. 
Mizunoa, A., N. Amizukab, K. Irieb, A. Murakamia, N. Fujisea, T. Kannoa, Y. Satoa, N. 
Nakagawaa, H. Yasudaa, S. Mochizukia, T. Gomibuchia, K. Yanoa, N. Shimaa, 
N. Washidaa, E. Tsudaa, T. Morinagaa, K. Higashioa, and H. Ozawab. 1998. 
Severe osteoporosis in mice lacking osteoclastogenesis inhibitory 
factor/osteoprotegerin. Biochem. Biophys. Res. Comm. 247:610-615. 
Mohamed E. Z. 2011. Impact of mycotoxins on humans and animals. J. Saudi Chem. 
Soc. 15:129-144. 
Monegue, H. J., C. E. Combs, G. T. Edds, and H. D. Wallace (Eds.). 1977. The Effects of 
Various Levels of Aflatoxins on Young Swine. Florida Agriculture Experiment 
Station Report AL-1977-5. 
Monegue, J. S. 2013. All structures and pictures. JPEG file. 
Money, D. F. L., and G. L. Laughton. 1981. Biotin-responsive lameness in New Zealand 
pigs. N.Z. Vet. J. 28:33-34. 
Morishima, A., M. M. Grumbach, E. R. Simpson, C. Fisher, and K. Qin. 1995. 
Aromatase deficiency in male and female siblings caused by a novel mutation and 
the physiological role of estrogens. J. Clin. Endocrinol. Metab. 80:3689-3698. 
Mosselman, S., J. Polman, and R. Dijkema. 1996. ER beta: identification and 
characterization of a novel human estrogen receptor. FEBS Lett. 392:49-53. 
Motelin, G. K., W. M. Haschek, D. K. Ness, W. F. Hall, K. S. Harlin, D. J. Schaeffer, and 
V. R. Beasley. 1994. Temporal and dose-response features in swine fed corn 
screenings contaminated with fumonisin mycotoxins. Mycopathologia 126:27-40. 
Murakami, K., K. Okajima, M. Uchiba, M. Johno, T. Nakagaki, H. Okabe, and K. 
Takatsuki. 1997. Activated protein C prevents LPS-induced pulmonary vascular 
injury by inhibiting cytokine production. Am. J. Physiol. 272:197-202. 
Musculoskeletal system. In: Gray’s Anatomy, 39th Ed., edited by Standring S, New 
York, Elsevier, 2004, pp. 83–135. 
Nakagawa, K., Y. Hirota, N. Sawada, N. Yuge, M. Watanabe, Y. Uchino, N. Okuda, 
 
125 
 
Y. Shimomura, Y. Suhara, and T. Okano. 2010. Identification of UBIAD1 as a 
novel human menaquinone-4 biosynthetic enzyme. Nature. 468:117-121. 
National Academy of Sciences. 2001. Dietary Reference Intakes for Vitamin A, Vitamin 
K, Arsenic, Boron, Chromium, Copper, Iodine, Iron, Manganese, Molybdenum, 
Nickel, Silicon, Vanadium, and Zinc. Institute of Medicine, Food and Nutrition 
Board. Available online at http://fnic.nal.usda.g-ov/dietary-guidance/dietary-
reference-intakes/dri-reports. Accessed on October 1,2013. 
Nelson, P. E., A. E. Desjardins, and R. D. Plattner. 1993. Fumonisins, mycotoxins 
produced by fusarium species - biology, chemistry, and significance. Annu. Rev. 
Phytopathol. 31:233-252. 
Nicholson, G.C., J. M. Moseley, P. M. Sexton, F. A. Mendelsohn, and T. J. Martin. 1986. 
Abundant calcitonin receptors in isolated rat osteoclasts. Biochemical and 
autoradiographic characterization. J. Clin. Invest. 78:355-360. 
Nicolaes, G. A. F., and B. Dahlbäck. 2002. Factor V and thrombotic disease: description 
of a janus-faced protein. Arterioscler. Thromb. Vasc. Biol. 22:530–538. 
Nguyen, M., J. Arkell, and C. J. Jackson. 2000. Activated protein C directly activates 
human endothelial gelatinase A. J. Biological Chemistry. 275:9095-9098. 
NRC. 1994. Nutrient Requirements of Poultry (9th Ed.). Natl. Acad. Press, Washington, 
DC. 
NRC. 1998. Nutrient Requirements of Swine (10th Ed.). Natl. Acad. Press, Washington, 
DC. 
NRC. 2007. Nutrient Requirements of Horses (6th Ed.). Natl. Acad. Press, Washington, 
DC. 
NRC. 2012. Nutrient Requirements of Swine (11th Ed.). Natl. Acad. Press, Washington, 
DC. 
Oliver, W. T., J.R. Miles, D.E. Diaz, J.J. Dibner, G.E. Rottinghaus, and R.J. Harrell. 
2012. Zearalenone enhances reproductive tract development, but does not alter 
skeletal muscle signaling in prepubertal gilts. Anim. Feed Sci. Tech. 174:79-85. 
Osuna, O. and G. T. Edds. 1982. Toxicology of aflatoxin B1, warfarin, and cadmium in 
young pigs; Clinical chemistry and blood coagulation. Am. J. Vet. Res. 43:1387-
1394. 
 
126 
 
Osweiler, G. D., D. C. Pankratz, K. W. Prasse, H. M. Stahr, and W. B. Buck. 1970. 
Porcine hemorrhagic disease. Med. Vet. Pract. 51:35-37. 
Pace, P., J. Taylor, S. Suntharalingam, R. C. Coombes, and S. Ali. 1997. Human estrogen 
receptor beta binds DNA in a manner similar to and dimerizes with estrogen 
receptor alpha. J. Biol. Chem. 272:25832-25838. 
Parfitt, A. M. 1994. Osteonal and hemiosteonal remodeling: The spatial and temporal 
framework for signal traffic in adult bone. J. Cell Biochem. 55:273-276. 
Parfitt, A. M. 2002. Targeted and nontargeted bone remodeling: Relationship to basic 
multicellular unit origination and progression. Bone 30: 5–7. 
Passmore, R., and M. A. Eastwood. 1986. Davidson and Passmore Human Nutrition and 
Dietetics, 8th edition, Edinburgh, Churchill Livingsone. 
Pérez, V. G., A. M. Waguespack, T. D. Bidner, L. L. Southern, T. M. Fakler, T. L. Ward, 
M. Steidinger, and J. E. Pettigrew. 2011. Additivity of effects from dietary copper 
and zinc on growth performance and fecal microbiota of pigs after weaning. J 
Anim. Sci. 89:414-425. 
Penny, R. H. C., R. D. A. Cameron, S. Johnson, P. J. Kenyon, H. A. Smith, A. W. P. 
Bell, J. P. L. Cole, and J. Taylor. 1980. Foot rot of pigs: the influence of biotin 
supplementation on foot lesions in sows. Vet. Rec. 107:350-351. 
Perrin, W. R., and J. B. Bowland. 1977. Effects of enforced exercise on incidence of leg 
weakness in growing boars. Can. J. Anim. Sci. 57:245–253. 
Peterlik, M., S. Boonen, H. S. Cross, and C. Lamberg-Allardt. 2009. Vitamin D and 
Ca insufficiency related chronic diseases: An emerging world-wide public health 
problem. Int. J. Environ. Res. Public Health. 6:2585-2607. 
Peterson, C. A., J. A. C. Eurell, and J. W. Erdman Jr. 1995. Alterations in Ca intake 
on peak bone mass in the female rat. J. Bone Miner. Res. 10:81-95. 
Pettersson, K., K. Grandien, G. G. Kuiper, and J. A. Gustafsson. 1997. Mouse estrogen 
receptor beta forms estrogen response element-binding heterodimers with 
estrogen receptor alpha. Mol. Endocrinol. 11:1486-1496. 
Piironen, V., and T. Koivu. 2000. Quality of vitamin K analysis and food composition 
data in Finland. Food Chem. 68:223–226. 
Piironen, V., T. Koivu, O. Tammisalo, and P. Mattila. 1997. Determination of 
 
127 
 
phylloquinone in oils, margarines, and butter by high-performance liquid 
chromatography with electrochemical detection. Food Chem. 59:473–480. 
Pike, J. W. 2011. Genome-wide principles of gene regulation by the vitamin D receptor 
and its activating ligand. Mol. Cell Endocr. 347:3–10. 
Pittet, A. 1998, Natural occurrence of mycotoxins in foods and feeds - an updated review. 
Rev. Vet. Med. 149:479–492. 
Pickle, J., and A. Gould. 2011. Analyzing Digital Images (Version 2.0). Available online 
at http://www.lawrencehallofscience.org/gss/rev/ip/index.html. 
Plattner, R. D., and D. D. Shackelford. 1992. Biosynthesis of labeled fumonisins in liquid 
cultures of fusarium-moniliforme. Mycopathologia 117:17-22. 
Plotkin, L.I., J. I. Aguirre, S. Kousteni, S.C. Manolagas, and T. Bellido. 2005. 
Bisphosphonates and estrogens inhibit osteocyte apoptosis via distinct molecular 
mechanisms downstream of extracellular signal-regulated kinase activation. J. 
Biol. Chem. 280:7317-7325. 
Pluym, L., A. VanNuffel, and D. Maes. 2013. Treatment and prevention of lameness with 
special emphasis on claw disorders in group-housed sows. Live. Sci. 156:36-43. 
Pluym, L., A. VanNuffel, J. Dewulf, A. Cools, F. Vangroenweghe, S. Vanhoorebeke, and 
D. Maes. 2011. Prevalence and risk factors of claw lesions and lameness in 
pregnant sows for two types of group housing. Vet. Med. Czech. 56:101–109. 
Pollmann, D. S., B. A. Koch, L. M. Seitz, H. E. Mohr, and G. A. Kennedy. 1985. 
Deoxynivalenol-contaminated wheat in swine diets. J. Anim. Sci. 60:239-247. 
Pork Industry Handbook. 2007. History of the pig and the U.S. pork industry. Coop. Ext. 
Service, Purdue University, West Lafayette, IN, PIH-15-05-01. 
Potts, J., and H. Jüppner. 2008. Chapter 353: Disorders of the Parathyroid Gland and 
Ca Homeostasis. In: Harrison's Principles of Internal Medicine (18 ed.). McGraw-
Hill. 
Prelusky, D. B., R. G. Gerdes, K. L. Underhill, B. A. Rotter, P. Y. Jui, and H. L. 
Trenholm. 1994. Effects of low-level dietary deoxynivalenol on haematological 
and clinical parameters of the pig. Natural Toxins 2:97-104. 
Prelusky, D. B., J. D. Miller, and H. L. Trenholm. 1996. Disposition of C-14-derived 
 
128 
 
residues in tissues of pigs fed radiolabelled fumonisin B1. Food Addit. Contam. 
13:155-162. 
Price, P. A., M. K. Williamson, and J. W. Lothringer. 1981. Origin of the vitamin K 
dependent bone protein found in plasma and its clearance by kidney and bone. J. 
Biol. Chem. 256:12760-12766. 
Price, P. A., and S. K. Nishimoto. 1980. Radioimmunoassay for the vitamin K-dependent 
protein of bone and discovery in plasma. Proc. Natl. Acad. Sci. USA 77:2234-
2238. 
Quick, A. J., M. Stanley-Brown, and F. W. Bancroft. 1935. A study of the coagulation 
defect in hemophilia and in jaundice. Am. J. Med. Sci. 190:501-511. 
Rainey, M. R., R. C. Tubbs, L. W. Bennett, and N. M. Cox. 1990. Prepubertal exposure 
to dietary zearalenone alters hypothalamo-hypophysial function but does not 
impair postpubertal reproductive function of gilts. J. Anim. Sci. 68:2015-2022. 
Raymond, S. L., T. K. Smith, and H. V. L. N. Swamy. 2005. Effects of feeding a blend of 
grains naturally contaminated with fusarium mycotoxins on feed intake, 
metabolism, and indices of athletic performance of exercised horses. J. Anim. Sci. 
83: 1267-1273. 
Revankar, C. M., D. F. Cimino, L. A. Sklar, J. B. Arterburn, E. R. Prossnitz. 2005. A 
transmembrane intracellular estrogen receptor mediates rapid cell signaling. 
Science. 307:1625–1630. 
Richy, F., E. Schacht, O. Bruyere, O. Ethgen, M. Gourlay, and J. Y. Reginster. 2005. 
Vitamin D analogs versus native vitamin D in preventing bone loss and 
osteoporosis-related fractures: a comparative meta-analysis. Calcif. Tissue Int. 
76:176-186. 
Riley, R. T., E. Wang, J. J. Schroeder, E. R. Smith, R. D. Plattner, H. Abbas, H. S. Yoo, 
and A. H. Merril Jr. 1996. Evidence for disruption of sphingolipid metabolism as 
a contributing factor in the toxicity and carcinogenicity of fumonisins. Nat. 
Toxins 4:3-15. 
Riley, R.T., and J. Petska. 2005. Mycotoxins: metabolism, mechanisms and biochemical 
markers. In: The Mycotoxin Blue Book. D.E. Diaz (Ed.). Nottingham University 
Press, UK, pp. 279–294. 
 
129 
 
Ringot, D., A. Chango, Y. J. Schneider, and Y. Larondelle. 2006. Toxicokinetics and 
toxicodynamics of ochratoxin A, an update.  Chemico-Biological Interactions.  
159:18-46. 
Robinson, J. A., S. A. Harris, B. L. Riggs, T. C. Spelsberg. 1997. Estrogen regulation of 
human osteoblastic cell proliferation and differentiation. Endocrinology. 
138:2919-2927. 
Rodrigues, A. M., J. Caetano-Lopes, A. C. Vale, B. Vidal, A. Lopes, I. Aleixo, J. Polido 
Pereira, A. Sepriano, I. P. Perpétuo, J. Monteiro, M. F. Vaz, J. E. Fonseca, and H. 
Canhão. 2012. Low OC/collagen type I bone gene expression ratio is associated 
with hip fragility fractures.  Bone 51:981-989. 
Rodriguez-rodriguez, E., B. N. Lomban, A. M, Lopez-sobaler, and R. M. O. Anta. 2010. 
Review for future perspectives on recommended Ca intake. Nutr. Hosp. 25:366-
374. 
Ronden, J. E., H. H. W. Thijssen, and C. Vermeer. 1998. Tissue distribution of K 
vitaminers under different nutritional regimens in the rat. Biochim. Biophys. Acta. 
1379:16–22. 
Rossi, F., M. Morlacchini, G. Fusconi, A. Pietri, and G. Piva. 2011. Effect of insertion of 
Bt gene in corn and different fumonisin content on growth performance of 
weaned piglets. Italian J. Anim. Sci. 10:95-100. 
Rotter, B. A., B. K. Thompson, and M. Lessard. 1995. Effects of deoxynivalenol-
contaminated diet on performance and blood parameters in growing swine. Can. J. 
Anim. Sci. 75:297-302.  
Rotter, B. A., D. B. Prelusky, A. Fortin, J. D’ Miller, and M. E. Savard. 1997. Impact of 
pure fumonisin B1 on various metabolic parameters and carcass quality of 
growing-finishing swine - Preliminary findings. Can. J. Anim. Sci. 77:465-470. 
Rotter, B. A., D. B. Prelusky, and J. J. Pestka. 1996a. Toxicology of deoxynivalenol 
(vomitoxin). J. Toxicol. Environ. Health 48:1-34. 
Rotter, B. A., B. K. Thompson, D. B. Prelusky, H. L. Trenholm, B. Stewart, J. D’Miller, 
and M. Savard. 1996b. Response of growing swine to dietary exposure to pure 
fumonisin B1 during an eight-week period: growth and clinical parameters. Nat. 
Toxins 4:42-50. 
 
130 
 
Sack, W. O. 1982. Essentials of Pig Anatomy – Horowitz/Kramer Atlas of 
Musculoskeletal Anatomy of the pig. Veterinary Textbooks, Ithaca, N.Y. 
Samson, R. A., and E. S. V. Reenen-Hoekstra. 1988. Introduction to food-borne fungi. 3th 
ed. Centraalbureau voor Schimmelcultures, Institute of the Royal Netherlands 
Academy of Arts and Sciences, Baarn, Delft, p. 299. 
Sato, Y., Y. Honda, H. Kunoh, and K. Oizumi. 1997. Long-term oral anticoagulation 
reduces bone mass in patients with previous hemispheric infarction and 
nonrheumatic atrial fibrillation. Stroke 28:2390–2394. 
Sato, T., Y. Ohtani, Y. Yamada, S. Saitoh, and H. Harada. 2002. Difference in the 
metabolism of vitamin K between liver and bone in vitamin K-deficient rats. Br. 
J. Nutr. 87:307–314. 
Sato, T., R. Kawahara, S. Kamo, and S. Saito. 2007. Comparison of menaquinone-4 and 
menaquinone-7 in rats. Vitamins. 81:377–381. 
Sato, T., L. J. Schurgers, and K. Uenishi. 2012. Comparison of menaquinone-4 and 
menaquinone-7 bioavailability in healthy women. Nutr. J. 11:93-98. 
Saunders, P. T., S. M. Maguire, J. Gaughan, and M. R. Millar. 1997. Expression of 
oestrogen receptor beta (ER beta) in multiple rat tissues visualised by 
immunohistochemistry. J. Endocrinol. 154:13-16. 
Schendel, H. E., and B. C. Johnson. 1962. Vitamin K deficiency in the baby pig. J. Nutr. 
76:124-130. 
Schenk, E., J. Merchant-Forde, and D. Lay. 2010. Sow lameness and longevity. USDA 
ARS-MWA Livestock Behavior Research Unit, Purdue University, West 
Lafayette, IN. 
Schurgers, L. J., and C. Vermeer. 2000. Determination of phylloquinone and 
menaquinones in food. Haemostasis. 30:298-307. 
Schurgers, L.J., and C. Vermeer. 2002. Differential lipoprotein transport pathways of K 
vitamins in healthy subjects. Biochim. Biophys. Acta. 1570:27–32. 
Schurgers, L. J., K. J. Teunissen, K. Hamulyák, M. H. Knapen, H. Vik, and C. Vermeer. 
2007. Vitamin K containing dietary supplements: comparison of synthetic vitamin 
K1 and natto-derived menaquinone-7. Blood. 109:3279-3283. 
Scudamore, K. A., 1994, The genus Aspergillus: from taxonomy and genetics to 
 
131 
 
industrial application. In: Aspergillus Toxins in Food and Animal Feedingstuffs, 
edited by K. A. Powell, A. Renwick and J. F. Peberdy (New York: Plenum), pp. 
59–71. 
Seerley, R. W., O. W. Charles, H. C. McCampbell, and S. P. Bertsch. 1976. Efficacy of 
menadione dimethylpyrimidinol bisulfite as a source of vitamin K in swine diets. 
J. Anim. Sci. 42:599-607. 
Shapiro, R., and R. P. Heaney. 2003. Co-dependence of Ca and P for 
growth and bone development under conditions of varying deficiency. Bone. 
32:532-540. 
Shaw, A. W. 1930. A method of determining the variations in the vertebral column of the 
live pig. Sci. Agric. 10:690-696. 
Shearer, M. J., A. McBurney, and P. Barkhan. 1974. Studies on the absorption and 
metabolism of phylloquinone (vitamin K1) in man. Vit. Horm. 32:513-542. 
Shearer, M. J., P. Barkhan, and G. R. Webster. 1970. Absorption and excretion of an oral 
dose of tritiated vitamin K1 in man. Br. J. Haematol. 18:297-308. 
Shearer, M. J. 1988. The assessment of Human vitamin K status from tissue 
measurements. In: Current advances in vitamin K research. J. W. Suttie, ed. pp. 
437-452. New York: Elsevier. 
Shearer, M. J. 1992. Vitamin K metabolism and nutriture. Blood Revs. 6:92-104. 
Shearer, M. J. 1995. Fat-soluble vitamins: vitamin K. Lancet, 345:229-234. 
Shearer, M. J., A. Bach, and M. Kohlmeier. 1996. Chemistry, nutritional sources, tissue 
distribution and metabolism of vitamin K with special reference to bone health. J. 
Nutr. 126:1181-1186. 
Shiraki, M., Y. Shiraki, C. Aoki, and M. Miura. 2000. Vitamin K2 (menatetrenone) 
effectively prevents fractures and sustains lumbar bone mineral density in 
osteoporosis. J. Bone Miner. Res. 15:515–521. 
Siciliano, P. D., L. K. Warren, and L. M. Lawrence. 2000. Changes in vitamin K status of 
growing horses. J. Equine Vet. Sci. 20:726–729. 
Silva, A. M. S., M. Weidenborner, and J. A. S. Cavaleiro. 1998. Growth control of 
different fusarium species by selected flavones and flavonoid mixtures. Myco. 
Res. 102:638-640. 
 
132 
 
Silver, I. A., R. J. Murrills, and D. J. Etherington.1988. Microelectrode studies on the 
acid microenvironment beneath adherent macrophages and osteoclasts. Exp. Cell 
Res. 175:266-276. 
Simon, R. R., S. M. Beaudin, M. Johnston, K. J. Walton, and S. G. Shaughnessy. 2002. 
Long-term treatment with sodium warfarin results in decreased femoral bone 
strength and cancellous bone volume in rats. Thromb. Res. 105:353–358. 
Simonet, W. S., D. L. Lacey, C. R. Dunstan, M. Kelley, M. S. Chang, R. Lüthy, H. Q. 
Nguyen, S. Wooden, L. Bennett, T. Boone, G. Shimamoto, M. DeRose, R. Elliott, 
A. Colombero, H. L. Tan, G. Trail, J. Sullivan, E. Davy, N. Bucay, L. Renshaw-
Gegg, T. M. Hughes, D. Hill, W. Pattison, P. Campbell, S. Sander, G. Van, J. 
Tarpley, P. Derby, R. Lee, and W. J. Boyle. 1997. Osteoprotegerin: a novel 
secreted protein involved in the regulation of bone density. Cell. 89: 309-319. 
Simonian, S. X., and A. E. Herbison. 1997. Differential expression of estrogen receptor 
alpha and beta immunoreactivity by oxytocin neurons of rat paraventricular 
nucleus. J. Neuroendocrinol. 9:803-806. 
Slevin, J., J. Wiseman, M. Parry, and R. M. Walker. 2001. Effect of protein nutrition on 
bone strength and incidence of osteochondrosis in gilts. In: Proceedings of the 
British Society of Animal Sciences, York, p.11. 
Slootweg, M.C., A. G. Ederveen, L. P. Schot, W. G. Schoonen, and H. J. Kloosterboer. 
1992. Oestrogen and progestogen synergistically stimulate human and rat 
osteoblast proliferation. J. Endocrinol. 133:5-8. 
Smith, E.P., J. Boyd, G. R. Frank, H. Takahashi, R. M. Cohen, B. Specker, T. C. 
Williams, D. B. Lubahn, and K. S. Korach. 1994. Estrogen resistance caused by a 
mutation in the estrogen-receptor gene in a man. New Engl. J. Med. 331:1056-
1061. 
Smith, J. E., 1997. Aflatoxins.  In: Handbook of Plant and Fungal Toxicants. D’Mello, 
J.P.F. (Ed.). CRC Press, Boca Raton, FL, pp. 269-285. 
Smith, T. K. 1980. Influence of dietary fiber, protein and zeolite on zearalenone toxicosis 
in rats and swine. J. Anim. Sci. 50:278-285. 
Speijers, G. J. A., and M. H. M. Speijers. 2004. Combined toxic effects of mycotoxins. 
Toxicol. Lett. 153:91-98. 
 
133 
 
Stafford, D. W. 2005. The vitamin K cycle. J. Throm. Haemo. 3:1873-1878. 
Stearns-Kurosawa, D. J., S. Kurosawa, J. S. Mollica, G. L. Ferrell, and C. T. Esmon. 
1996. The endothelial cell protein C receptor augments protein C activation by the 
thrombin-thrombomodulin complex. Proc. Natl. Acad. Sci. USA. 93:10212–
10216. 
Stoev, S. D., M. Paskalev, S. MacDonald, and P. G. Mantle. 2002. Experimental one year 
ochratoxin A toxicosis in pigs. Experimental and Toxicologic Pathology. 53:481-
487. 
Suda, T., N. Takahashi, N. Udagawa, E. Jimi, M. T. Gillespie, and T. J. Martin. 1999.  
Modulation of osteoclast differentiation and function by the new members of the 
tumor necrosis factor receptor and ligand families. Endocr. Rev. 20:345-357. 
Suttie, J. W. 1992. Vitamin K and Human nutrition. J. Am. Diet. Assoc., 92:585-590. 
Suttie, J. W. 1995. The importance of menaquinones in Human nutrition. Ann. Rev. Nutr. 
15: 399-417. 
Szczech, G. M., W. W. Carlton, J. Tuite, and R. Caldwell. 1973. Ochratoxin A toxicosis 
in swine. Vet. Path. 10:347-364. 
Szulc, P., M. C. Chapuy, P. J. Meunier, and P. D. Delmas. 1993. Serum 
undercarboxylated OC is a marker of the risk of hip fracture in elderly women. J. 
Clin. Invest. 91:1769–1774. 
Szulc, P., M. C. Chapuy, P. J. Meunier, and P. D. Delmas. 1996. Serum 
undercarboxylated OC is a marker of the risk of hip fracture: a three year follow-
up study. Bone 18:487–488. 
Takayanagi, H., S. Kim, T. Koga, H. Nishina, M. Isshiki, H. Yoshida, A. Saiura, M. 
Isobe, T. Yokochi, J. Inoue, E. F. Wagner, T. W. Mak, T. Kodama, and T. 
Taniguchi. 2002. Induction and activation of the transcription factor NFATc1 
(NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. 
Dev. Cell. 3:889-901. 
Takeuchi, Y., M. Suzawa, S. Fukumoto, and T. Fujita. 2000. Vitamin K2 inhibits 
adipogenesis, osteoclastogenesis, and ODF/ RANK ligand expression in murine 
bone marrow cell cultures. Bone 27:769–776. 
Takeuchi, A., Y. Masuda, M. Kimura, R. Marushima, R. Matsuoka, M. Hasegawa, M. 
 
134 
 
Takahama, and M. Onuki. 2005. Minimal effective dose of vitamin K2 
(menaquinone-4) on serum OC concentration in Japanese subjects and safety 
evaluation of vitamin K2 supplemented in Ca tablet. J. Jpn. Soc. Clin. Nutr. 
26:254-260. 
Tan, B., and K. Mai. 2001. Effects of dietary vitamin K on survival, growth, and tissue 
concentrations of phylloquinone (PK) and menaquinone-4 (MK-4) for juvenile 
abalone, Haliotis discus hannai Ino. J. Exp. Marine Biol. Ecol. 256:229-239. 
Tanaka, S., N. Takahashi, N. Udagawa, T. Tamura, T. Akatsu, E. R. Stanley, T. 
Kurokawa, and T. Suda. 1993. Macrophage colony-stimulating factor is 
indispensable for both proliferation and differentiation of osteoclast progenitors. 
J. Clin. Invest. 91:257-263. 
Taylor, F. B., Jr., A. Chang, C. T. Esmon, A. D’Angelo, S. Vigano-D’Angelo, and K. E. 
Blick. 1987. Protein C prevents the coagulopathic and lethal effects of E. coli 
infusion in the baboon. J. Clin. Invest. 79:918–925. 
Thijssen, H. H. W., M. J. Drittij, and M. A. Fischer. 1996. Phylloquinone and 
menaquinone-4 distribution in rats: synthesis rather than uptake determines 
menaquinone-4 organ concentrations. J. Nutr. 126:537–543. 
Thijssen, H. H. W., M. J. Drittij, C. Vermeer, and E. Schoffelen. 2002. Menaquinone-4 in 
breast milk is derived from dietary phylloquinone. Br. J. Nutr. 87:219–226. 
Thijssen, H. H., L. M. Vervoort, L. J. Schurgers, and M. J. Shearer. 2006. Menadione is a 
metabolite of oral vitamin K. Br. J. Nutr. 95:260-266. 
Tilyard, M. W., G. F. Spears, J. Thomson, and S. Dovey. 1992. Treatment of 
postmenopausal osteoporosis with calcitriol or Ca. New Engl. J. Med. 326:357-
362. 
Trenholm, H. L., B. K. Thompson, B. C. Foster, L. L. Charmley, K. E. Hartin, R. W. 
Coppock, and M. A. Albassam. 1994. Effects of feeding diets containing fusarium 
(naturally) contaminated wheat or pure deoxynivalenol (DON) in growing pigs. 
Can. J. Anim. Sci. 74:361-369. 
Tremble, G. B., A. Tremble, N. G. Copeland, D. J. Gilbert, N. A. Jenkins, F. Labrie, and 
V. Giguere. 1997. Cloning, chromosomal localization, and functional analysis of 
the murine estrogen receptor beta. Mol. Endocrinol. 11:353-365. 
 
135 
 
Trenholm, H. L., R. M. G. Hamilton, D. W. Friend, B. K. Thompson, and K. E. Hartin. 
1984. Feeding trials with vomitoxin (deoxynivalenol)-contaminated wheat effects 
on swine, poultry, and dairy-cattle. J. Am. Vet. Med. Assoc. 185:527-531. 
Ueno, Y. 1984. Toxicological features of T-2 toxin and related trichothecenes. Fund. 
Appl. Toxicol. 4:124-132. 
Usui, Y. 1990. Vitamin K concentrations in the plasma and liver of surgical patients. Am. 
J. Clin. Nutr. 51:846-52. 
van Summeren, M. J., L. A. Braam, M. R. Lilien, L. J. Schurgers, W. Kuis, and C. 
Vermeer. 2009. The effect of menaquinone-7 (vitamin K2) supplementation on 
OC carboxylation in healthy prepubertal children. Br. J. Nutr. 102:1171-1178. 
Vergnaud, P., P. Garnero, P. J. Meunier, G. Breart, K. Kamihagi, P. D. Delmas. 1997. 
Undercarboxylated OC measured with a specific immunoassay predicts hip 
fracture in elderly women: the EPIDOS Study. J. Clin. Endocrinol. Metab. 
82:719–724. 
Vermeer, C., K. S. G. Jie, and M. H. J. Knapen. 1995. Role of vitamin K in bone 
metabolism. Annu. Rev. Nutr. 15:1-22. 
Vermeer, C., M. J. Shearer, A. Zittermann, C. Bolton-Smith, P. Szulc, S. Hodges, P. 
Walter, W. Rambeck, E. Stocklin, and P. Weber. 2004. Beyond deficiency: 
potential benefits of increased vitamin K for bone and vascular health. Eur. J. 
Nutr. 43:325-335. 
Vesonder, R. F., and C. W. Hesseltine. 1981. Vomitoxin - natural occurrence on cereal-
grains and significance as a refusal and emetic factor to swine. Process. Biochem. 
16: 12-15. 
von Kries, R., M. Shearer, P. T. McCarthy, M. Haug, G. Harzer, and U. Göbel. 1987. 
Vitamin K1 content of maternal milk: influence of the stage of lactation, lipid 
composition, and vitamin K1 supplements given to the mother. Pediatr. Res. 
22:513-517. 
Walbeek, W. V., P. M. Scott, J. Harwig, and J. W. Lawrence. 1969. Penicillium 
viridicatum Westling: a new source of ochratoxin A. Can. J. Microbiol. 15:1281-
1285. 
Walters, M. R. 1992. Newly identified actions of the vitamin D endocrine system. 
 
136 
 
Endocr. Rev. 13:719-764. 
Wang, E., W. P. Norred, C. W. Bacon, R. T. Riley, and A. H. Merrill. 1991. Inhibition of 
sphingolipid biosynthesis by fumonisins - implications for diseases associated 
with fusarium-moniliforme. J. Biol. Chem. 266:14486-14490. 
Watkins, K. L., L. L. Southern, and J. E. Miller. 1991. Effect of dietary biotin 
supplementation on sow reproductive performance and soundness and pig growth 
and mortality. J. Anim. Sci. 69:201-206. 
 
Weary, D. M., J. Jasper, and M. J. Hotzel. 2008. Understanding weaning distress. Appl. 
Anim. Behaviour Sci. 110:24–41. 
Will, B. H., and J. W. Suttie. 1992. Comparative metabolism of phylloquinone and 
menaquinone-9 in rat liver. J. Nutr. 122:953-958. 
Windahl, S. H., G. Andersson, J. A. Gustafsson. 2002. Elucidation of estrogen receptor 
function in bone with the use of mouse models. Trends Endocrinol. Metab. 
13:195–200. 
White, B., M. Schmidt, C. Murphy, W. Livingstone, D. O’Toole, M. Lawler, L. O’Neill, 
D. Kelleher, H. P. Schwarz, and O. P. Smith. 2000. Activated protein C inhibits 
lipopolysaccharide- induced nuclear translocation of nuclear factor κB (NF- κB) 
and tumour necrosis factor α (TNF- α) production in the THP-1 monocytic cell 
line. Br. J. Haematol. 110:130–134. 
Wu, Q. H., V. Dohnal, K. Kuca, and Z. H. Yuan. 2013. Trichothecenes: structure-toxic 
activity relationships. Current Drug Metabolism. 14:641-660. 
Xiao H., S. Madhyastha, R. Marquardt, S. Li, J. K. Vodela, A. A. Frohlich, and B. W. 
Kemppainen. 1996. Toxicity of ochratoxin A, its opened lactone form and several 
of its analogs: structure-activity relationships. Toxicol. Appl. Pharm. 137:182-
192. 
Xue, M., P. Thompson, I. Kelso, and C. Jackson. 2004. Activated protein C stimulates 
proliferation, migration and wound closure, inhibits apoptosis and upregulates 
MMP-2 activity in cultured human keratinocytes. Exp. Cell Res. 299:119–127. 
Xue, M., D. Campbell, and C. J. Jackson. 2007. Protein C Is an Autocrine Growth Factor 
for Human Skin Keratinocytes. J. Bio. Chem. 282:13610–13616. 
 
137 
 
Yasuda, H., N. Shima, N. Nakagawa, S. I. Mochizuki, K. Yano, N. Fujise, Y. Sato, M. 
Goto, K. Yamaguchi, M. Kuriyama, T. Kanno, A. Murakami, E. Tsuda, T. 
Morinaga, and K. Higashio. 1998. Identity of osteoclastogenesis inhibitory factor 
(OCIF) and osteoprotegerin (OPG): a mechanism by which OPG/OCIF inhibits 
osteoclastogenesis in vitro. Endocrinology. 139: 1329-1337. 
Yiannikouris, A., and J. P. Jouany. 2002. Mycotoxins in feeds and their fate in animals: a 
review. Anim. Res. 51:81-99. 
Yoshizawa, T., Y. Handa, Y. Uematsu, S. Takeda, K. Sekine, Y. Yoshihara, T. 
Kawakami, K. Arioka, H. Sato, Y. Uchiyama, S. Masushige, A. Fukamizu, T. 
Matsumoto, and S. Kato. 1997. Mice lacking the vitamin D receptor exhibit 
impaired bone formation, uterine hypoplasia and growth retardation after 
weaning. Nat. Genet. 16:391-396. 
Young, L. G., and G. J. King. 1986. Low concentrations of zearalenone in diets of boars 
for a prolonged period of time. J. Anim. Sci. 63:1197-1200. 
Young, L. G., H. Ping, and G. J. King. 1990. Effects of feeding zearalenone to sows on 
rebreeding and pregnancy. J. Anim. Sci. 68:15-20. 
Young, L. G., L. McGirr, V. E. Valli, J. H. Lumsden, and A. Lun. 1983. Vomitoxin in 
corn fed to young-pigs. J. Anim. Sci. 57:655-664. 
Young, L. G., R. F. Vesonder, H. S. Funnell, I Simons, and B. Wilcock. 1981. Moldy 
corn in diets of swine. J. Anim. Sci. 52:1312-1318. 
Zain, M. E. 2011. Impact of mycotoxins on humans and animals. J. Saudi Chem. Soc. 15: 
129-144. 
Zielonka, L., G. Gorlo, K. Obremski, M. Gajecka, A. Jakimiuk, and M. Gajekil. 2009. 
Histopathology of selected organs of the reproductive tract of pigs supplied with 
feed containing zearalenone destroyer. B. Vet. I. Pulawy. 53:411-414. 
Zinedine, A., J. M. Soriano, J. C. Molto, and J. Manes. 2007. Review on the toxicity, 
occurrence, metabolism, detoxification, regulations and intake of zearalenone: An 
oestrogenic mycotoxin. Food Chem. Toxicol. 45:1-18. 
 
 
 
 
138 
 
Vita 
 James Seth Monegue was born in Lexington, KY to Jim and Sharon 
Monegue. Seth graduated from Dunbar High School in Lexington in 2003. Seth attended 
the University of Kentucky in Lexington, KY in the fall of 2003. He earned his 
bachelor’s degree in Animal Sciences in 2007 and his M.S. in swine nutrition in 2009, 
both from UK.  
 Growing up as the son of a swine farm manager, Seth’s interest and 
fascination for pigs started at a young age. This led to the pursuit of the aforementioned 
degrees in animal nutrition. Seth began his PhD research at the University of Kentucky in 
January of 2010.  
 
